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A bstract
This thesis describes the development of physiological and pharmacological models 
for the  control of anaesthesia. These models form the basis of techniques intended 
to  support the  autom atic control of anaesthesia. Each technique has been 
im plem ented and has perform ed successfully in the operating theatre.
In more detail, the thesis describes the development and use of an estim ation 
scheme, based upon a pharmacological model, to  estim ate a p a tien t’s cardiac 
ou tpu t and tissue anaesthetic tensions during anaesthesia. The scheme employs a 
physiologically-based model of inhaled anaesthetic pharm acokinetics. The thesis 
describes the representation of physiologically-based pharm acokinetic models, the 
param eterisation of a physiologically-based model of isoflurane pharm acokinetics, 
a scheme to m atch such a model to individuals, and the  sim ulated and actual 
perform ance of the estim ation scheme.
A physiological model forms the basis of a scheme developed to diagnose 
inappropriate physiological and pharmacological conditions in the pa tien t’s state  
during anaesthesia. This scheme is based upon a model of homeostasis and 
the  stress response. The thesis describes the development of this model, the 
perform ance of a prototype im plem entation, its developm ent to allow the diagnosis 
of inappropriate conditions and its diagnostic perform ance both using stored data  
and in the  operating theatre.
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C hapter 1
Introduction
SUMMARY
This chapter summarises the application o f automatic control in 
anaesthesia and describes the structure o f this thesis. Consideration 
o f automatic control activity includes both the control o f depth o f 
anaesthesia and the control o f purely physiologic quantities such as 
blood pressure. Three themes are drawn from  current approaches to the 
control o f depth o f anaesthesia and these are assessed. The approaches 
adopted and contributions made by work described in this thesis are 
introduced and the structure o f the thesis is outlined.
1.1 A naesthesia
Anaesthesia is the “absence of sensation” but in a clinical context, involves both 
the absence of sensation for the patient and the existence of suitable operating 
conditions for the surgeon. The anaesthetist is responsible for the provision 
of anaesthesia and the m aintenance of the p a tien t’s physiological state. This 
process can involve the adm inistration of both inhaled and intravenous anaesthetic
1
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drugs, injected analgesic drugs *, neuromuscular blockers (to produce reversible 
muscle paralysis during surgery) and others according to  the surgical requirements. 
The nature  of surgery also dictates th a t the anaesthetist manages blood loss 
using blood or fluid replacement and, where muscle relaxation is involved, the 
anaesthetist also manages the ventilation of the patient.
Patien ts of wide-ranging age, health and fitness undergo surgery. The 
anaesthetist relies upon education, training and experience in order to provide 
suitable anaesthetic conditions for each patient.
1.1.1 T he M aintenance o f A n aesth esia
W hile surgery is in progress, the anaesthetist aims to  m aintain anaesthesia 
and m anage any physiological problems of the patien t which may arise. In 
qualitative term s, the anaesthetist performs tasks which are analogous to feedback 
control: The suitability of the anaesthetic and the p a tien t’s physiologic condition 
are assessed, and drugs, fluids and gases are adm inistered according to  the 
requirem ents perceived by the anaesthetist. This analogy has encouraged the 
application of control engineering to anaesthesia. Control Engineering has been 
accom panied by other related approaches, in particular, those which have grown 
out of artificial intelligence.
1.2 Control Engineering in A naesthesia
To the  control engineer, superficially at least, anaesthesia is a rich and extensive 
area of application: The anaesthetist routinely makes m any m easurem ents, some 
quantita tive  and autom atically recorded, some qualitative and relying upon 
observation. Based upon interpretation of those m easurem ents, the anaesthetist 
decides upon drug delivery, fluid delivery and sometimes ventilation requirements. 
1 analgesic drugs alter the perception of pain
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In collaboration with the anaesthetist, schemes which deliver drugs according to 
the value of one m easurem ent, or the combination of several m easurem ents can 
be envisaged.
Control systems have been developed for the au tom atic  control of drug delivery 
in m any areas of medicine. Some of these specifically allow the  anaesthetist to  
provide and m aintain conditions appropriate for surgery, and others aim to  control 
the ‘depth  of anaesthesia’ of the patient. Systems for the autom atic  control of drug 
adm inistration have been reviewed by Linkens and Hacisalihzade [1], Summers 
[2], Packer [3], Carson [4] and Linkens [5]. The autom atic  control of anaesthesia 
has been reviewed by Chilcoat [6]. These reviews include applications which are 
not directly related to anaesthesia and should be consulted for such information. 
W ithin the confines of anaesthesia, the following are relevant
1. The control of muscle relaxation.
2. T he control of arterial blood pressure.
3. The control of depth of anaesthesia.
1.3 A utom atic Control R elated  to  A naesthesia
1.3.1 A u tom atic  Control o f M uscle R elaxation
General anaesthetic agents produce a reduction in the  resting tone of skeletal 
muscle in a dose-related manner. A reduction in skeletal muscle tone makes 
it easier for the  surgeon to m anipulate organs and structures which lie beneath 
skeletal muscle. W hile it is possible to produce sufficient reduction in muscle 
tone w ith anaesthetic agents, the doses required are in excess of those which 
are reasonable. Neuromuscular blocking drugs are therefore adm inistered so as 
to provide a practically useful level of muscle relaxation. The anaesthetist is 
responsible for the adm inistration of the neurom uscular blocking drugs.
Chapter 1. Introduction  4
In controlling the adm inistration of muscle relaxants, the anaesthetist may 
choose to  deliver a continuous infusion of the drug bu t more commonly adm in­
isters repeated boluses of it. The extent of muscle relaxation can be assessed 
using a Relaxograph [7]. This m easurement allows the dynamics between drug 
adm inistration and the relaxant effect to be modelled and supports control design 
using a model. Workers have observed and described a wide range of individual 
responses to  muscle relaxant drug adm inistration and the response to  a repeated 
dose may change even within the duration of an anaesthetic. Fixed controllers 
have been developed to perform PI and PID control [8] [9] with reasonable perfor­
mance. A daptive controllers have included self-tuning pole placem ent and Smith 
predictor structures [10] and self-tuning PID [7]. The controller described by 
Jaklitsch and Westenkow [11] operates in two phases. One controller achieves the 
initial establishm ent of muscle relaxation at the desired level and another is an 
adaptive controller which regulates the m uscle-relaxation afterwards. Recently, 
approaches have included the application of fuzzy logic [12] to  the control of mus­
cle relaxation, and some effort has been made to integrate the m easurem ent of 
muscle relaxation, the adm inistration of muscle relaxation and the control of the 
adm inistration in one device [13].
1.3.2 A u tom atic  Control o f B lood  P ressure
The control of arterial blood pressure is desirable during some surgical procedures 
and following others. In some operations carried out on the ear, nose or throat, 
blood pressure is deliberately reduced so as to  cut down or elim inate bleeding 
around the operation site [14]. Similar procedures are necessary during eye surgery 
and often in intensive care units after m ajor surgery.
In simple term s, blood pressure results from the flow of blood through the 
resistance presented by blood vessels. If the flow increases, due to  an increase in 
the ra te  at which the heart pumps blood (the cardiac ou tpu t) but the resistance
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of the blood vessels (the peripheral vascular resistance) remains constant, then 
the  blood pressure will increase. Similarly, if flow, rem aips copstaijt,. a  .reduction 
in the resistance of the blood vessels will cause a reduction in blood pressure.
These mechanisms, although simplified for clarity, offer two distinct routes 
to the regulation of blood pressure: the m anipulation of cardiac o u tpu t and 
peripheral resistance. Practically, however, it is not appropriate to  reduce blood 
flow in order to  reduce cardiac output because this compromises nutrient delivery 
to, and waste product removal, from tissues.
The autom atic control of blood pressure has been reviewed by Linkens and 
Hacisalihzade [1], Linkens [5], Carson [4] and Packer [3]. Schemes for control 
of blood pressure have relied upon drugs which cause vasodilation2 and affect 
the  heart. The most extensively used vasodilator in the control development 
perform ed has been sodium nitroprusside.
A u tom atic  Control of B lood  Pressure using Sodium  N itroprusside
Sodium nitroprusside acts on blood vessels causing vasodilatation. The infusion 
of sodium nitroprusside therefore allows control of blood pressure. Early work 
using sodium nitroprusside, described by Sheppard [15], used a table of gain 
values to param eterise a PID controller. The model described by Slate et al. 
[16] was used in an adaptive scheme as described by Slate and Sheppard [17]. 
Many adaptive approaches have been pursued including self-tuning m inim um - 
variance control [18], model reference adaptive control [19] and an extension 
of a m inim um  variance controller called the Control Advance Moving Average 
Controller (CAMAC) [20]. M artin et al. [21] describe a m ultiple-m odel adaptive 
controller for sodium nitroprusside infusion which employs S late’s model. More 
recent work by Behbehani and Cross [22] has employed an integrating self-tuning 
control strategy. M artin et al. [23] [24] have focussed on m aintaining control
2 vasodilation is the widening of blood vessels
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perform ance in the regulation of blood pressure bu t preventing th e  controller from 
responding to physiologic or pharmacologic disturbances or m easurem ent artifacts. 
This scheme involves the development of a supervisor to prevent unnecessary 
controller action. The TITR A TO R  system is a commercially available device, 
developed by the IVAC Corporation and described by Voss [25]. TITR A TO R  
infuses sodium  nitroprusside so as to control blood pressure. Voss suggested th a t 
early results of product evaluation indicated th a t the autom atic  controller not only 
produced b e tte r control during the period of control bu t also th a t the pa tien t’s 
requirem ent for blood products and for emergency surgery were reduced as was 
the  overall tim e spent in the recovery areas. This may im ply th a t autom atic 
control can improve patient outcome in those areas [25].
A u tom atic  Control of B lood Pressure using Isoflurane
Isoflurane is an inhaled anaesthetic and is routinely used in general anaesthesia. 
Isoflurane has many desirable properties in term s of its effects upon the organ 
system s of the body [26]. Isoflurane appears to cause very little  change in cardiac 
ou tpu t over a range of concentrations [27] but causes a dose-dependent decrease 
in peripheral vascular resistance. This enables isoflurane to  be used in the control 
of blood pressure.
This approach has been adopted by M illard et al. [14] and Monk et al. 
[28]. These workers used a self-tuning controller to m aintain a model of the 
p a tien t’s response to isoflurane and to m aintain control perform ance. The authors 
identify the need for supervisory software to ensure th a t the self-tuner can operate 
properly w ithout user interaction.
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1.4 A utom atic Control o f A naesthesia
A naesthesia can be produced by a combination of drugs. Inhaled anaesthetics can 
be delivered to the patient in the inspired gas stream  and injected anaesthetics can 
be delivered by infusion. The delivery of insufficient anaesthetic may result in the 
patien t responding to surgical stim ulation. The delivery of excessive anaesthetic 
m ay result in unwanted effects upon the respiration and circulation of the patient 
and will prolong the pa tien t’s recovery from surgery. The concept of ‘depth of 
anaesthesia’ is used by anaesthetists to describe the suitability  of the  anaesthetic 
s ta te  of the  patient. A ‘light’ anaesthetic is inadequate and is likely to be 
accompanied by characteristic changes in cardiovascular and respiratory variables 
and specific clinical signs. A ‘deep’ anaesthetic is excessive and and is also likely 
to be accompanied by characteristic changes in cardiovascular and respiratory 
variables and other clinical signs. Unfortunately, there is no single m easurem ent, 
or com bination of m easurem ents which can be used to indicate ‘dep th ’ for all 
patients and all drug combinations. The depth of anaesthesia cannot be measured 
directly and is perceived by the anaesthetist.
In the  absence of a m easurem ent of depth of anaesthesia, it is not possible to 
model the  relationship between drug inputs and the resulting depth. This process 
is further hindered by the inability to measure or otherwise quantify the extent 
of surgical stim ulation. In the absence of either a model or a m easurem ent, a 
controller which directly m anipulates depth of anaesthesia cannot be developed. 
Despite this, the depth of anaesthesia has been controlled autom atically using 
indirect means. The indirect m ethods developed can be grouped as shown in 
Figure 1.1.
The motivations for these approaches and work of relevance are summarised 
as follows:
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Control of Depth of Anaesthesia
Control of a 
Pharmacological Quantity
Control of a 
Related Variable
Control of 
Inferred Depth
Figure 1.1: Sum m ary of Approaches to  the Control of Anaesthesia
1.4.1 T he Control o f D ep th  of A n aesth esia  using a Phar­
m acological Q uantity
G eneral anaesthetic agents act in the central nervous system  (spinal column and 
brain). The effect of the anaesthetic is related to its concentration in these 
tissues although the precise relationship is not known [27] [29]. The concentration 
in the central nervous system is related to the dose of the drug administered 
and its adm inistration timecourse. Pharmacology describes the relationships 
between drug dose and effect. W ithin pharmacology, pharm acokinetics describe 
the  relationship between the drug dose and the drug concentration at the site of 
action; pharm acodynam ics describes the relationship between the concentration 
at the sites of effect and the effects produced. Although pharm acodynam ic 
relationships for general anaesthetics are not adequately understood, general 
anaesthetic pharmacokinetics are reasonably well described.
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General anaesthetic pharmacokinetics have formed the basis of several con­
trollers for anaesthesia. These are all ‘open-loop’ controllers in th a t they aim 
to produce a drug concentration in the central nervous system  bu t because this 
cannot be m easured, no feedback can be applied.
C ontrol of Propofol A naesthesia
Propofol is an intravenous anaesthetic agent which has advantageous pharm a­
cokinetic properties allowing rapid induction of anaesthesia and rapid recovery 
afterwards. A scheme for the m anual adm inistration of propofol [30] was subse­
quently im plem ented using a com puter-controlled infusion [31]. Schuttler et al. 
[32] used the m ethod described by Schwilden [33] to  im plem ent controlled infu­
sions of both  propofol and alfentanil during anaesthesia. W hite and Kenny [34] 
using a three-com partm ent model for propofol, developed a controller to achieve 
concentrations of propofol in the blood. This system  adopted the three com part­
m ent model derived by Gepts et al. [35]. M arsh et al. [36] developed the scheme 
described by W hite and Kenny for use in paediatric surgery. This process involved 
the  generation of a propofol pharm acokinetic model for children.
Control of Inhaled A gent D elivery  using a Pharm acological M odel
Physiologically-based pharmacological models for inhaled agents have been devel­
oped by Mapleson [37] [38] [39] [40] and other authors [41] [42] [43] [44] [45] [46]. 
M apleson’s models use physiologically accurate tissue groups, volumes and perfu­
sions and use experim entally derived physicochemical param eters for each drug. 
The full structure of the Mapleson models is described in C hapter 3. Relevant pa­
ram eters of the physiological components of the model are; tissue volumes, tissue 
perfusions, cardiac outpu t and alveolar ventilation. The technique of Mapleson 
et al. [47] uses estim ates of alveolar ventilation and cardiac ou tpu t to fully pa- 
ram etcrise a physiologically-based model of a dog. The model was then used to
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determ ine the  inspired concentration of halothane to be delivered to  the dog in 
order to m aintain the .arterial tension of anaesthetic a t. a  se tp o in t.............................
A later development [48] used a physiologically-based model for a dog to 
determ ine the necessary inspired halothane concentration required to achieve a 
desired brain anaesthetic tension. Again this approach proved successful.
A more extensive description of the control scheme is given by Chilcoat et 
al. [7q]. In these experim ents, im pedance cardiography was used to estim ate 
changes in the  cardiac output of the dog. Alveolar ventilation was measured 
using a respirom eter and the model was m atched to  the  patient. During the 
experim ents, arterial blood samples were taken every 10 m inutes and, every 30 
m inutes, the anaesthetic tension in the sample was used to  ‘correct’ th a t predicted 
by the model. The correction of the model involved changing the m odel’s cardiac 
ou tpu t so as to  m atch the measured and predicted arterial tensions. Despite some 
unreliability in measurem ents, these experim ents suggested th a t such an approach 
to  the control of brain tension and hence control of dep th  of anaesthesia is valid.
The m ethod of Tatnall, Morris and West [49] controlled the alveolar (end- 
tidal) halothane tension. This approach identified two constants during the first 8 
to  10 breaths of halothane m ixture and used these to param eterise a  simple model 
relating inspired tension, alveolar tension and m ixed-venous tension. Initially, this 
approach was applied to off-line da ta  from 20 cases and dem onstrated encouraging 
perform ance. Further work [50] applied the same scheme to 80 patients and 
dem onstrated its ability to cope w ith a wide range of patients and to  be robust 
to m easurem ent disturbances.
Tatnall [51] describes further enhancem ent of the control scheme to incorporate 
a PI controller following 60 to 90 breaths. This change allows any error between 
the actual and desired alveolar tensions to be elim inated by the  integral action of 
the controller. The enhanced system was involved in 120 trials in patients ranging 
in age from 7 months to 62 years and is reported to have perform ed reliably in all
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cases.
Control of Inhaled A gent D elivery  w ithout a Pharm acological M odel
The use of a pharmacological model allows control perform ance to  be  m atched to  
the individual patient. In the absence of a model, m ore simple control algorithm s 
can be used.
Ross et al. [52] describe a simple proportional controller for the  control of 
end -tida l halothane. Not surprisingly, this controller produced a steady-sta te  
error. 0 ’Callaghan et al. [53] describe the use of the  sam e scheme to  adm inister 
isoflurane. Sm ith et al. [54] describe the modification of a  P I type controller 
[55] for use in controlling end-tidal halothane concentration. Their m ain aim  was 
however to compare the perform ance of the controller w ith th a t of the anaesthetist 
and so detailed description of the control perform ance was not given. Ritchie et 
al. [56] [57] [58] describe an integrated set of controllers for ventilation, oxygen, 
nitrous oxide and anaesthetic delivery. The controllers are fixed P I controllers and 
no account for patient variability in uptake is taken. Hayes et al. [59] used PID 
controllers to  control the concentrations of oxygen, nitrous oxide and enflurane in 
an anaesthesia delivery system.
More recently, adaptive controllers for oxygen and halothane concentrations 
have been developed [60]. These controllers have achieved more reliable perfor­
m ance than  fixed controllers.
1.4.2 Control o f A naesthesia  using a P hysio logica l M ea­
surem ent
To date, no combination of m easurem ents has proved generally applicable to the 
assessment of anaesthetic depth and the best indication seems to be provided by 
the  clinical signs routinely used by the anaesthetist [61]. In some circumstances, 
however, some measured quantities can provide a reasonable indication of depth of
Chapter 1. Introduction  12
anaesthesia in the presence of specific drugs or drug combinations. An extensive 
review of some suggested m easurem ents and combinatipns of m easurements. is. 
given by Robb [61]. Robb concluded th a t “no single clinical sign can be used as 
an indicator of anaesthetic depth in all cases” but th a t the com bination of several 
signs is clinically useful. In consideration of some other suggested indicators of 
anaesthetic depth, Robb concluded that: The raw encephalogram (EEG ) cannot 
be usefully applied to the assessment of depth  of anaesthesia. The processed EEG 
which includes frequency domain measures such as the spectral edge frequency 
(SEF), zero-crossing frequency (ZXF) and the m edian frequency (M F) provides 
useful inform ation although it is not clear whether the changes in these measures 
genuinely reflect the anaesthetic state. Sensory evoked potentials such as the 
auditory evoked potential (AEP) also undergo changes related to the  anaesthetic 
dose bu t again, it is unclear whether these reflect a change in the  anaesthetic 
state. Overall, the use of the EEG measures is ham pered by agent specific EEG 
changes and the influence of other physiological variables such as arterial carbon 
dioxide. Further effects on the EEG include the actions of narcotics as discussed 
by Hug [62].
Robb also appraised the electromyogram (EMG) and both  the spontaneous 
and provoked lower osophageal contractility (LOC) as m easures of depth of 
anaesthesia. The use of the EMG, he concluded, is ham pered by large inter­
individual variability, the use of opiates and the presence of muscle relaxants. 
LOC is similarly affected by inter-individual variability and indeed, in some 
people, activity in the lower osophagus may be absent even during inadequate 
anaesthesia.
Although no particular sign, m easurem ent or com bination thereof appears to 
offer a reliable route to the assessment in all cases, for a wide range of drugs, of 
the anaesthetic depth, the autom atic control of the depth of anaesthesia based 
upon such measures lias been successful in some circumstances.
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C ontrol o f A naesthesia  using the Processed  EEG
B ecause‘EEG changes'are agent specific,* it* has proved* necessary to  evaluate the 
changes in EEG resulting from varying doses of different drugs and combinations of 
drugs. The effects of inhaled agents on the  EEG are sum m arised by Stoelting [27]. 
The effects upon the EEG of isoflurane in nitrous oxide have been investigated by 
Schwilden and Stoeckel [63]. The effects upon the EEG of fentanyl and alfentanil 
have been investigated by Scott et al. [64].
The work of Thom sen et al. [65] [66] has produced a scheme for the assessment 
of depth  of anaesthesia during isoflurane anaesthesia [65] and for isoflurane, 
halothane and etom idate/fen tanyl anaesthesia [66]. This approach classified the 
EEG waveform components in order to produce a m easure of anaesthetic depth.
Schwilden et al. [67] used a simple bi-exponential model to  represent the 
pharm acokinetics of m ethohexitone, and a simple sigmoid relationship to  represent 
its effect upon the EEG m edian frequency. This model was used within a controller 
for m edian frequency which delivered m ethohexitone. The pharm acodynam ic 
relationship between drug concentration and the m edian frequency was assumed 
constant and the pharm acokinetic model was adjusted to m atch the pa tien t’s 
median frequency with th a t predicted by the model. The pharm acokinetic model 
was then  used to determ ine the  propofol infusion rate. In a later scheme [68], the 
authors developed an EE G -based propofol infusion scheme.
The scheme described by Schils et al. [69] uses the spectral edge frequency 
and m ean arterial pressure as input variables to control the adm inistration of 
halothane. At any tim e, the controller m anipulates only one variable: either 
the m ean arterial pressure or the spectral edge frequency. A ‘coordinator’ was 
developed to select the variable to  be controlled and this was integrated into the 
control scheme.
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C o n tro l  o f A n a e s th e s ia  u s in g  th e  E M G
Recent work by Chang*et al: [70} tested the  useofaU  EM C ftiOnitot during surgery. ‘ 
Although not involved in closed-loop control, the usefulness of the EMG trace 
was investigated by either allowing or denying the anaesthetist access to it. The 
authors concluded th a t the EMG was not a useful indicator of depth  of anaesthesia 
due to  individual variabi lity and th a t the availability of the m easurem ent did not 
improve the resulting control of anaesthesia.
C o n tro l o f  A n a e s th e s ia  u s in g  C a rd io v a sc u la r  a n d  R e s p ir a to r y  V a ria b le s
Cardiovascular signs such as heart rate, blood pressures and the peripheral pulse 
are im portan t components in the clinical signs used by the anaesthetist to  assess 
anaesthetic depth. The results of Savege et al. [71] suggest th a t the  cardiovascular 
response to noxious stimulus may be more sensitive than  any of the changes 
in the processed EEG. The control of anaesthesia based upon the values of the 
cardiovascular variables may therefore provide a suitable anaesthetic state.
Suppan advocated the use of pulse rate, systolic arterial pressure, respiration 
ra te  and tidal volume to control the delivery of halothane, injected analgesics and 
fluids during anaesthesia. He described the results of clinical studies using the 
pulse ra te  [72], respiratory patterns [73] and arterial pressure [74] as the controlled 
variable. In his scheme, m easurem ents were passed to  ‘integrators’ which had ‘low’ 
and ‘high’ lim its. The movement of an integrator outpu t below the low lim it or 
above the high lim it caused a drug change. Given the sim plicity of the proposed 
schemes, the perform ance achieved was surprisingly good.
The controller of Lam pard et al. [75] m anipulated ventilation, the delivery of 
anaesthetic (halothane) and the provision of muscle relaxation. The anaesthetic 
was delivered so as to control blood pressure.
Robb [61] developed and trialled PI type controllers for the delivery of 
enflurane and isoflurane in order to m aintain systolic arterial pressure at a target
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value. An additional rule was added so as to deliver a m orphine bolus if the 
volatile agent concentration had exceeded certain lim its over the  last 5 minutes.
T he control of systolic arterial pressure achieved a satisfactory anaesthetic 
s ta te  in the m ajority  of patients. This also produced a satisfactory physiological 
s ta te  during surgery and a good recovery afterwards.
One case described by Robb, and in which the controller was used, involved 
significant blood loss by the patient. The blood pressure dropped as a result 
and this caused the controller to deliver no anaesthetic until the  provision of 
fluids by the anaesthetist had restored the blood volume and hence the blood 
pressure had recovered. This apparently did not result in a  period of anaesthetic 
inadequacy. It does however illustrate th a t because blood pressure results from 
the  complex interaction of physiologic and pharmacologic effects, interpretation 
of blood pressure solely as an indicator of depth of anaesthesia may result in 
inappropriate  interpretations and subsequent inappropriate anaesthetic states.
1.4.3 C ontrol o f A n aesth esia  using an Inferred D ep th  of 
A naesthesia
An alternative approach to the autom atic control of anaesthesia involves the 
inference of depth  of anaesthesia and the subsequent delivery of drugs in order to 
m anipulate  the  inferred depth.
The RESAC system described by Linkens, Greenhow and Asbury [76] and 
Greenhow [77] employs a rule-based backward chaining Bayesian inference engine 
w ith fuzzy logic. The aims of RESAC were to provide both  an assessment of 
the  depth  of anaesthesia and to suggest appropriate concentrations of anaesthetic 
agent which should be adm inistered in order to control the depth of anaesthesia. 
RESAC includes a sophisticated user-interface for the input of qualitative and 
quantitative inform ation on both clinical sign values and drug delivery. A further 
feature is the interfacing of RESAC to a m onitor so as to  periodically receive
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arterial pressure and heart rate  measurements. RESAC was developed to  in terpret 
the values of and changes in systolic arterial pressure, heart rate , m ovem ent, pupil 
size, pupil divergence, pupil movement, sweating and respiration rate. Three goals 
were tested  in assessing the depth of anaesthesia. These were ‘anaesthesia too 
light’, ‘anaesthesia OK’ and ‘anaesthesia too deep’. This assessment incorporated 
drug effects through the concept of ‘relevance’. For exam ple, the adm inistration 
of muscle relaxant caused respiration ra te  cease to be relevant as an indicator 
of depth  of anaesthesia. A fourth goal of RESAC was used to determ ine the 
necessary action in order to control anaesthesia. Evaluation of this goal, as 
described by Greenhow [77] takes account of reductions in anaesthetic requirem ent 
caused by the concom itant adm inistration of muscle relaxants or analgesics. As 
explicit examples, RESAC took account of the  effects of m orphine, fentanyl, 
atracurium  and vecuronium when determ ining the concentration of anaesthetic 
to  be adm inistered.
A detailed and informative account of the iterative refinements of RESAC 
following clinical trials is given by Greenhow [77]. Later versions of RESAC have 
clearly dem onstrated very effective results.
1.5 A ppraisal o f the Current D irections in Con­
trol o f A naesthesia
1.5.1 D rug D elivery  based upon P harm acological M od­
els and M easurem ents
Considering work of this type developed to control depth  of anaesthesia and also 
related work in the control of muscle relaxation and control of blood pressure, 
several them es emerge with respect to modelling and control. These are:
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1. The use of a pharm acokinetically-related variable as feedback in a  simple 
controller. .......................................................................
2. The use of population pharm acokinetic models to  determ ine the  infusion 
ra te  for a drug in an individual.
3. The use of simple transfer function models in adaptive schemes to m atch the 
model to  the patient and then control drug delivery based upon the model.
4. The use of sophisticated physiologically-based m odels m atched to the 
individual to  determ ine the rate  of drug delivery in the individual.
Schemes of type 1 cannot provide consistent control perform ance over a range 
of patients because they cannot adapt. Schemes of type 2 are also weakened by 
the  differences between the response of the individual and the  response of the 
population. In using their control scheme to control propofol infusion in children, 
M arsh et al. [36] actually developed new models to  represent the  pharm acokinetics 
of propofol in children thereby moving the response of the model much closer 
to  th a t of the individual w ith associated improvement in control performance. 
M aitre et al. [78] illustrated th a t significant errors resulted from the use of 
a population pharm acokinetic model to predict plasm a concentrations. Similar 
errors are therefore possible if a population model is used in control. Adaptive 
control schemes involving the identification of a simple model (type 3) are largely 
justified in order to accom m odate both the wide range of individual responses and 
the  apparent tim e-varying response even within an individual. These schemes 
have proved capable of good perform ance in a wide range of patients.
The presence of inter-individual and in tra-indiv idual variation in drug re­
sponse has prom pted the development of adaptive controllers. C hapter 4 analyses 
the effects of different body composition on the pharm acokinetics of isoflurane. Al­
though the pharm acodynam ics of inhaled agents are not adequately understood,
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it becomes apparent th a t a significant component of the in ter-indiv idual vari­
ability can be a ttrib u ted  to  pharm acokinetic differences alone. Similarly, during, 
anaesthesia, changes in respiration and circulation occur in response to  changes in 
anaesthetic dose. As analysed in C hapter 4, the alteration of alveolar ventilation 
and cardiac ou tpu t cause changes in the apparent dynamics of the  pharm acoki­
netic response. The need for adaptive control schemes may therefore be partly  due 
to  the  ineffective modelling of the physical systems involved. Intuitively, it can be 
expected th a t an obese individual would have a different anaesthetic requirem ent 
to th a t of an ath le te  and it is equally apparent th a t the apparent tim e-varying 
dynam ics in the individual cannot be due to changes in body mass or composition 
during the anaesthetic but instead is due to  fundam ental physiological changes 
caused by drugs.
The use of physiologically-based models to  control drug delivery (type 4) al­
lows explicit representation of both  in ter-individual body com position changes 
and in tra-indiv idual physiological changes. In consideration of previous ap­
proaches to the  control of depth of anaesthesia, Chilcoat, Lunn and Mapleson 
[79] concluded th a t most control systems involved “the feedback control of some 
variable used as an indirect measure of anaesthetic depth, such as some aspect 
of the EEG, the arterial pressure, or the end-tida l anaesthetic concentration” . 
They further stated  th a t “We consider th a t, in any one individual, a closer corre­
late  of depth of anaesthesia is brain tension” . Although brain tension cannot be 
m easured, it seems th a t the direct relationship between the brain tension and the 
anaesthetic effect is more straightforward than  the relationships between depth of 
anaesthesia and the other variables.
In the belief th a t the use of physiologically-based models and the control of 
brain tension (or brain concentration) of anaesthetic represent the most realistic 
means of approaching the modelling and control of anaesthesia pharmacokinetics, 
this approach has been adopted in the work described in this thesis.
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1.5.2 C ontrol o f A n aesth esia  by C ontrolling a R elated  
. . .  V a r ia b le .......................................................................................
W ithout exception, this approach involves the indirect m onitoring of a pharm aco­
logic effect using a physiological variable. Such effects, however, have significant 
interactions w ith other physiologic and pharmacologic processes. For example, 
changes occur in the EEG with changes in arterial carbon dioxide tension; blood 
pressure changes can occur in response to  stressful stimuli and blood volume 
changes as well as in response to  anaesthetic agents and other drugs. In using 
a related variable as an indicator of depth of anaesthesia, it is therefore essen­
tial to  ensure th a t none of the additional physiological or pharmacological factors 
which also affect the variable are present. In consideration of the unreliability of 
m ost routinely available m easurem ents as indicators of depth  of anaesthesia, this 
approach has not been pursued in the work described in this thesis.
1.5.3 Inferring D ep th  o f A n aesth esia
The RESAC system of Linkens et al. [76] and Greenhow [77] interprets an 
extensive range of quantitative and qualitative clinical signs, in the context of the 
drugs being given to  the patient, to  infer depth  of anaesthesia. A further step is the 
determ ination of volatile agent concentration to be adm inistered to  the patient 
in order to  control the depth of anaesthesia. This system  has been developed 
following discussion with anaesthetists and aims to replicate their performance.
This approach is itself a significant contribution to  the reliable inference and 
subsequent control of anaesthesia. In recognition of this, work in this thesis adopts 
a sim ilar direction so as to in terpret clinical signs in consideration of anaesthetic 
and other drugs. As a further step, the in terpretation of clinical signs in term s 
of both pharmacologic events (drug adm inistration) and physiologic changes is 
pursued. This direction is consistent with th a t of RESAC although the actual
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approach, as described in C hapter 7, is different.
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1.6 C ontributions o f th is T hesis
As described above, this thesis adopts the direction of some previous work in the 
area and in so doing introduces some new approaches to  both  the assessment and 
control of anaesthesia. In summary, the thesis contributes the  following:
• An unambiguous graphical representation for the physiologically-based 
models of pharm acokinetics such as those of M apleson [40] and Davis and 
Mapleson [45].
• A physiological and physicochemical param eterisation of such a model to 
represent the pharmacokinetics of isoflurane.
•  A scheme to allow matching of a physiologically-based model to an individ­
ual patien t using only m easurements of body mass and an estim ate of body 
fat.
• A scheme for the estim ation of cardiac o u tpu t and tissue anaesthetic tensions 
in the individual undergoing surgery.
• A physiologically-based qualitative model of the  homeostasis processes 
involved in the control of respiration, blood pressure and blood volume, 
the response to an extrem e stressor and the  effects of depressant drugs 
(anaesthetics).
•  A qualitising filter for description of the trends of physiological and phar­
macological variables.
• A scheme for the differential diagnosis of physiological and pharmacological 
imbalances in the pa tien t’s anaesthetic state.
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•  An architecture for the overall control of the anaesthetic state
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• •  CLASS*: The Closed-L'oOp Aiiafesthesia Support System* — An ob ject- 
oriented software library allowing in terrupt driven com m unication handling 
and virtual devices for anaesthetic monitors, an infusion pum p and a servo- 
vaporiser.
•  GAEL: The Glasgow Anaesthesia Estim ation Library — An object-oriented 
software library providing facilities to m atch a physiologically-based model 
to  the  individual patient, load individual inhaled drug physicochemical 
properties and estim ate the patient tissue tensions and cardiac ou tpu t.
•  MASIE: M odel-based A naesthetic S tate  Imbalance Evaluation — An ob ject- 
oriented software library allowing the creation of variable threshold quali- 
tising filters and the evaluation of possible anaesthetic sta te  imbalances in 
the current patient anaesthetic state.
1.7 Sum m ary o f C ontribution and D irection
In sum m ary, work in this thesis involves;
1. The development and use of physiologically-based pharm acokinetic models 
w ith the intent of controlling drug delivery so as to  achieve desired brain 
anaesthetic tensions.
2. The development and use of physiologically-based m odels to support the in­
terpreta tion  of clinical signs in the context of physiologic and pharmacologic 
events.
Figure 1.1 gave an overview of previous approaches to the  control of anaesthesia.
Figure 1.2 includes the contributions of this thesis in th a t context.
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Figure 1.2: The Approaches Presented in this Thesis
1.8 T he Structure o f this T hesis
This thesis has been organised in three areas. The first consists of C hapter 2 
and acts as an overview of anaesthesia. The second area consists of C hapter 3, 
C hapter 4 and C hapter 5. These chapters cover the use of pharmacology and 
physiology to develop models which can be used in the delivery of anaesthetic 
and related drugs, and in the estim ation of inhaled anaesthetic tensions in the 
body. The th ird  area consists of C hapter 6 and C hapter 7 and describes the use 
of physiology to develop a model of the homeostasis loops and stress response of 
the  body which can be used to assess the anaesthetic s ta te  of a patient undergoing 
surgery. Each chapter is described in more detail below:
C hapter 2 of this thesis considers the processes and components of anaesthesia. 
A brief historical note is presented before the effects of local anaesthetic, analgesic 
and general anaesthetic drugs are described in term s of their physiological effects.
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General anaesthesia is summarised and the activities im portan t in m onitoring 
anaesthesia are introduced. The chapter concludes w ith the description .of. 
conventional drug delivery and m onitoring equipm ent used in anaesthesia and 
specialised software and hardware made available and developed for use in the 
work described in this thesis.
C hapter 3 introduces basic relations in pharmacology and describes the 
modelling of pharmacology in anaesthesia. The use of com partm ent models is 
discussed along w ith the use of physiologically-based pharm acokinetic models. 
The graphical representation of pharm acokinetic models using the bond graph 
model representation technique is then explained.
Chapter 4 describes the physiological and physicochemical param eterisation 
of a physiologically-based model of isoflurane pharm acokinetics. Physiologically, 
the model is based upon da ta  presented by other authors. Physicochemically, it 
makes use of in-v itro  experim ental da ta  available in the  literature.
C hapter 5 describes the use of the model derived in C hapter 4 to produce 
a scheme for the estim ation of cardiac outpu t and tissue tensions in patients 
undergoing surgery. A procedure for m atching the pharm acokinetic model to the 
patien t using only simple measurements is described. The sim ulated and on-line 
perform ance of the estim ation scheme are illustrated.
Chapter 6 of the thesis describes the homeostasis loops and stress response 
of the body which are relevant to anaesthesia. A m odel of homeostasis and the 
stress response based upon the qualitative descriptions of physiology is described. 
The model is intended to predict the compensation of the body for a range of 
physiological stresses. The performance of a prototype im plem entation of the 
model is illustrated.
Chapter 7 describes the use of the model of homeostasis and the stress response 
in the assessment of the anaesthetic state  of the patien t. A prelim inary version 
of this reversed model has been im plem ented. Its off-line perform ance on logged
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d a ta  and its on-line performance in theatre  are presented.
C hapter 8 concludes the work described in the thesis in assessing the achieve­
m ents made and the lessons learned during development. The thesis presents two 
different techniques for use in anaesthesia and this chapter outlines an architec­
tu re  which allows their combination in order to provide control of the anaesthetic 
state. Trials of this architecture are not docum ented in the thesis and these are 
therefore suggested, along with other topics, as areas of future development.
C hapter 2
A n aesth esia
SUMMARY
This chapter introduces Anaesthesia and the equipment used in the 
work described in this thesis. A brief historical introduction precedes 
description o f the physiological bases o f pain and anaesthesia. General 
anaesthesia is specifically discussed and working definitions provided 
fo r  use in the remainder o f the thesis. M onitoring during general 
anaesthesia is outlined and the chapter concludes with discussion o f 
specialised hardware and software used later to test prototype schemes.
2.1 A naesthesia
2.1.1 G eneral D efin ition
The word anaesthesia means “absence of sensation” . General anaesthesia is the 
absence of all sensation and is associated w ith unconsciousness. In a clinical 
context, anaesthesia entails both absence of sensation for the patien t and the 
provision of suitable operating conditions for the surgeon.
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2.1 .2  H istorical P erspective
•The‘first-successful demonstration*of anaesthesia was given*by W illiam  M orton ‘ 
in 1846. M orton adm inistered ether vapour to  a patien t having a tum our in his 
neck removed. At the tim e, M orton term ed the process “etherisation” .
An onlooker a t the dem onstration, Oliver W endell Holmes, suggested th a t 
the term  “anaesthesia” should be adopted. Holmes also introduced the phrases 
“anaesthetic s ta te” and “anaesthetic agent” .
Relatively soon afterwards, in 1847, chloroform was used as an anaesthetic by 
Jam es Young Simpson in Edinburgh. The use of ether as an anaesthetic preceded 
bo th  the  use of antiseptics and the development of the hypoderm ic syringe.
Following M orton’s dem onstration, the use of ether became prevalent with 
chloroform also being readily applied. The use of anaesthesia perm itted  more 
lengthy surgery w ithout compromising the patient. Surgical techniques developed 
accordingly, in parallel with developments in the  use of existing and new 
anaesthetic agents.
P rior to  the use of anaesthesia, pain relief for the  patien t was inadequate 
and consisted of alcohol or opium ingestion. Surgical conditions were created by 
physical restrain t of the patient, and the surgeon relied upon speed of operation 
to  m inim ise the patien t’s suffering.
2.2 Pain: The P erception  o f N oxious Stim uli
“Pain is the conscious perception of a noxious stim ulus” [80]. The perception 
of pain occurs when tissues are being damaged and provokes action to remove 
the painful stim ulus. The body contains receptor cells which are sensitive to a 
variety of stimuli such as mechanical deformation, tem perature, chemicals and 
tissue damage. The receptors involved in the detection of pain are sensitive to 
the physical or chemical damage of tissues and are called nociceptors. Nociceptors
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are responsive to  stimuli which can damage tissue bu t can be stim ulated by any 
stim ulus of sufficient m agnitude. There are three types of pain receptor present 
in skin; mechanosensitive pain receptors are activated by intense mechanical 
stim ulation, m echanotherm al pain receptors are activated by mechanical and 
therm al stim ulation, and polymodal pain receptors are responsive to  mechanical, 
therm al and chemical stimuli.
Pain receptors generate nerve impulses in response to  stim ulation. The 
frequency of the impulses depends upon the severity of the stim ulus. The nature 
of the  perceived pain depends upon the nerve fibres in which the impulses from 
the pain receptors travel. Mechanosensitive and m echanotherm al pain receptors 
transm it impulses via AS fibres. Polym odal pain receptors transm it impulses 
through C fibres. AS  fibres conduct nerve impulses a t high velocities (6 to 25 
m /sec) and give rise to a perceived stabbing pain. C fibres conduct impulses 
more slowly (0.5 to 2 m /sec) and give rise to burning or aching pain.
Pain impulses are conducted from pain receptors in the skin or in other struc­
tures, to  the spinal column. Nerve impulses then pass along the spinothalam ic 
trac t which consists of nerves running along the spinal column to the thalam us. 
The thalam us is an area of the brain which, amongst o ther tasks, is responsible 
for the  routing of pain impulses from the spinothalam ic trac t to  other brain cen­
tres. The thalam us routes impulses to the som esthetic area of the cerebral cortex 
which is responsible for the in terpretation of the location of the painful stimulus, 
assessment of its severity, and determ ination of the natu re  of the pain.
The transm ission pathways involved in the perception of pain are represented 
in the schem atic Figure 2.1.
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Figure 2.1: The Anatomy of Sensory Pathways
2.3 D rugs w hich alter the P erception  o f  
N oxious Stim uli
T he perception of noxious stimuli requires th a t an in tact and functional pathway 
exists between active nociceptors, through prim ary afferent neurons into the spinal 
colum n, up the spinothalam ic trac t to the thalam us, and from the  thalam us to  the 
som esthetic area of the cerebral cortex. A lterations in the perception of a noxious 
stim ulus can be brought about via the inhibition or im pairm ent of function of the 
com ponents involved in the generation, transm ission and in terpreta tion  of nerve 
impulses due to  noxious stim ulation. Such effects can be produced using local 
anaesthetic, analgesic and general anaesthetic drugs. Each of these drug types 
alters the function of one area of the sensory pathway between the  nociceptors 
and the cerebral cortex.
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2.3.1 Local A n aesth etic  Drugs
Lpcal anaesthetic ageiits.bfocjk the initiation and propogation. of nerve.impulses, 
in and along neurons. The initiation and propogation of impulses in a neuron 
depends upon the  presence of sodium channels and potassium  channels in the cell 
m em brane. These channels can open and close in response to  voltage changes 
between the cell’s interior and exterior. At rest, the interior of a neuron has a 
potential of between -60 and -90 mV relative to  the exterior. In this state , the 
cell is said to  be polarised. Additionally, the environm ents of the cell and its 
surroundings are such th a t the concentration of sodium ions ( N a +) is 14 times 
greater outside the cell than  inside, and the concentration of potassium  ions ( K +) 
is 18 to  20 tim es larger inside the cell than outside it. In the  polarised state, 
the sodium  channels in the cell mem brane are closed and the potassium  channels 
are very nearly closed. A stimulus from a receptor, such as a pain receptor, or 
a propogating impulse in the neuron cause the potential of the  interior of the 
cell to rise to around -50mV relative to the exterior. In this range of potential 
difference, the  sodium channels of the m em brane begin to  open allowing sodium 
ions to  move inside the cell due to electrical and concentration gradients. The 
influx of positive sodium ions further reduces the potential difference across the 
cell m em brane. This process is called depolarisation. As the  voltage of the interior 
of the cell reaches around -30 mV the sodium channels close preventing further 
movement of sodium ions. Also, during the depolarisation process, the potassium  
channels open further, but open much more slowly than  the sodium channels. This 
allows potassium  to move out of the neuron thus making the potential difference 
between interior and exterior return  towards the initial value. This process is 
repolarisation. The flux of ions involved in this process establishes local currents 
around the m em brane which cause propogation of the im pulse along the neuron. 
A graph of the changes in the potential of the interior of a neuron with respect to 
the  exterior for a local region of the m em brane is given in Figure 2.2.
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Figure 2.2: Potential Changes during Nerve Impulse Conduction
The dom inant action of local anaesthetics is to  block sodium channels in the 
neuron m em brane. The mem brane then cannot depolarise, impulses cannot be 
propogated along the neuron, and the transm ission of nerve impulses from pain 
receptors to  the  brain along the nerve containing the affected neurons is prevented. 
By a sim ilar m echanism, local anaesthetics also inhibit the generation of impulses 
by receptor ceils.
2.3.2 A nalgesic Drugs
Some analgesic drugs increase the perm eability of potassium  channels in neurons 
causing the hyperpolarisation of the cell m em brane [29]. The hyperpolarisation of 
the cell m em brane causes transmission of impulses along the neuron to be more 
difficult as additional effort is required to depolarise the membrane. Analgesic 
drugs also act a t the junction or synapses between neurons. The pathway between 
a nociceptor and the cerebral cortex involves synapses between the  peripheral
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sensory neuron and the spinothalam ic trac t, and between the spinothalam ic trac t 
neurons and those connecting the thalam us and cerebral cortex. In m qst,central 
nervous system  nerves, nerve impulse transm ission across a  synapse involves 
chemicals known as neurotransm itters. At such a chemical synapse, the arrival of 
a nerve impulse a t the synapse causes release of some neurotransm itter into the 
synaptic cleft between the presynaptic end bulb and the postsynaptic structure 
(Figure 2.3).
synaptic cleft
receptors
post-synaptic neuronpre-synaptic neuron
neurotransmitter
polarisedrepolarised depolarised
Figure 2.3: N eurotransm itter Function a t a Synapse
The postsynaptic structure contains receptors for the neurotransm itter. De­
pending upon the neurotransm itter, the neuro transm itter-recep tor interaction can 
either be excitatory or inhibitory. In an excitatory interaction, the postsynaptic 
neuron moves closer to depolarisation. N eurotransm itters which cause excitatory 
interaction do so by either increasing the m em brane perm eability to sodium ions 
directly, or by activating an enzyme called adenylate cyclase which participates 
in a chemical reaction resulting finally in increased m em brane perm eability to
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sodium ions.
An inhibitory neurotransm itter-receptor interaction causes hyperpolarisatipn 
of the  post-synaptic  neuron by increasing the m em brane perm eability to potas­
sium. This makes the conduction of an impulse across the synapse more difficult. 
A further m echanism for inhibiting nerve impulse conduction occurs when an 
inhibitory neuron synapses with another presynaptic neuron. The release of in­
hibitory neurotransm itter by the inhibitory neuron suppresses the  release of exci­
ta to ry  neurotransm itter by the other neuron causing a decrease in the stim ulation 
of the  postsynaptic neuron.
Analgesic drugs can cause presynaptic inhibition to  occur thereby reducing the 
conduction of impulses from nociceptors to the cerebral cortex. The activation 
of receptors for opioid analgesics, which exist on neurons, causes inhibition of 
adenylate cyclase activity thus reducing excitatory effects in the postsynaptic 
neuron.
Analgesics therefore cause reduced transm ission of nerve impulses from noci­
ceptors by a combination of effects which include;
1. hyperpolarisation of neurons,
2. pre-synaptic  inhibition and
3. reduction of post-synaptic excitatory activity.
2.3.3 G eneral A n aesth etic  Drugs
General anaesthetics produce inhibition of the conduction of a nerve impulse along 
a  neuron, and can also inhibit transmission across a synapse. To inhibit conduction 
along a neuron requires higher concentrations than  those required to inhibit 
synaptic transm ission [29]. Similarly, surgical levels of anaesthesia cause little  or 
no inhibition of impulse transmission in peripheral nerves (i.e., outside the brain 
and spinal chord). W hile these observations are accepted, the exact mechanism
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of action of anaesthetics is not known and several com peting hypotheses exist. 
A naesthetics have beep pbserved to .cause reductions in the. release of excitatory- 
neurotransm itter, to  reduce the sensitivity of the post-synap tic  neuron to  the 
neurotransm itter, and to reduce the electrical excitability of the post-synaptic  
neuron [29]. Anaesthetics have also been found to inhibit the m etabolic breakdown 
of an inhibitory neurotransm itter (gam m a-am inobutyric acid, GAB A) [27].
These effects do not occur in equal potency throughout the central nervous 
system . The loss of consciousness and am nesia caused by anaesthetics probably 
result from anaesthetic effects in the reticular form ation and hippocam pus regions 
of the  brain a t lower concentrations. Higher concentrations cause effects upon the 
m otor centres which control movement, and the centres involved in the regulation 
of the  body’s physiological variables.
General anaesthetics exert their effects by inhibiting the  transm ission of 
impulses. This occurs more easily in the central nervous system than  in the 
peripheral nervous system, and more easily in the brain centres concerned with 
consciousness and short-term  memory than  in others.
2.4 Typ es o f A naesthesia
The previous section described the mechanisms of drug action for local anaes­
thetic, analgesic and general anaesthetic drugs. The drugs are obviously cate­
gorised in term s of the effects which they produce. A lthough there are only three 
subdivisions of drug types, the use of different drugs gives rise to several different 
anaesthetic techniques. These are sum m arised below.
2.4.1 Local and R egional A n aesth esia
A local anaesthetic drug, as described earlier, is capable of inhibiting the 
generation of nerve impulses by a receptor and the transm ission of nerve impulses
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along a nerve. This effect allows the transm ission of impulses between a site of 
noxious stim ulation and the cerebral cortex to.bp in terrup ted  and the sensation-of- 
pain in response to  the noxious stim ulation is avoided. Figure 2.1 illustrated the 
functional characteristics of the body’s sensory pathways. Anatom ical knowledge 
supports the inhibition of nerve impulse transm ission a t different places in the 
body, w ith different effects.
The inhibition of receptor activity is involved in topical anaesthesia and 
infiltration anaesthesia. Topical anaesthesia requires th a t local anaesthetic is 
applied to  a  mucous membrane. Infiltration anaesthesia requires deposition of 
the drug beneath  the skin or a membrane.
The inhibition of nerve impulse transm ission in the peripheral nervous system 
can be used to  produce anaesthesia for a region of the  body. The deposition of 
drug around a nerve prevents all receptors which transm it nerve impulses along 
th a t nerve from passing information to the brain.
The adm inistration of drug around the spinal column can produce anaesthesia 
for large areas of the  body w ithout causing other undesirable effects such as 
unconsciousness. This is spinal anaesthesia.
2.4.2 G eneral A naesthesia
W hile a local or regional anaesthetic involves the introduction of a drug in the 
vicinity of an anatom ical site, general anaesthetic drugs are adm inistered either 
by intravenous injection or by inhalation, and reach all tissues of the body. As 
described earlier, general anaesthetics have their m ost potent effects within the 
central nervous system  and produce com paratively m inor effects in the peripheral 
nervous system  at clinical doses. In depressing brain activity, general anaesthetics 
in terrup t the  interpretation of nerve impulses transm itted  from a site of noxious 
stim ulation, to the brain. Once again, the pathway between the nociceptors 
and the cerebral cortex is functionally in terrupted and prevents the conscious
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perception of pain. The rem ainder of this thesis is concerned w ith general 
anaesthesia and more extensive discussion of this is given bqlqw.. . . . . . . .
2.5 G eneral A naesthesia
In the first anaesthetics adm inistered, using ether or chloroform, the anaesthetic 
vapour was the only drug used. As such, it was required to  produce not only 
anaesthesia, bu t also other effects which supported the surgeon. As drugs 
developed, including more specific general anaesthetics, analgesics and muscle 
relaxants, it becam e necessary to control the adm inistration of several drugs in 
order to manage the anaesthetic. The evolution of new drugs continues and the 
anaesthetist is routinely responsible for the adm inistration of general anaesthetic 
and analgesic drugs during anaesthesia, along w ith the adm inistration of blood 
or fluids when needed. If surgery is to be assisted by muscle relaxation, the 
respiratory muscles of the patient will also be paralysed. Because of this, the 
anaesthetist m ust in itiate and control the artificial ventilation of the patient, 
the anaesthetist inherits responsibility, not only for the adm inistration of muscle 
relaxant bu t also for the ventilation of the patient.
These processes are further complicated by the range of patients undergoing 
surgery. This range is extensive both in term s of the physical condition of the 
patients and in term s of their co-existing disease and m edication.
W hile the  skills of anaesthetists have been extended to  cope w ith the capacity 
to m anipulate efFects using a combination of drugs, the  concepts and definitions 
of anaesthesia have been slow to follow.
2.5.1 D eb ate  in G eneral A naesthesia
Perhaps the most widely accepted definition is th a t of anaesthesia. P rys- 
Roberts [80] suggests th a t “the state  of anaesthesia can be defined as tha t in
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which, as a result of drug-induced unconsciousness, the patient neither perceives 
nor [subsequently] recalls noxious stim ulation” . The im portan t aspects, of this 
definition are th a t it is defined for the patient, and th a t it encompasses both 
perception during a procedure and recall afterwards. As pointed out by Robb [61]
“ ‘anaesthesia’ is a  retrospective diagnosis” .
D ebate continues, however, in consideration of the features of an “anaesthetic” . 
Robb states th a t the anaesthetist “aims to produce a reversible state  which 
includes:
1. “Hypnosis...
2. M aintenance of physiological variables...
3. Reflex suppression...
4. A safe and comfortable post-operative recovery...”
Pinsker [81] argues th a t “paralysis, unconsciousness and attenuation of the 
stress response are the necessary and sufficient components of the anesthetized 
sta te” . W oodbridge [82] suggested th a t the components of anaesthesia were hyp­
nosis, analgesia, muscle relaxation and the suppression of reflexes. Prys-R oberts 
[80] argues th a t “Analgesia, muscle relaxation and suppression of autonomic ac­
tivity, are not components of anaesthesia. R ather they should be considered as 
desirable supplem ents to the state  of anaesthesia as a means to  enable surgery to 
be perform ed” .
2.5.2 D efin ition s used in th is T hesis
In recognition th a t there is no single set of consistent, universally-accepted 
definitions of term s related to anaesthesia, the following definitions will be adopted 
and used in the  rem aider of the thesis:
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- The definition given by Prys-R oberts is adopted i‘.e.‘,
“the s ta te  of anaesthesia can be defined as th a t in which, as a result 
of drug-induced unconsciousness, the patien t neither perceives nor 
[subsequently] recalls noxious stim ulation” .
A naesth etic
As discussed, the features of an “anaesthetic” or of “anaesthesia” are the subject 
of continuing debate. Until a more suitable term  evolves which encompasses all 
of the activities of the anaesthetist in theatre, confusion is inevitable. The use of 
the  term  “anaesthetic” to cover the activities of the anaesthetist will not be used 
in the  rem ainder of the thesis.
T he G oals o f an A naesthetist
The goals of an anaesthetist are defined so as to  encompass all of the activities of 
the anaesthetist. The goals of an anaesthetist are therefore considered to be, to 
provide a reversible state  including;
1. anaesthesia for the patient,
2. m aintenance of a stable physiological state  for the patien t and,
3. the provision of suitable conditions for surgery.
D epth  o f A naesthesia
Depth of anaesthesia is a concept used to classify the  anaesthesia provided for 
the patient. D epth of anaesthesia is considered to  be a continuum  with “light 
anaesthesia” and “deep anaesthesia” being at either end of the  clinically useful 
range. Light anaesthesia exists when the patien t is receiving inadequate general
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anaesthetic drug for the current level of surgical stim ulation. Deep anaesthesia 
exists when the  patien t is receiving excessive general anaesthetic drug .for the * 
current level of surgical stim ulation.
T he A n aesth etic  S tate
The anaesthetic sta te  of the patient is considered to be composed of both  the 
p a tien t’s physiological state  and their pharmacological state. This definition of 
anaesthetic s ta te  is adopted to emphasise the  m utual dependence of physiological 
and pharmacological events in anaesthesia.
A n aesth etic  S tate  Im balance
The pa tien t’s anaesthetic state  was defined to consist of both  physiological and 
pharmacological states. The goals of the anaesthetist are to  provide an appropriate 
anaesthetic state. Because work in this thesis is intended to provide support 
for the control of anaesthesia, a definition for an appropriate anaesthetic state  
is desirable. Such a definition is, however, not available. A naesthetists, while 
being unable to agree upon an appropriate anaesthetic state , seem to have quite 
consistent opinions on the characteristics of an inappropriate  anaesthetic state. 
An anaesthetic s ta te  may become inappropriate due to  a change in the patien t’s 
physiological sta te  e.g., a reduced circulating blood volume following bleeding, 
or due to a change in the patien t’s pharmacological s ta te  e.g., the anaesthetic 
delivery is reduced and the anaesthetic becomes light.
To support the development of a controller for the anaesthetic state, an anaes­
thetic  sta te  im balance is therefore considered to  be an inappropriate condition 
of a component of the anaesthetic state  which can be rem edied by a change in 
the physiological or pharmacological states of the patien t. A physiological anaes­
thetic sta te  im balance can be rectified by a change in the  physiological s ta te  of the
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patien t e.g., a reduced circulating blood volume can be rem edied by the adm inis­
tra tio n  of blood of fluids. A pharmacological, aijaesthejtic s ta te  im balance can.be 
rectified by a change in the pharmacological sta te  of the patien t e.g., inadequate 
muscle relaxation can be remedied by further adm inistration of muscle relaxant; 
deep anaesthesia may be remedied by the reduction of anaesthetic adm inistration.
A ppropriate A naesthetic State
Following on from the previous definition, an appropriate anaesthetic state  is 
defined to  exist when there are no anaesthetic s ta te  imbalances.
2.5.3 T h e P hases o f G eneral A naesth esia
The phases of general anaesthesia are the individual com ponents involved in the 
overall assessment and m anagem ent of a patient before, during and after general 
anaesthesia. There are five phases [83] and these are sum m arised as follows:
P re-op erative A ssessm ent
The anaesthetist requires to  assess the state  of each patien t prior to adm inistering 
an anaesthetic. The anaesthetist aims to  anticipate the effect of surgery and the 
anaesthetic upon the patient and also establish any changes which the patient will 
require in the anaesthetic technique. The surgical procedure to  be carried out will 
d ictate  the  anaesthetic state  required and also give an estim ate of the recovery 
tim e for the patient.
The pre-operative assessment is used to establish basic anatom ical information 
about the patien t so as to determ ine ease of in tubation, ease of access to  veins for 
cannulation, and ease of ventilation.
Investigation of the previous illnesses of the patien t give indication of other 
complications due to cardiovascular or respiratory disease. History of previous 
anaesthetics highlight drug sensitivity or allergy. The degree of anxiety or
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apprehension of the patient gives an indication of the  need for pre-operative 
sedation. .....................................................................................
P re-operative M edication
Pre-operative medication is intended to make the tim e before surgery comfortable 
for the patient, and to forestall potential problems following surgery.
The main complication prior to surgery is norm ally the anxiety of the patient. 
Pre-operative adm inistration of a sedative drug in the hours before surgery can 
reduce anxiety. O ther drugs may be adm inistered to  cope w ith co-existing disease 
of the patient, to reduce post-operative vom itting (anti-em etics) or to reduce 
salivation (anti-sialogogues).
Induction
Induction represents the most dram atic change in the physiological s ta te  of the 
patient during the anaesthesia process. The aim of induction is to rapidly and 
safely achieve a depth of anaesthesia appropriate to the perform ance of surgery.
Prior to induction, a cannula is inserted into one of the p a tien t’s veins to allow 
ease of adm inistration of intravenous drugs and fluids. Following induction, an 
endotracheal tube may be inserted in the pa tien t’s trachea. An endotracheal tube 
secures access to the pa tien t’s lungs and prevents passage of any foreign m aterial 
into the lungs.
M aintenance of A naesthesia
The initial depth of anaesthesia achieved during induction is usually produced 
using a fast acting barb itu rate  drug (e.g. thiopentone). The m aintenance 
of an appropriate depth is achieved by adm inistration of volatile (gaseous) or 
intravenous anaesthetics.
Initially, following induction, it is necessary to a ttach  the patien t to drug
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delivery system s, a ttach  necessary instrum ent sensors to the  patien t and place 
the patien t in the correct operating position.
The transition  from the conscious patient prior to  induction to  th e  unconscious, 
anaesthetised patien t involves significant changes in the physiological s ta te  of the 
patient. The m easurem ents made in the period im m ediately following induction 
show wide variation as the combined effects of changes in physical position and 
the influences of drugs interact.
W hen the  anaesthetist is satisfied th a t the patien t is adequately anaesthetised 
and th a t no other complications exist, surgery can proceed. The anaesthetist 
is now responsible for changes in delivery of drugs and fluids to  the  patient in 
accordance w ith the anaesthetic state  of the patien t and, if muscle relaxants are 
being used, the control of muscle relaxation and ventilation.
Drug delivery is stopped as surgery reaches com pletion and the patien t is 
disconnected from instrum entation and drug systems when a satisfactory level of 
protective reflexes has been attained.
R ecovery
The patien t is transferred to the recovery room for observation until a safe level of 
protective reflexes has returned. In the initial part of recovery, the patien t still has 
a significant am ount of anaesthetic present in the body. This is likely to  reduce 
the respiratory drive of the patient. Continual, vigilant observation of the patient 
in the recovery room is thus essential.
2.6 M onitoring during G eneral A naesthesia
During the m aintenance of anaesthesia, the anaesthetist is concerned w ith the 
m onitoring of four distinct areas. These are
1. the anaesthesia machine and drug delivery devices,
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2. the physiological state  of the patient,
3‘. the dep th” of anaesthesia of the patient and,
4. the conditions provided for surgery.
Obviously, unreliable or faulty perform ance of the  anaesthesia machine or a 
drug delivery device can cause subsequent alteration in the physiological state  of 
the patien t or in their depth of anaesthesia. Similarly, inappropriate depth of
anaesthesia can compromise the physiological s ta te  of the patien t. These three
areas are therefore inter-dependent. Similarly, inappropriate surgical conditions 
will hinder the  surgeon and make surgery more difficult.
The provision of appropriate surgical conditions such as muscle relaxation has 
not been pursued in the work described in this thesis. Aspects of the  monitoring 
of surgical conditions are therefore not discussed further.
2.6.1 M onitoring th e A naesth esia  M achine and D ru g-  
delivery D evices  
The A naesthesia  M achine, Vaporiser and Circle S ystem
The anaesthesia machine is used to adm inister m etered am ounts of gases to the 
patient. The anaesthesia machine may operate solely on supplies of gases from 
cylinders, or may use pipeline supply with the cylinders on the m achine acting 
as emergency reserves. Controls on the anaesthesia machine allow the flow rates 
of oxygen, nitrous oxide, carbon dioxide and air in the inspired m ixture to be 
altered. This m ixture of gases can then be passed through a vaporiser which 
adds a volatile anaesthetic vapour to the gas stream . The flow of oxygen, air, 
carbon dioxide and nitrous oxide is measured using “ro tam eter” flowmeters[84]. 
In a ro tam eter flowmeter, a bobbin is suspended in the gas stream  in a tube of 
tapered diam eter as shown in Figure 2.4. The gas flow is calibrated a t a particular
Chapter 2. Anaesthesia  43
tem perature  and pressure and this is incorporated on the flowmeter tube. The 
ro tam eter flowmeter is a simple .deyice bu t because the-bobbin is suspended in 
the  gas stream , it is comparatively easy to determ ine w hether there  is actually a 
flow in the device.
bobbin
tapered tube
Figure 2.4: A Cross-section of a R otam eter Flowm eter
The combined gas stream  flows into a  vaporiser. In the vaporiser, some of the 
gas is passed over liquid volatile agent and then recombined with the rem ainder 
of the gas which bypassed the liquid. This process is calibrated over a range of 
flow rates and is tem perature compensated. This arrangem ent is schem atically 
represented in Figure 2.5.
The anaesthesia machine also features an autom atic  ventilator to  perm it 
ventilation of patients when tha t is appropriate. W hen used, the ventilator 
draws gas from the gas m ixture leaving the vaporiser and passes the gas into the 
pa tien t’s lungs according to pressure or volume settings. The p a tien t’s expiration 
during ventilation is passive due to the elasticity of the lungs and chest wall. The 
ventilator can be bypassed when the patient breathes spontaneously. Ventilators 
generally employ bellows to perform ventilation. The frequency and am plitude 
of the bellows movement determ ine the characteristics of the ventilation. An
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to the patient
Vaporiser
Rotameters
m Cylinder Supplies
Figure 2.5: A Schematic of the Anaesthesia Machine
additional feature of bellows ventilators is th a t their movement can be easily 
observed thus providing vital information on ventilator function.
In m any anaesthetics, a circle breathing system  is used. A circle breathing 
system conserves anaesthetic gases and therefore reduces both  cost and atm o­
spheric pollution A typical arrangem ent is shown in Figure 2.6. The inspiratory 
and expiratory valves are typically placed in clear plastic housings which enable 
their movements to be observed.
Due to  the volume of the circle system , the penalty for the  reduced cost 
and pollution is a dela3'ed change of inspired concentration after a change of the 
vaporiser concentration setting or other fresh gas component and the dependence 
upon soda lim e for the removal of carbon dioxide.
Correct A naesthesia  M achine Function
A correctly functioning anaesthesia machine and delivery system  will ensure th a t 
the gas flows measured by the flow meters enter the vaporiser where the  volatile 
agent joins the fresh gas flow. The vaporiser, if functioning correctly, ensures tha t 
the concentration of volatile agent entering the gas stream  is the same as th a t on
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Figure 2.6: A Schematic of a Circle Breathing System
the vaporiser dial. If a ventilator is used, it should deliver the requested volume 
of gas a t the requested rate  and w ithout exceeding pressure lim its. If a circle 
breathing system is employed, gas flow should be unidirectional in the circle if the 
valves are functioning correctly. The carbon dioxide absorber should be capable 
of removing all expired carbon dioxide from the p a tien t’s exhaled gas.
A naesthesia  M achine M onitoring
The ability to m onitor the function of the anaesthesia m achine is greatly enhanced 
by m onitors which can measure inspired gas concentrations. Using monitors of 
this type, allows m easurem ent of inspired (and end-tidal) oxygen, carbon dioxide, 
nitrous oxide and volatile anaesthetic. Therefore, if the anaesthesia machine has 
been set up to deliver 1 litre /m inu te  oxygen and 1 litre /m in u te  nitrous oxide, 
the  inspired oxygen and nitrous oxide concentrations would then be 50% if no 
circle system  was present. The inspired volatile anaesthetic agent concentration 
m easurem ent can be used to monitor the function of the vaporiser. The inspired 
carbon dioxide m easurem ent indicates the efficacy of the carbon dioxide absorber 
in removing carbon dioxide from the exhaled gas.
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Despite the uncom plicated layout of the anaesthesia machine and breathing 
circuit, their use appears to be the source p f a 4la,rg<s num ber of problem atic 
incidents in anaesthesia. In a study of avoidable problems during anaesthesia, 
Cooper et al. [85] found th a t 19% of incidents were due to  ventilation or breathing 
circuit problems, 19% were related to the use of the anaesthesia m achine and 7% 
were related to  infusion devices. This would imply th a t m ore effective monitoring 
of the anaesthesia machine and drug delivery equipm ent could significantly reduce 
the  incidence of untoward events.
A pproaches to  the A utom atic M onitoring of th e  A naesthesia  M achine
The U tah Anesthesia W orkstation described by Loeb et al. [86] has been designed 
to  assist in the m onitoring and control of the anaesthesia m achine. Associated 
w ith this developm ent is a set of m onitor functions which are capable of correctly 
identifying many anaesthesia machine faults including; disconnections, blockages, 
leaks, em pty cylinders etc. This system incorporates a graphical display to 
illustrate, where appropriate, both  the fault and its location. The system  uniquely 
and correctly identified 88% of all faults presented to  it in a trial. This kind of 
approach may be used to significantly reduce the incidence of anaesthesia machine 
related mishaps in anaesthesia.
2.6.2 M onitoring the P hysiological S ta te  o f th e  P atien t
Greenburg and Peskin [87] state  tha t “The prim ary objective of m onitoring is the 
early detection of physiologic instability.”
Physiological instability is the deviation of physiological variables from stable 
values. Stable values are those which can be m aintained adequately by regulatory 
loops of the body. W hen a regulatory loop is unable to m aintain a value through 
either already exerting maximal effect or through im paired ability to com pensate, 
the  regulated variable becomes unstable. The early detection of a physiologic
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instability  allows compensatory therapy to be in itiated  so as to minimise or avoid 
subsequent effects.
The regulatory loops of the body are highly complex and also interact 
significantly. It is however convenient to group regulatory loops together in 
‘system s’. In considering monitoring in a surgical intensive care unit, Greenburg 
and Peskin [87] suggest the 10 systems listed below.
1. Respiratory 6. M etabolic
2. Cardiovascular 7. Renal
3. Oxygen Transport 8. Hepatic
4. Fluid and Electrolyte 9. G astrointestinal
5. Haem atologic/Coagulation 10. Neurologic
Of these, the first four are of greatest im portance during anaesthesia largely 
because changes in the condition of these systems occur quickly and are associated 
w ith a rapid change in the condition of the patient. The aims and extent of 
m onitoring for these systems is described in the following sections.
M onitoring the R espiratory System
The respiratory system is responsible for the uptake of oxygen into the body, and 
the  removal of carbon dioxide from it. Failure to  either take up sufficient oxygen or 
remove sufficient carbon dioxide causes stim ulation of sym pathetic  nervous system 
activity  and results in significant changes in clinical signs. During anaesthesia with 
inhalational agents, the respiratory system additionally provides the mechanism 
for the uptake and removal of inhaled drugs. Ensuring correct function of the 
respiratory system is therefore vital to both  the physiological s ta te  of the patient 
and to  the adm inistration of an anaesthetic.
As described in the previous section, the anaesthesia m achine and gas delivery 
system can, in faulty conditions, either fail to deliver the required amounts of
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oxygen, nitrous oxide or volatile agent, or can fail to remove carbon dioxide 
from exhaled gas. Adequate monitoring of the anaesthesia machine is therefore 
prerequisite to assuring appropriate respiratory function.
Benumof [88] suggests th a t an “essential m onitoring system ” for the respiratory 
system  involves:
• checking the anaesthesia machine
• monitoring the oxygen-delivery system
• m onitoring apnea
• monitoring m inute ventilation
• m onitoring gas exchange
• m onitoring airway mechanics
• monitoring cardiovascular changes
• monitoring muscle relaxation and,
•  monitoring tem perature.
Assuming th a t the first two of these activities are perform ed during the 
m onitoring of the anaesthesia machine and drug delivery devices, the m onitoring 
of apnea, m inute ventilation and gas exchange are usually m ost im portan t. These 
are discussed below.
1. M onitoring of Apnea
Apnea exists when the patient ceases to breathe. The m ost effective 
determ ination of apnea is achieved by listening to breathing sounds with 
a stethoscope. Breathing can also be assessed by observing the pa tien t’s 
chest movement and the movements of the. anaesthesia m achine reservoir 
bag. Typical respiration monitors calculate respiration rate  using the gas
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stream  carbon dioxide concentration. This has the form shown in Figure 2.7
C02 Partial 
Pressure in 
mmHg Inspiration i Expiration
40- -
time
Figure 2.7: An Example E nd-T idal Carbon Dioxide Waveform
Dips in carbon dioxide concentration occur during inspiration where very 
little  carbon dioxide is expected to be inspired. The peaks in carbon dioxide 
concentration result from the m easurem ent of carbon dioxide in exhaled 
gas. In the event of reduced ventilation or perfusion of the alveoli due to 
disease of obstruction, the ra te  of rise of the C O 2 waveform during expiration 
decreases. This is because gas which has been unable to  equilibrate with 
blood is present in greater quantities than  w ith norm al ventilation and 
perfusion. Respiration monitors calculate respiration ra te  from the period 
of the  carbon dioxide concentration waveform, and deduce apnea when the 
wave features no oscillations.
2. M inute Ventilation.
M inute ventilation is the product of respiratory ra te  and tidal volume. The 
tidal volume is the am ount of gas passing into the patient in each inspiration. 
An adequate m inute ventilation ensures th a t sufficient gas is delivered to the
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lungs to  equilibrate with the blood.
. . M ore correctly, it is the-gas delivery to perfused alveoli which is important* 
and this is called alveloar m inute ventilation. Alveolar m inute ventilation is 
less than  m inute ventilation due to anatom ical and physiological deadspace.
Anatom ical deadspace is composed of the areas of the m outh, nose, trachea 
and bronchi where inspired gas reaches bu t which cannot equilibrate with the 
blood. Physiologic deadspace exists because not all alveoli are perfused at 
all tim es. Inspired gas in the vicinity of unperfused alveoli cannot equilibrate 
with the blood passing through the lungs.
In circum stances where the tidal volume is decreased, m inute ventilation 
can be m aintained by increasing respiratory rate. In such circumstances, 
however, although m inute ventilation is m aintained, the  alveolar m inute 
ventilation is decreased. This is illustrated by an example; Let MVi, 
R R i  and TV\ be a m inute volume, a respiratory ra te  and a tidal volume 
respectively, with
MV-i =  RRi ■ TVi
Now let R R 2 =  2 • R R i  be a new respiratory ra te , and TV2 =  0.5 • T V 1 be a 
new tidal volume. The new m inute volume is then
M V 2 = R R 2 • TV 2 =  M V\
B ut, let the combined physiological and anatom ical deadspace be D S, then 
for the first instance, the alveloar ventilation A  Vi is,
AVi = R R t  • (TVi -  D S) = M V i -  R R i  • D S. (2.1)
For the second case, the alveloar ventilation A \ 2 is given by
AV2 = R R 2 • (TV2 -  D S ) = M V i -  2 - R R i-  D S. (2.2)
Thus, the m aintenance of m inute ventilation does not ensure the m ainte­
nance of alveloar m inute ventilation.
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The anaesthesia machine generally features sufficient instrum entation to 
allow m easurem ent of respiration rate , tidal volume and m inute volume. 
Using estim ates for physiological and anatom ical deadspace allow alveloar 
m inute ventilation to be estim ated.
3. Gas Exchange.
As stated  earlier, it is essential to deliver sufficient oxygen to  tissues and to 
remove sufficient carbon dioxide from them . It is possible to m easure the 
oxygen saturation in blood reaching the  fingers using a finger probe. The 
probe is calibrated so as to give a reading in % saturation  of Haemoglobin. 
Oxygen is bound to Haemoglobin to allow its transport around the body. 
The oxygen-haemoglobin saturation curve depicts the relationship between 
percent saturation of haemoglobin and the arterial oxygen partia l pressure 
and is shown in Figure 2.8.
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Figure 2.8: Oxygen-Haemoglobin Saturation Curve
Thus values of oxygen partial pressure of 80 mmHg or more result in 95% 
saturation of haemoglobin.
In contrast to  oxygen, carbon dioxide is in solution in blood. Physiologically,
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appropriate values for carbon dioxide partia l pressures are also known. 
Expected values for arterial carbon dioxide are in. the range .35TQ 45 rprpHg. t 
The measurem ent of end-tidal carbon dioxide correlates well with arterial 
carbon dioxide m easurem ents and can thus provide a good non-invasive 
estim ate of arterial carbon dioxide partial pressure.
M onitoring the Cardiovascular System
The aim of m onitoring the cardiovascular system  [89] [90] is to ensure th a t all 
tissues receive an adequate supply of oxygenated blood at all times. Normal 
function of the respiratory system allows oxygen to  be taken up by the body and 
carbon dioxide removed from it. The uptake and later elim ination of inhaled 
anaesthetics also relies upon the respiratory system. The process of delivering 
oxygen and drugs to tissues and removing carbon dioxide and drugs from them 
depends upon the cardiovascular system.
Normal function of the cardiovascular system  requires the norm al function of 
the heart, which pumps blood around the body, and of the blood vessels through 
which the blood is pumped.
1. M onitoring the Heart.
The heart pumps blood through the blood vessels thereby delivering oxygen 
and other nutrients to tissues and removing carbon dioxide and other waste 
products from them . The heart functions as a pulsatile pum p and thus 
discrete volumes of blood are ejected into the arterial system  by the heart 
on each heart beat. The pulsatile nature  of the  heart allows a ‘pulse’ to be 
felt in the arteries of the body. The function of the  heart can be routinely 
and non-invasively measured using the following;
(a) Peripheral Pulse
Observing a pulse in a peripheral tissue site, e.g. the  wrist, establishes
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th a t the heart is functioning. Further inform ation is available from the 
characteristics of the pulse. This inform ation gives an indication of the 
state  of the heart and blood vessels.
The presence of a peripheral pulse suggests th a t the heart, brain and 
other vital organs will be receiving adequate blood supply. If the 
oxygen saturation in the peripheral tissues is adequate, the  vital organs 
will be adequately oxygenated.
(b) Electrocardiogram  (ECG)
The mechanical activity of the heart reflected in the  peripheral pulse 
results from the contraction of the muscle walls of the heart. Associated 
with muscle contraction are electrical currents and hence potential 
differences. The ECG measures the potential differences on the surface 
of the body which reflect the polarisation and depolarisation of heart 
muscles. In the presence of a peripheral pulse, with adequate oxygen 
saturation, the ECG can be used to provide heart ra te  inform ation. In 
the event of irregular peripheral pulse or another problem , the ECG 
can be used to determ ine the cause of the problem.
The ECG is responsive to changes in ion concentrations in the blood 
and the oxygenation of the heart muscle and so can be used to  assist 
the recognition of such problems.
2. Monitoring Blood Pressure
A rterial blood pressure reflects the flow of blood through the resistance 
offered by the blood vessels. For a constant cardiac ou tpu t (flow), an 
increase in the vascular resistance will cause an increase in pressure. A 
decrease in vascular resistance will cause a pressure decrease. Similarly, if 
the vascular resistance remains constant, a decrease in cardiac ou tpu t will 
cause a blood pressure decrease and an increase in cardiac ou tpu t will cause
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a blood pressure increase. Blood pressure therefore reflects the  activity of 
the  heart and blood vessels and is a valuable m easurem ent.
The systolic arterial pressure is the highest pressure in the arteries, the 
diastolic pressure is the lowest. The heart muscle is perfused between 
contractions of ventricles and its oxygenation depends upon the diastolic 
pressure. All other tissues depend upon the systolic pressure for adequate 
perfusion. Low systolic pressure can prevent some organs from being 
perfused, low diastolic pressure prevents the heart from being adequately 
perfused.
Because blood pressure results from the flow of blood in the  vascular 
resistance, blood pressure can be m aintained in conditions of low flow 
by increasing the vascular resistance. This is acheived in the body by 
contracting the muscle walls of arteries, arterioles and veins so as to provide 
increased resistance to flow. This process, however, reduces the blood flow 
in the  peripheral tissues so th a t the peripheral pulse weakens.
The presence of a satisfactory peripheral pulse and a norm al arterial pressure 
indicate th a t blood flow and vascular resistance both  possess norm al values.
3. M onitoring Central Venous Pressure (CVP)
The central venous pressure, is the pressure in the  large veins which enter 
the heart. If the blood volume increases from norm al, the  central venous 
pressure increases as does cardiac output. If blood volume decreases, CVP 
and cardiac output decrease. In the presence of norm al heart function, 
m easurem ent of CVP can thus give an indication of the blood volume status 
of the  patient and provide a means of determ ining if fluid delivery is required. 
M onitoring of the CVP is advisable for individuals w ith cardiovascular 
disease or those undergoing m ajor surgery.
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2.6.3 M onitoring th e D ep th  o f A n aesth esia
The. use of- m easurem ents and observations supports assessment of the  physio- * 
logical s ta te  of a patient. Some other observations, in addition to m any of the 
m easurem ents and observations employed to assess the physiological sta te , can be 
used to  assess the  depth of anaesthesia for a patient.
In the  absence of noxious stim ulation, any anaesthetic is too deep. In the 
presence of surgical or other noxious stim uli, anaesthetic depth is assessed using 
the signs of the patient. The most accessible and commonly used signs are eye 
signs, blood pressure, pulse ra te  and rhythm , respiration, muscle relaxation and 
sweating [91] [92].
Eye Signs
Eye signs such as pupil size, pupil response to light, eye movement and eyelash 
reflex have historically been considered to be useful indicators of the  depth of 
anaesthesia. Eye signs are sensitive to drugs being used and do not offer reliable 
indication of the depth  of anaesthesia [91] [92] [61].
Cardiovascular Signs
the cardiovascular signs of routine use in the assessment of dep th  of anaesthesia 
are the blood pressures and heart rate.
1. Blood Pressures
Changes in blood pressure reflect the status of the cardiovascular system  as 
described in Section 2.6.2. If it is established th a t no significant physiological 
im balances exist in the cardiovascular system , then the blood pressure can 
be employed as an indicator of anaesthetic depth. Generally, increasing 
depth  of anaesthesia causes a decrease in systolic arterial pressure [27] [91] 
[93]. This effect is however agent specific. The effects of several anaesthetic
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Agent 1 MAC 1.5 MAC 2 MAC
Halothane 80 70 60
Isoflurane 75 65 45
Isoflurane +  N^O 85 80 75
Table 2.1: Systolic A rterial Pressures as a Percentage of Awake Values for different 
Agents and Concentrations
2. H eart R ate
H eart ra te  changes also reflect the cardiovascular status of a patient 
(Section 2.6.2). If no significant cardiovascular imbalance is present, heart 
ra te  can serve as an indicator of depth of anaesthesia. A sum m ary of 
the effects of several agents and combinations upon heart ra te  is given in
Table 2.2[27].
Agent 1 MAC 1.5 MAC 2 MAC
Halothane 100 100 100
Isoflurane 120 120 120
Table 2.2: H eart Rates as a Percentage of Awake Values for different Agents and 
Concentrations
R espiration  Signs
Assuming otherwise normal respiratory function, changes in respiration can 
indicate changes in depth of anaesthesia, many inhalational agents cause decreases 
in tidal volume with increasing depth of anaesthesia. This is often accompanied by 
a com pensatory increase in respiration ra te  so as to m aintain m inute ventilation. 
Despite this, as outlined in Section 2, the alveolar m inute volume is likely to be 
decreased.
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Drugs such as narcotic analgesics cause reductions in respiratory ra te  bu t tend 
not to  alter tidal volume. As anaesthetic depth increases the breathing patterns 
change and ultim ately respiration ceases.
The value of respiration as an indicator of anaesthetic dep th  is dependent 
upon the effects of the anaesthetic agent(s) being used. W hen muscle relaxants 
are being used respiration information is clearly not available and cannot be used.
Sw eating and Lacrim ation
Robb [61] concluded th a t sweating and lacrim ation were too dependent upon 
pharmacological and environm ental factors to be objectively assessed as indicators 
of depth  of anaesthesia.
M ovem ent
Movement of a patient in response to surgery provides the  m ost categorical 
indication of light anaesthesia. It is however likely th a t cardiovascular signs 
will indicate the presence of light anaesthesia before movement occurs [71]. For 
procedures involving the adm inistration of muscle relaxants, patien t movement is 
prevented thus removing movement as an indicator of anaesthetic depth.
O ther M easurem ents
Aside of the use of clinical signs to assess anaesthetic depth, m any other indicators 
have been proposed. These were summarised in the C hapter 1. Further appraisal 
of these measures was m ade by Thom as and Runcim an [92].
2.7 Specialised Equipm ent used in th is W ork
The overall aim of the work described in this thesis has been to develop techniques 
which support the autom atic control of anaesthesia. Although the rem ainder of
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the thesis is devoted to the description of the developm ent, im plem entation and 
perform ance of these techniques, some more fundam ental activities have been 
carried out during the timescale of the work described in this thesis.
2.7.1 Specialised  Hardware D evelopm en t
Two item s of specialised equipm ent had already been designed and built for 
use in the control of anaesthesia and these were m ade available a t an early 
stage for this work. Firstly, an interface box was available for a Datascope 
3100 m onitor. The Datascope 3100 provides m easurem ents of heart rate , blood 
pressures, tem peratures and oxygen saturation. The interface box coverts the 
Datascope standard bus ou tpu t to RS-232 standard  which can then be directly 
connected to the RS-232 port of a computer.
Secondly, a servo-vaporiser developed by W.M. Gray and staff of the West 
of Scotland Health Boards’ D epartm ent of Clinical Physics and Bioengineering 
and described by Nieman et al. [94] was available. This device consists of a 
stepping-m otor and gearbox m ounted on a standard  vaporiser. In its original 
form, the servo-vaporiser controller was interfaced to  a  parallel port of a  small 
com puter. The com puter was required to  generate direction line inform ation, 
all of the pulses for each vaporiser movement and a safety ‘watchdog’ signal 
waveform. In recognition th a t the generation of the  m otor drive pulses presented 
a significant programming overhead, an interface board was designed to interface 
a com puter with the existing controller. The interface board was designed so tha t 
the  com puter needed only to load the num ber of pulses to be generated to  it. The 
new interface board then autom atically generated th a t num ber of pulses. This 
board has been implem ented by the West of Scotland Health Boards’ D epartm ent 
of Clinical Physics and Bioengineering.
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2.7.2 Specialised  Software D evelopm ent
In addition to the servo-vaporiser described above; this Work has involved'the tise 
of a Braun Perfusor Secura syringe pum p, a Datascope 3100 m onitor and a Datex 
U ltim a monitor. As described previously, the servo-vaporiser requires a parallel 
communication interface to a com puter. Both m onitors and the syringe pum p 
require serial interfaces. Each of the serial devices operates a t a  different baud 
ra te  and with a different protocol.
In recognition th a t this combination of m onitors and drug delivery devices 
allows autom atic m easurem ent of a wide range of clinical signs and m anipulation 
of m ultiple drug inputs, the Closed-Loop Anaesthesia Support System (CLASS) 
libraries have been developed. The CLASS libraries provide v irtual devices to 
allow safe, reliable and efficient communication with the devices described above. 
To maximise processor utilisation, in terrupt-driven  com m unications have been 
employed. To make the use of the libraries as easy as possible, all hardware 
and communication protocol details are hidden from the  user. For instance, the 
CLASS library device which handles the servo-vaporiser autom atically generates 
watchdog pulses of the correct form. The structure  of the  CLASS virtual devices 
is illustrated in Figure 2.9.
A Viglen III/LS PC clone has formed the basis for the im plem ented techniques 
described in this thesis. In order to interface this machine to each of the devices, 
three serial ports and one parallel port are required. Because in terrupt-driven  
communications were used, each port was required to generate independent 
interrupts. The PC therefore had the following added to it;
• Amplicon PC 47 AT Dual Independent RS-232 Serial Port Interface Board
• Amplicon PC 36 LP 24 line Parallel In p u t-O u tp u t Interface Board
The CLASS libraries are currently implemented in C + +  using the Zortech C + +  
compiler to generate code for 286 processors. Further details of the  program m ers’
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Figure 2.9: T he Structure of the CLASS V irtual Devices
interfaces provided by the  CLASS libraries are included in Appendix A.
C hapter 3 
M odelling  th e  P harm acology o f  
A n aesth esia
SUMMARY
This chapter introduces the concepts and relations o f pharmacology. 
Approaches used to model pharmacokinetics are described, in partic­
ular, the use o f physiologically-based pharmacokinetic models. The 
use o f bond graphs to represent physiologically-based pharmacokinetic 
models o f both inhaled and injected drugs is described following the in­
troduction o f bond graph notation and the derivation o f the bond graph 
representation fo r  compartment models.
3.1 Pharm acology
Pharm acology is the study of the m anner in which the function of living systems 
is affected by chemical agents [29]. A naesthetists employ a subset of the available 
drugs to provide an appropriate anaesthetic state. This includes anaesthesia, 
analgesia, muscle relaxation and also rapid and safe anaesthetic induction. Models 
of the pharm acology of drugs used in anaesthesia can satisfy several goals.
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These goals include prom oting be tter understanding of the mechanisms of drug 
distribution, and. action, and. developing better-w ays of using th e ‘drugs. - W ithin * 
pharmacology, pharm acodynam ics describe the relationship between the drug 
concentration at the site of action, and its effect. Pharm acokinetics describe the 
relationship between an adm inistered dose and its route of adm inistration, and 
the concentration established a t the site of action.
3.2 Pharm acodynam ics
For a drug to  create an effect, it m ust alter the behaviour of cells. For m any 
drugs, the effect created can be described in term s of cellular changes resulting 
from the binding of drug molecules to ‘receptors’. There are many different types 
of receptors in the cells of the body and m any more are likely to  b e  found. Each 
type of receptor is responsible for specific effects when it has a  drug bound to it. 
The variation in receptor types and densities in different tissues of the body can 
cause the same drug to exert different effects in each tissue. As an exam ple, there 
are five groups of receptors associated with the effects of opioid analgesics such 
as m orphine and fentanyl. These receptor types are « and cr receptors.
The binding of the opioid drugs to these receptors causes different effects. The 
specific effects of each opioid drug can be explained in term s of the receptors to 
which it binds.
W hen the production of a drug effect does depend upon the binding of drug 
molecules to  receptors, the binding reaction can be represented as follows. For a 
drug A  and receptors R ,
ki
A  + R  ±  A R  (3.1)
ki and k2 are the forward and reverse reaction ra te  constants respectively, A R  is 
the drug-receptor complex. Let N a be the num ber of occupied receptors, N t the 
to tal num ber, and x a the concentration of drug A. From the Law of Mass Action,
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at equilibrium ,
therefore,
w ith K* =
ki • • (Nt -  Na) =. k2 -N a . . .
X a ' N t X cN n =
0 .2)
(3.3)
This gives the relationship between receptor site occupancy (i.e. the fraction 
of sites occupied) and drug concentration as shown in Figure 3.1.
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Figure 3.1: Graph of receptor occupancy versus drug concentration
The relationship in Equation 3.3 describes only the num ber of receptor 
sites occupied at various drug concentrations. It is possible for two drugs to 
produce different effects even when they occupy the  same receptors with the  same 
occupancy. Some drugs are capable of producing a m axim al physiological effect 
even w ithout occupying all the receptors. These drugs are term ed fu ll agonists. 
Drugs which bind to the receptors but which cannot exert m axim um  effect at any
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occupancy are term ed partial agonists. An antagonist is a drug which binds to a
receptor w ithout producing any effects. ...................................................................
Several different drugs can bind to the same receptor sites. If two or more 
of such drugs are present simultaneously, they ‘com pete’ for the receptor sites. 
Taking, as an example, two drugs A  and B  w ith receptor binding reactions
A + R  ku& °  A R
and
B  + R  B R
respectively. Let the concentration of drugs A and B be x a and Xb respectively, let 
N a be the num ber of receptors bound to drug A, Nf, the  num ber bound to drug 
B, and N t the  to tal. Again, by the Law of Mass Action, a t equilibrium ,
and
These give
h a  • x a • (N t — N a — Nt,) =  k2a • N a
hb  • Xb • (N t — N a — Nb) = k2b • Nb
N « =  7— r r r ; ------- k t N , (3.4)(x a +  K a) + x b KaKb
where K a — and Kb = Thus increasing concentrations of drug B displace 
drug A from the receptor sites. If drug B is an antagonist, the to ta l drug effect 
will be reduced due to the reduced occupation of receptor sites by drug A. An 
exam ple of this effect for hypothetical drugs A  and B  w ith K a — 1 and Kb = 1 
or Kb =  10 is shown in Figure 3.2. In this example, the  concentration of drug A 
varies between 0 and 10 units. The concentration of drug B is kept constant at 5 
units.
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Figure 3.2: Com petitive Binding between Drugs
3.3 P  har m acokinet ics
The effect of the drug depends upon the num ber of receptors occupied and 
the extent to which the drug can exert effects. The occupation of receptors 
depends upon the existence of sufficient drug concentration in the  vicinity of 
the  receptors as described by Equation 3.3. Pharm acokinetics describes the 
relationship between the adm inistered dose and the concentration a t the  site of 
effect.
During anaesthesia, drugs are adm inistered most commonly via inhalation or 
intravenous injection. A drug adm inistered intravenously flows through the vein 
in which it is adm inistered to join venous blood returning to  the heart. The heart 
pum ps venous blood through the lungs and then into the  arteries. Once in the 
arteries, the drug is distributed throughout the tissues of the body and ultim ately 
to the sites a t which it exerts its effects.
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An inhaled drug is mixed with the gas breathed in by the patient. The drug 
is then able to reach the alveoli of the lungs and, according tp its physicochemical 
properties, to pass into the blood passing through the lungs. The inhaled drug is 
then  distributed to the tissues of the body in the sam e way as injected drugs.
The transport of a drug by the blood allows it to  reach all tissues of the body. 
This process does not result in equal delivery to  all tissues. The m ost im portant 
organs and tissues of the body receive the largest blood supply in bo th  absolute 
term s and in term s of the perfusion per gram m e of tissue. Some exam ple tissues 
are shown in Table 3.1 [27],
Tissue % cardiac output perfusion
kidneys 18.8 4.5
liver 6.9 0.26
brain 11.5 0.55
muscle 17.7 0.021
fat 5.3 0.024
Table 3.1: The Relative Perfusion of Selected Tissues
These differences in perfusion allow concentrations of drug to build up more 
quickly in the well perfused organs (kidneys and brain) than  in the less well 
perfused organs (muscle and fat). The perfusion of an organ or tissue is therefore 
a main determ inant of the concentration timecourse.
The second main determ ining factor of the drug concentration tim ecourse is 
the ability of the drug to enter cells by crossing cell mem branes. The ability to 
cross cell m embranes allows the drug to diffuse into o ther tissues. In some parts 
of the body, drug can only enter tissues b}' diffusion. This is the case for drugs 
which must enter the brain from the bloodstream . In contrast to  the blood vessels 
in other parts of the body, those of the brain have a continuous wall. A drug must 
therefore travel through the walls of the cells in the brain blood vessels in order 
to  enter the brain.
Cell membranes are largely composed of lipid m aterial. In order to diffuse
Chapter 3. M odelling the Pharmacology o f Anaesthesia  67
across a m em brane, a drug m ust therefore be lipid soluble. More lipid soluble 
drugs paij establish high concentrations-in the-m em brane and thus support high ‘ 
concentration gradients across the m em brane and rapid diffusion. Less lipid 
soluble drugs establish lower concentrations in the m em brane, lower concentration 
gradients across it and less rapid diffusion.
Most of the drugs employed in general anaesthesia are highly lipid soluble 
so th a t the  build up of concentration across a  cell m em brane depends upon the 
ra te  of delivery of drug to the diffusion site. The ra te  of delivery of drug is 
determ ined by the perfusion of the site. In such an instance, the equilibration 
of drug concentrations is said to be perfusion limited. If the lim iting step in the 
process was the rate  at which the drug could diffuse across the m em brane, the 
process would be diffusion limited.
W hile the bloodstream  provides the mechanism for transporting  drug around 
the body in order to diffuse across mem branes, o ther effects alter the am ount of 
drug and timecourse of drug concentration a t receptor sites. In general, drugs 
can dissolve in fat, can bind to proteins and can form ionised species. The overall 
equilibration of a drug involves equilibration between these forms.
3.3.1 P artition  into Fat
Many drugs are capable of dissolving in fat (more correctly lipids). In the body, 
am ounts of fat are present in and around all tissues and sum to a to ta l of between 
3% and 60% of body weight in the population. The relative solubility of a drug 
in fat is expressed in term s of its fatrwater partition  coefficient. Therefore,
c, at — A CWater (^-^)
where C /at is the concentration of the drug in fat, Cwater is the concentration of 
the unionised drug in the water with which the fat is in equilibrium , and A is the 
partition  coefficient.
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3.3.2 P rote in  B inding
.Drugs .can bind, to  protein molecules in the-blood and tissues: In general, mote* 
lipid soluble drugs are also more highly bound to protein. Protein  binding involves 
the  reversible binding of drug molecules to protein molecules. The relationships 
involved can be described using the Law of Mass Action to  give
\D) +  [5] [DS\ (3.6)
where [ D ] is the free drug concentration, [ S ] the concentration of free binding 
sites, [ DS ] the concentration of bound sites, and ki and k2 are the forward and 
backward rates of reaction respectively. Let the free drug concentration be Xd, N b 
be the num ber of bound sites and N t be the to tal num ber of binding sites then 
by the Law of Mass Action.
ki - x d ' (N t -  N b) = k2 - N b
Thus,
Nk =  ir r r  ~ N ‘ =  - t e * *  =  — r j r N t (3-7)k2 -f k\.Xd Xd T ^  Xd T  N a 
where K a =  j -^, the equilibrium constant. If P  is the concentration of protein in
the tissue or fluid, the concentration of bound drug is then
Cb =  w ' p  = i r n r  • p  (3-8)iVf Xd “r
This has the form of a rectangular hyperbola as illustrated  in Figure 3.3.
The precise description of the protein binding relationship for a drug requires 
knowledge of the specific protein sites to which the drug binds, the  concentration 
of those binding sites, and the concentration of the drug in the vicinity of 
the sites. The lack of specific knowledge of the protein binding sites often 
dictates th a t estim ates of protein binding are made. As examples, thiopentone 
is estim ated to be 70% bound to plasm a proteins at therapeutic  concentrations.
M orphine is estim ated to be about 30% bound to plasm a proteins at therapeutic
concentrations.
Chapter 3. M odelling the Pharmacology o f Anaesthesia 69
0.5
0.45
0.4
0.35
S  0.3 
1
2  0.25U-i
I
8
& 0.15
iKa=200.1
0.05
Concentration of Drug
Figure 3.3: Relationship between Drug Concentration and Bound Protein Sites
3.3.3 Ionisation
The th ird  m ain determ inant of drug concentration is the  ionisation of the drug. 
Ionisation involves the establishm ent of equilibrium  between the unionised form 
of a drug and its ionised species. The equilibrium  position depends upon the 
physicochemical properties of the drug and the pH of the fluid in which it is 
present. Ionisation is described by the Henderson-Hasselbach equations which 
are; for a base,
B//+ & B +  H +
[BH+Jp K a =  pH  + logw -
[S]
(3.9)
for an acid,
K
A H ^ A ~  +  H +
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....................................................pK.  =  p l l + j o g j ^ .................................................... ( 3.10) .
where [B H +] is the concentration of ionised base, [B] is the concentration 
of unionised base, [AH] is the concentration of unionised acid, [A ~] is the 
concentration of ionised acid, and [H+] is the hydrogen ion concentration.
3.3.4 E quilibration  w ith in  a T issu e or F lu id
Each fluid or tissue contains am ounts of water, fat and proteins. A drug will 
therefore be able to  ionise, dissolve in lipids and bind to protein in order to 
establish equilibrium . Symbolically, this can be represented as shown in Figure 3.4
dissolved ^  dissolved
protein bound ^ --------------  inwater ^ --------------  inUpids
Figure 3.4: Equilibration within a fluid space
Of course, the p a rt of the drug dissolved in water is divided between unionised 
and ionised fractions as described by the  Henderson-Hasselbach equations (3.9) 
and (3.10). Equation (3.7) relates the drug dissolved in tissue w ater to th a t bound 
to protein. Equation (3.5) relates drug in fat to th a t in the  tissue water. If d is the 
to ta l am ount of a basic drug in the tissue or fluid, x a is the  concentration of the 
free unionised form of the drug in water, W t  is the mass of the tissue or fluid, P  is 
the concentration of protein in the tissue, F j and Fw are the mass fractions of fat 
and water respectively and A is the fat:w ater partition coefficient, then equations
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3.7, 3.5 and 3.9 can be combined to give,
. d =  W T ■ { , f *,, . ■ P  +  A - x i  • F / '+  x,' ■ Fw + : x ,  ■ Fw] ' (3.11)
•T3 i -**p6
This equation contains term s in x s on both  the num erator and denom inator. 
Solution of the  equation for x a therefore requires iteration  in order to  establish 
the  equilibrium  point.
For some drugs, however, the degree of binding to  protein is relatively constant 
throughout the  therapeutic range of concentrations. This is the case for drugs 
which occupy only a small proportion of the available protein sites a t therapeutic 
concentrations. For such drugs, the relationship between the  concentration of 
free drug and the concentration of bound drug can be approxim ated by a linear 
relationship. This approxim ation is possible because when only a small number 
of protein binding sites are occupied, the term  xd is much smaller than K a in 
Equation 3.7. The equation therefore approxim ates to
Equation 3.8 then gives
Cb = j7 -  ■ P- (3.12)
and Equation 3.11 then becomes
d =  W T • { - £ -  • P  +  A • x ,  ■ Ff  +  x , • Fw +  ■ x» • Fw} (3.13)
Mpb
Because x 8 only appears in the num erator of this equation, knowledge of the drug 
am ount in a tissue or fluid space can be used to directly solve for the free unionised 
concentration of the drug.
3.3.5 E quilibration betw een  T issu es or F luids
Only the unionised form of a drug can diffuse through cell mem branes. Equilibra­
tion between two tissues therefore depends upon the unionised drug concentration
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on either side of the m em brane, and the solubility of the  drug in the  membrane. 
The equilibration of two fluid spaces separated by a cell m em brane can be scherpaf- 
ically represented as shown in Figure 3.5.
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Figure 3.5: Equilibrium  of Drug Across a  M embrane
Thus, a t equilibrium,
• Free, unionised parts have equal concentrations either side of the  m embrane.
• The to ta l amount of drug contained in the system  is unchanged
This assumes th a t a negligible am ount of drug becomes stored in the m em brane 
and th a t equilibration is complete. Thus, using Equation 3.11, for the drug in 
fluid 1 before equilibration
d l = W n - {  -  • A  +  A • • Fn  + x n ■ Fwl +  . Fwl} (3.14)
for the drug in fluid 2 before equilibration
d l = W t 2 ’ { ' S  2
*^S2 Kpb2
■ P2 + A• x n  ■ Ff t  + x „  • Fw2 + 10( • x sj • Fm2} (3.15)
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after equilibration, th e  concentration of unionised fractions of the drug is the same 
on either side of the  m embrane. Therefprp, . . . .  ............................................* ■
Because no drug has been added to or removed from the system , 
dl +  d2 = W t\  ■ {---- ——jp— • Pi +  A • xSl • Ffi +  x 9l • Fw\x 3l ~r Fpbi 
+  10(PA'a-pWl) . . FwiJ
+  W T 2 ■ { -------~ ~  ■ p 2 +  A • • F n  +  * «  • f - 13'S2 i" l^ p62 
+ 1 0 (PA 'a - P; / 2) . , Fu>2j
(3.16)
Assuming th a t the pH values, pH \ and pH 2 of both  tissues are known, or can 
be estim ated, the am ount of drug in each form can be derived. If drug delivered 
to  or removed from the tissues is included, the tim ecourse of concentrations, and 
am ounts of drug unionised, ionised, protein bound, dissolved in fat and transfer­
ring between tissues can be derived. The equation for the  equilibration between 
two tissues (Equation 3.16) requires iterative solving. If the  approxim ation used to 
generate Equation 3.13 is valid, then once again, a solution for the free unionised 
concentration of the drug can be found directly.
In general, the  unionised species of the drug is required to bind to a receptor 
in order to exert the effect. The concentration of unionised drug in the vicinity 
of the  receptors may however be much less than  the  notional concentration. This 
process can be illustrated  by considering two examples.
1. Thiopentone.
Thiopentone is a weak acid with a pKa of around 7.5 and is approxim ately 
70% bound to  plasm a protein at therapeutic concentrations. Thiopentone is 
highly lipid soluble and has a fa,t:water partition  coefficient of about 10. The 
equilibration of thiopentone is described as follows: let d mg of thiopentone
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be added to  the K  litres of blood. Using d a ta  from Davis and Mapleson 
[45], the blood is assumed to be composed of 80%, w ater, Q.65% fat .and. 
18% protein and to have a pH of 7.4. Let the free unionised concentration 
of thiopentone be C8 then, the concentration in fat C fat =  10 • C3. The 
ionised and unionised concentrations of thiopentone in w ater are related by 
the  Henderson-Hasselbach equation for an acid drug (Equation 3.10). The 
concentration of the ionised drug in water C; is then
C; =  C, ■ 1 0 =  10-o.l . Q ' _  o 7943 . C'
Because 70% of the drug is protein bound, only 30% rem ains dissolved in 
fat or water. Thus, using equation (3.11)
0.30d =  0.0065 • CJat ■ Vb + 0.80 ■Ci -Vi + 0.80 • C , ■ Vb =  1.50 ■ C , ■ Vb
so,
0.30d „ d
3 ~  1.50 -Vk ~  Vb
The free concentration is thus only 20% of the notional blood concentration. 
This concentration forms the concentration gradient across cell membranes.
2. Morphine.
M orphine is a weak base w ith a pK a of around 8.5. Approxim ately 30% 
of m orphine is bound to plasm a proteins a t therapeu tic  concentrations. 
M orphine is lipid soluble and has a  fat:w ater partition  coefficient of around 
0.4.
Consider d mg of morphine injected to V& litres of blood. Let the free 
unionised concentration of m orphine be C3. The free ionised concentration 
of m orphine is related to the free unionised concentration by the Henderson- 
Hasselbach equation for a weak base (Equation 3.9). Therefore,
Ci = C„ • l o ^ - p W )  =  1 0 14 • c, =  25.1189 • C,
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As 30% of m orphine is protein bound then 70% remains unbound and is 
dissolved in fat and water. T h e , bfoqd com position was detailed for the . 
th iopentone example. Thus, using equation (3.11),
0.7 • d =  0.0065 • (0.4 • C .) • Vh 4- 0.80 • C{ • Vb +  0.80 • C8 • Vb =  20.8977 -Vb -C a
The concentration of free, unionised form of the drug is
0-70 ■ d _  d 
C* =  T, =  0.0335 —20.8977 • Vb Vb
and therefore only about 3% of the notional concentration of the drug is 
contributing to the concentration gradient across cell membranes.
The higher lipid solubility of thiopentone and the greater fraction of free, 
unionised drug allows it to achieve rapid equilibration w ith tissues and this is 
only lim ited by the perfusion of the tissues. This is consistent w ith thiopentone’s 
suitability  as an induction agent.
M orphine requires a longer tim e to achieve equilibration due to  its relatively 
sm aller lipid solubility and greater degree of ionisation. The sm aller fat:water 
partition  coefficient for m orphine does however ensure th a t large reservoirs of the 
drug do not form in body fat. This is a desirable characteristic and supports rapid 
recovery.
3.3.6 R em oval o f D rugs from th e B od y
In order for the effects of a drug to  reduce, the concentration of the unionised 
free form of the drug in the vicinity of the receptors for it m ust fall. The fall in 
the  free unionised drug concentration shifts the equilibrium  of the drug-receptor 
reaction (Equation 3.1) so as to reduce the concentration of the drug-receptor 
complex and thus the effects of the drug.
In general, the concentration of a drug falls if the drug is either metabolised 
by the body to  form other products which do not exert effects, or if the drug is 
excreted and hence leaves the body.
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The main site in the body where m etabolism  occurs is the liver. Some 
drugs are however m etabolised in blood plasm a, the  lungs, or the lining of (th.e t 
gastrointestinal tract. M etabolism involves the transform ation of a drug into a 
m etabolite via a chemical reaction. The m etabolite may be pharmacologically 
active and also exert effects, may be pharmacologically inactive, j and may be 
excreted from the body.
The excretion of drugs can be achieved by the  kidneys or the  liver. The kidneys 
pass drugs into urine and the liver passes the drug into bile. Inhaled agents can 
leave the body via the lungs. For many inhaled anaesthetic agents, this route is 
the only mode of elim ination because they are highly lipid soluble thus resisting 
excretion by the kidneys and they are only insignificantly m etabolised.
3.4 C om partm ental M odels o f  P harm acokinet­
ics
Pharm acokinetic studies often provide only plasm a (or blood) drug concentration 
data. In the absence of knowledge of drug concentrations in other tissues and 
fluid spaces, it is difficult to  develop a model to represent the pharm acokinetics 
of those tissues. Most pharm acokinetic models therefore aim  to produce plasm a 
concentration estim ates which m atch experim ental data. Typical experim ental 
work involves either injecting a drug bolus or infusing the drug for a period of 
tim e. The plasm a drug concentration timecourse is then m easured and used to 
generate a model.
The most commonly applied modelling scheme is com partm ental modelling. 
Using the definition of Cobelli [95]:
“A com partm ental model represents the system  by a finite num ber 
of components, the com partm ents, and by the m aterial exchange 
between them . A com partm ent is an am ount of m aterial which acts
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kinetically in a  homogeneous and distinctive m anner; it is characterised 
by its physico-chemical stat.e ,. its location or .both. . The-flux • • 
of m aterial between com partm ents corresponds either to physico­
chemical conversion of one m etabolite to another in the same location 
or the transport of a  substance from one location to another w ithout 
change of form ”
The most commonly used com partm ental models have either two or three 
com partm ents. Given th a t excretion and absorption can be considered to 
occur in each com partm ent of the model, several arrangem ents are possible for 
combinations of com partm ents. As examples, two possible configurations of a two 
com partm ent model are shown in Figure 3.6.
Figure 3.6: Two Possible Arrangem ents of a Two C om partm ent Model
Conceptually, com partm ent models are often considered to  be composed of 
a central com partm ent which notionally contains intravascular fluid and well 
perfused tissues such as the kidneys, liver, heart, brain and lungs. The volume of 
the central com partm ent is however generally calculated from experim ental d a ta  
and is not chosen to reflect the volumes of the tissues considered to exist w ithin 
it. The rem ainder of body’s tissues are considered to exist in one of the other
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com partm ents which also have volumes which are not necessarily directly related
to the  tissue c o m p o n e n ts . ..................................................................................................
M athem atically, com partm ental models are arranged so th a t transfers between 
and out of com partm ents are related to the am ount of drug w ithin the com part­
m ent. This gives rise to an exponential term  for each com partm ent, e.g. for the 
two com partm ent model shown in Figure 3.7, if x i  is the  am ount of drug in com­
partm en t 1 and X2 is the am ount of drug in com partm ent 2, the ra te  of change of 
these am ounts is given by
dx i
- j j -  — — \ k i o  +  k i 2 )  * %i  +  &21 ’ x 2
and
  * ,
~jj~ — M2 ' X1 ~  &21 * x 2
1 k 12 2
k 21
k 10
Y
Figure 3.7: A Two Com partm ent Model
The solution for the am ount of drug in the central com partm ent is therefore 
the sum m ation of two exponential decays. An example for a hypothetical drug 
has com partm ent volumes V\ =  10 and V2 =  30, transfer coefficients k l0 =  0.1, 
k \ 2  =  0.3 and &2 i =  0.04. A simulation of this system  for an initial bolus dose of 
drug in the central com partm ent gives the curves for com partm ent am ounts shown 
in Figure 3.8. The bolus was represented by the deposition, instantaneously, of 5 
units of mass in the central com partm ent.
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Figure 3.8: Com partm ent Amounts of Drug versus Tim e
C om partm ental models are often developed to represent the pharm acokinetics 
of drugs in the  population. Development of such models involves the m easurem ent 
of the responses of a representative range of individuals. From this collection 
of inform ation, the param eters of a population pharm acokinetic model can be 
selected. This procedure is outlined in standard  com partm ental model texts such 
as [96] and [97]
C om partm ental models olfer a simple representation of drug pharm acokinetics 
which supports the development of dosing strategies. The lim itation to  the 
practical developm ent of com partm ental models lies in the difficulty associated 
with identifying com partm ental models using experim ental data. Some solutions 
to this problem  are presented by Godfrey [97] and Godfrey and DiStefano [98].
Despite some lim itations, the use of com partm ent models provides conceptual 
and m athem atical simplicity and they are therefore widely applied. Work such 
as tha t of V ajda et al. [99] aims to  generate “param eter space boundaries” for
Chapter 3. Modelling the Pharmacology o f Anaesthesia  80
unidentifiable com partm ental models thereby constraining the  num ber of possible 
solutions. Such effort significantly, reduces .the problems .associated w ith-these - - - 
models.
3.5 Physiologically—based M odels o f Pharm a­
cokinetics
A physiologically-based model represents the tissues of the individual in order 
to predict drug handling by the individual. The level of modelling dictates 
w hether tissues are represented individually or are lum ped together in tissue 
groups. Because tissue perfusion is represented in a  physiologically-based model, 
changes in perfusion can be investigated. The representation of tissue masses and 
volumes allows investigation of the efFects of altered body composition.
3.6 Physiologically—based M odels o f Inhaled Agent 
P har m acokinet ics
Inhaled anaesthetics are added to the gas m ixture breathed by the patient during 
surgery. For some inhaled drugs, a very small concentration of the agent is 
adequate to cause the necessary anaesthetic efFect in the patien t, other drugs 
require larger concentrations. The inhaled drug enters the lungs as the patient 
inspires, and equilibrates in the alveoli. The alveoli of the lungs are highly perfused 
areas of tissue where, in normal circumstances, oxygen is taken up by the blood 
passing through each alveolus, and carbon dioxide is removed. The equilibration 
between alveolar gas and the blood passing through each alveolus is rapid and 
complete in normal circumstances. An inhaled drug is similarly capable of entering 
the bloodstream  through the alveoli. Inhaled anaesthetics are readily able to cross 
the walls of the alveoli therefore achieving rapid equilibration with the alveolar
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blood. If a large concentration of the inhaled anaesthetic is present, absorption of 
the agent into the  blood will cause a de,crpas.e pf the gas. volume in the lungs. In 
reality, this volume will be m ade up by a further inflow of gas m ixture to  the lungs. 
In such a case, a greater flow of drug into the lungs, and to the alveoli, occurs 
allowing increased movement of drug into the blood. This efFect is known as the 
concentration effect A similar increase in uptake can occur when one agent is 
adm inistered in the presence of another. A typical exam ple is the adm inistration 
of a small concentration of a volatile anaesthetic agent (e.g. 3% isoflurane) in a 
large concentration of nitrous oxide (around 50%). The uptake of nitrous oxide 
causes a  further inflow of gas m ixture including the volatile agent. The rate of 
inflow of the  volatile agent is therefore greater than  it would be in the absence of 
nitrous oxide. This efFect is known as the second gas effect
The am ount of inhaled anaesthetic crossing the  alveoli depends upon the 
solubility of the drug in blood and the concentration of the  agent in bo th  alveolar 
gas and in the blood of the alveoli. Drug moves across the alveoli until the  tension 
of the agent in the alveolar gas equals th a t in the blood. The tension of anaesthetic 
in a gas m ixture is the partial pressure of the anaesthetic gas. The tension, or 
p artia l pressure, of an anaesthetic agent in a liquid is “the  partial pressure of the 
agent in the gas phase with which the liquid is or would be in equilibrium .” [39].
Inhaled anaesthetics have different solubility in different tissues. Different 
concentrations of drug are therefore present when two different tissues equilibrate. 
A partition coefficient describes the ratio  of concentrations in two m edia at 
equilibrium . P artition  coefficients are generally stated  for blood:gas, tissuergas 
and tissue:blood interfaces. As an example, considering equilibration between a 
gas volume Vg, and a blood volume Vj, w ith bloodrgas partition  coefficient A I f  
there is initially no agent in the blood bu t am ount d in the gas then, assuming 
the concentration in the gas after equilibration to be c,
d>   C Vg “1“ A fjg • c * Vj,
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and,
d
............................................................ c +  h s - Vb ...........................................................
Arterial blood which has equilibrated w ith alveolar gas is pum ped, by the 
heart, to the tissues of the body. Each tissue equilibrates w ith the arterial blood 
anaesthetic tension according to its tissue:blood partition  coefficient, the volume 
of the tissue, and its blood flow. A simplified grouping of the body’s tissues 
into four groups is shown in Table 3.2 [27]. Clearly, as tissue volume increases,
Tissue Group % of Body Mass % of cardiac O utpu t
Vessel-Rich Group 10 75
Muscle Group 50 19
Fat Group 20 6
Vessel-Poor Group 20 <  1
Table 3.2: Relative Masses and Perfusions for Tissue Groups
more drug m ust enter the tissue in order for it to equilibrate w ith arterial blood. 
Also, highly perfused tissues receive a large blood supply which also delivers large 
am ounts of drug. Well perfused tissues are therefore able to  equilibrate more 
rapidly than  less well perfused tissues for equal volume. The tissue:blood partition 
coefficient dictates the ratio of drug concentrations in the  tissue and in the blood 
at equilibrium. As the tissue:blood partition  coefficient increases, more drug must 
enter the tissue in order to achieve equilibrium  concentration. These factors are 
summ arised in Table 3.3.
Factors Increasing Rate Factors Decreasing R ate
low tissue:blood partition  coefficient 
small tissue volume 
large blood flow
high tissue.'blood partition  coefficient 
large tissue volume 
small blood flow
Table 3.3: Factors Affecting the R ate of Tissue Equilibration
Recovery from anaesthesia requires the removal of drug from the tissues and
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blood. The removal of drug from each tissue depends upon the sam e factors as 
the ra te  of equilibration during uptake. The factors which increase tjie. r^te. of 
equilibration also increase its ra te  of removal of the  drug. Those which decrease 
the ra te  of equilibration slow down the removal of drug from the tissue. Removal 
of drug from the blood requires equilibration between alveolar gas and the blood 
in the alveoli as for uptake, except th a t the drug moves out of the blood.
M apleson [37] derived differential equations describing the  uptake of inhaled 
anaesthetic by the tissues of the body in term s of alveolar ventilation, cardiac 
ou tpu t, tissue perfusion, tissueigas and blood:gas partition  coefficients and tissue 
volumes. Mapleson derived an electric analogue of anaesthetic uptake which 
consisted of the passive electrical network shown in Figure 3.9. As indicated 
in this diagram , the component values were all based upon the physiological 
characteristics of the individual and the physicochemical properties or the drug. 
As a result of this, currents in the analogue actually correspond in value to mass 
flows of drug in the patient.
Mapleson [38] further developed the theory proposed in [37] to  accom m odate 
the concentration and second-gas effects. The incorporation of these effects 
within the  electrical analogue (Figure 3.9) was also described. In [37], Mapleson 
acknowledged th a t the electrical analogue did not represent either the tim e taken 
for the  blood, at alveolar tension, to travel from the  lungs to each tissue, or to 
travel from each tissue, at tissue tension, back to the lungs. In fact, these transfers 
were assumed to  be instantaneous.
In [40], Mapleson proposed an overall model structu re  which is reproduced in 
the schematic, Figure 3.10. In this model, each tissue, or tissue group possesses 
an ‘a rte ry ’ and a ‘vein’. The artery and vein are considered to contain a sequence 
of fractional stroke volumes which move from the lungs, along the artery, through 
the tissue, along the vein and back to the lungs. On each heart beat, a fractional 
stroke volume moves one step around the loop. The arteries and veins contain
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tissue blood flow 
x blood:gas coeffalveloar ventilationinspired tension
arterial tension
lung gas
lung tissue + 
arterial blood
tissue volume 
x tissue: gas coeff
Figure 3.9: M apleson’s Electrical Analogue for Inhaled Agent Uptake
sufficient fractional stroke volumes to represent the  circulation tim e of the tissue. 
The circulation tim e for the model is assumed to  be the m ean transit tim e for the 
tissue which is given by
volume of blood between two points
m ean transit tim e = ------------------- -------------------------------
now ra te
Because circulation tim es vary between tissues, the  num ber of fractional stroke 
volumes in the arteries and veins of each tissue also varies.
Mapleson also proposed four approximations to  this model for use in the 
com putation of tissue tensions. These models were nam ed model 0 ,  F, M and P 
[40]. In model 0 ,  all blood from the ‘arteries’ was placed in the lung com partm ent 
and blood from each vein was placed in the appropriate tissue. The explicit 
representation of circulation tim e is therefore lost, bu t because inspired gas must
equilibrate with all arterial blood, some delay is imposed. In model F, all arteries
and veins are reduced to the length of the shortest artery  and all arteries are then
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Figure 3.10: Mapleson Circulation Tim e Model
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joined together. Blood from the truncated  parts of the longer arteries and veins 
is placed in the appropriate tissue com partm ent. In this mode] th e re ,is .explicit 
representation of circulation tim e for the fastest tissues. Model M adopts the 
approach of model F with respect to the truncation of arteries and veins. Model 
M differs from model F in th a t the longitudinal mixing of blood in the arteries 
and veins is allowed and is modelled. Model P is also derived from model F but 
differs in th a t instead of the artery and vein being composed of a finite number 
of non-com m unicating stroke volumes, they become single well m ixed pools.
M apleson compared each approxim ation and concluded th a t the differences 
between models F, M and P were small so th a t model P presented the simplest 
and m ost convenient approxim ation to the original model (Figure 3.10). Using 
d a ta  from the International Com m ittee for Radiological Protection, Mapleson 
param eterised each model to  give tissue volumes, associated blood volumes for 
each tissue, and tissue perfusions. Assuming the pulm onary circulation tim e of 
7.5 seconds, and a “highway” circulation tim e of 5.5 seconds given by Mapleson
[40], each circulation has a component of circulation tim e of 13 seconds. The sizes 
of arterial, venous and tissue blood pools are then calculated. This is done by first 
calculating the total blood volume associated with each tissue using the equation
associated blood volume =  circulation tim e • tissue blood flow
The to ta l blood volume is then the sum of the  associated blood volumes for 
each tissue. Of this, one quarter was assumed by Mapleson to  be arterial and 
the  rem ainder was therefore assumed to be venous blood. These volumes were 
further subdivided to  give local tissue pools and the arterial and venous pools 
so as to accurately reproduce the local and ‘highway’ circulation tim es for each 
tissue. The circulation schematic diagram for M apleson’s model P is shown in 
figure 3.11.
O ther related work in this area has largely stem m ed from the m ultiple 
model struc tu re  proposed by Beneken and R ideout [44]. A m ultiple model is
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Figure 3.11: Circulation Schematic for M apleson’s Model P
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composed of m ultiple interacting submodels. For instance, the  original model 
described by Beneken and R ideout contained a cirqul.ation model and a  second 
model for a substance transported  in the blood. Zwart, Sm ith and Beneken
[100] [43] developed an electrical analogue of a m ultiple model to  represent the 
interaction between halothane uptake and circulation. In th is model, halothane 
concentrations caused alterations in cardiac ou tpu t and vascular resistance which 
has further effects upon halothane uptake. Ventilation was assumed to be 
constant. This model suggested th a t significant changes occurred as a  result of 
the interaction between halothane uptake and the circulation. Fukui and Sm ith
[41] [42] described a m ultiple model w ith representation of respiration, circulation 
and the uptake and distribution of halothane. This m odel used pulsatile flows 
in blood vessels and used halothane concentrations in one, or a combination, of 
three com partm ents to m odulate circulatory and respiratory performance.
The model of Schwid [101] also employed a m ultiple model consisting of a 
pharm acokinetic-pharm acodynam ic model, a  circulatory model, and a carbon 
dioxide and oxygen transport model. Schwid’s model aim ed to  represent the effects 
and interactions between inhaled and injected drugs in the  sim ulated patient.
3.7 Physiologically—based M odels o f Injected  
A gent Pharm acokinetics
Injection of a drug can be to  various anatom ical sites. Intram uscular injection 
deposits drug in a muscle from which it enters the  circulation. Intravenous 
injection places a drug directly in the blood in a vein. The drug then flows 
in the venous blood to the heart and is pum ped into the  arteries and through the 
tissues of the body. An in traarterial injection places drug in an artery  allowing 
significant concentrations of the drug to be developed in the tissues served by the 
artery. The distribution of drug following injection depends upon:
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1. the physico-chemical properties of the drug
and, ......................................................
2. the physiological characteristics of the body tissues.
T he physico-chemical properties of the drug include its pK a, its protein 
binding characteristics and its solubility in lipids. Physiological characteristics 
of relevance include the perfusion of the tissue, the volume of the  tissue, and its 
components as fat, water and protein.
As the drug enters the blood, from an injection site, equilibration occurs 
between free unionised, free ionised, protein bound and lipid dissolved drug. 
As blood passes through a tissue, drug may diffuse between the tissue and the 
blood of may pass through spaces in blood vessel walls. The net flow of drug 
may be either into or out of the blood depending upon the  equilibration. Blood 
leaving the tissue after equilibrating with it mixes w ith other venous blood in the 
large veins. Further equilibration occurs in these vessels. Description of injected 
agent pharmacokinetics requires representation of each stage in each equilibration 
process. This equilibration process w ithin a tissue or fluid space was schem atically 
represented in Figure 3.5.
In comparison with the processes for inhaled anaesthetics, injected agents 
present more complex calculations. The concept of anaesthetic tension allowed 
simple m anipulation of inhaled agent concentrations. The use of tensions is a 
realistic approximation for most inhaled agents because inhalational agents do 
not ionise to  any significant extent in solution. There is sim ilarly no evidence of 
the binding of inhaled anaesthetic drugs to specific sites in proteins. All of the 
drug is therefore dissolved in either fat, water or protein [102] and the tissue or 
fluid space can therefore be represented as a volume w ith an associated tissuergas 
partition  coefficient. Equilibration therefore results in the tensions in all tissues 
reaching the same levels. For injected agents, only unionised drug can dissolve in 
fat and, depending upon the drug, either unionised, ionised or both  unionised and
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ionised forms of the drug may bind to proteins [103]. I t is therefore not possible 
to consider a partition  cpefficjent which will represent th e  ‘capacity’ of a tissue'or 
fluid for a drug. The expression of such a param eter would be dependent upon 
pH, tem perature  and m any other factors.
As an example, Equation 3.11 expresses the to ta l am ount of a basic drug in a 
tissue or fluid space in term s of the free unionised form of the drug. Reproducing 
this equation for clarity,
d =  W T • { -  • ■P + \ - x , - F /  + x , - F w + lOf”* - ”" ’ • x a ■ F„ }x 8 + I<pb
The ratio  of the free unionised form of the drug to the  to ta l drug am ount is then 
given by
r a f ;0  ___________________EjH__________________
^  + A • F , +  (1 +  10<»*->-*)) • F„
If this ratio  is taken as a partition coefficient, it is therefore dependent upon the 
pH and the concentration of the drug and m ust be recalculated at each stage.
Davis and Mapleson [45] proposed a model for the pharm acokinetics of injected 
agents. The model was based upon M apleson’s model P [40] w ith slight alteration 
of d a ta  to  incorporate the 1975 ICRP standard  m an. Davis and Mapleson added 
explicit portal, liver and kidney circulation paths to  support representation of 
excretion and m etabolism . The single venous pool of M apleson’s model P was split 
into two parts in order to “perm it accurate representation of i.v. injections” [45]. 
The ICRP standard m an of 1975 included d a ta  on the  composition of each tissue 
in the body in term s of water, protein and fat. The circulation path  schematic 
diagram  of Davis and M apleson’s model is shown in Figure 3.12.
In his Ph.D . Thesis [46], Davis described the  steps involved in the simulation 
of injected agent pharmacokinetics and used pethidine as an example. Davis 
separated the body into two ‘regions’: blood and tissue. Each region had two 
sub-regions; red cells and plasm a for blood and tissue cells and interstitial fluid for 
tissue. Each sub-region was itself composed of specified am ounts of water, fat and
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Figure 3.12: The Circulation Path  Schematic for Davis and M apleson’s Model
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protein. Davis described relevant pharm acokinetic d a ta  describing the  ionisation, 
protein binding and partition into fat of pethidine, and chose representations of 
each relationship according to the quality of the da ta  available. Davis derived 
equations for the ra te  of change of to ta l drug am ount in a sub-region w ith respect 
to the  concentration of the free unionised form. The available da ta  for pethidine, 
and experim ental work carried out by Davis required th a t protein binding was 
represented by a relationship of the same form as Equation 3.8. In consideration 
of the am ount of drug in a tissue, Davis used equations of the form of Equation 3.11 
to  derive the am ount of the drug in the plasm a, red cells, tissue cells and in terstitial 
fluid of each tissue. The change in drug am ount was calculated as the  difference 
in drug content caused by the arrival of a new drug bolus and the departure of 
an old one. The free unionised concentration was then calculated by iteration so 
as to make the  estim ated am ount in the tissue, based upon the  estim ated free 
unionised concentration, move within a specific tolerance of the actual am ount of 
drug in the tissue which was kept via tallying.
Davis represented the m etabolism  of pethidine using a simple empirical 
relationship in which a constant fraction of the drug am ount in the blood arriving 
at the liver was removed. This relationship was chosen because information 
available on pethidine m etabolism  did not support quantification of a more specific 
relationship. Excretion of pethidine was also represented empirically bu t included 
the  effects or urine pH.
Higgins [103] used Davis’s model for pethidine as the basis for a  physiologically- 
based model of fentanyl pharmacokinetics. Higgins added a new nasal com part­
m ent to the pethidine model to allow for the modelling of intranasal adm inistration 
of fentanyl. The ionisation, protein binding and dissolution into fat of fentanyl 
was represented in accordance with existing studies in the area. The m etabolism  
of fentanyl was represented by removing a constant fraction of the drug from the
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blood entering the liver. Excretion of fentanyl by the kidneys was represented dif­
ferently to  th a t in Davis’s model and allowed for a concentrating effecjt ip the.renal 
tubule along with variation according to urine pH. Fentanyl apparently  binds to 
a sm all proportion of the available protein binding sites. The Scatchard equation 
which relates the protein bound and free forms of a drug is
=  rrfct (3-17>
where n is the num ber of protein binding sites per protein molecule, k is the 
binding constant, Cb is the ratio of mmol bound drug to  mmol protein and C 3 
is the  concentration of the free form in mmol drug per g water. W hen the  drug
binds to  only a  small fraction of the available protein sites, the term  k • Ca is small
and equation 3.17 approxim ates to
Cb =  n  • k • Cs
T he generation of the free unionised concentration of fentanyl in Higgins’ model 
therefore uses equations of the form of Equation 3.13 to  represent the distribution 
of a drug am ount w ithin each tissue. In this form, the free unionised concentration 
can be directly obtained given the am ount of drug in the tissue. This removes the 
need for com putationally expensive iteration.
In contrast to the work of Davis and Higgins, the model employed by Schwid
[101] was described as having the capacity to  represent pharm acokinetics and 
pharm acodynam ics of morphine, thiopentone, fentanyl, lidocaine, succinylcholine, 
pancuronium , atracurium  and neostigmine. Schwid describes an eight tissue 
group model where the tissue groups are defined in term s of mass, oxygen 
consum ption and carbon dioxide production. The equilibration of injected drugs 
within the  model is modelled by assigning a tissue:blood partition  coefficient for 
each drug. From Schwid’s description of the drug model, it is unclear whether 
tissue perfusions, blood volume and circulation tim es are reliably represented in
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the model. The basis of selection of the partition  coefficient for each tissue for
each drug is not described. .........................................................................................
In summary, the physiologically-based models developed by Mapleson [40],
Davis and Mapleson [45], Davis [46] and Higgins [103] each employ realistic 
param eters to represent tissue volumes and masses, compositions and perfusions.
The d a ta  available for the physico-chemical properties of the drugs appears 
to  present current lim itations to the quality of the modelling. Davis [46] 
actually performed some experim ents in order to  determ ine physicochemical 
data. Iliggins [103] required to arb itra te  between often inconsistent d a ta  in the 
available literature. It appears therefore, th a t the perform ance lim itations of 
physiologically-based models of pharm acokinetics are largely due to  the  lack of 
good quality physicochemical data. If physiologically-based models become more 
widely used in the analysis of drug pharm acokinetics, the system atic evaluation of 
physicochemical param eters through good experim ental design and performance 
should follow.
3.8 R epresentation  o f P hysiologically—B ased  Phar­
m acokinetic M odels
In a recent editorial, Hull [104] suggested th a t in order to  analyse drug disposition 
data, “the most satisfying approach is to  derive a physiological model tha t 
em ulates, as far as possible, what actually happens in the body” . Hull suggests 
th a t the  m ain advantage of this approach is th a t physiologic changes can be 
accom m odated. He also concedes th a t the  m ain disadvantage of these models 
is th a t “numerical values must be assigned to their m any param eters” . A 
further lim itation to the utility of physiologically-based models is the lack of 
an appropriate model representation.
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Physiologically-based models have been developed by several workers includ­
ing Mapleson [40], Davis and Maplejsop [45], Davis [46] and  Higgins [103] s These 
models have employed tex tual description and graphical schematics to  express the 
im portan t concepts of the models. W ithout exception, however, the actual repre­
sentation  of the model has involved m athem atical equations w ritten  in com puter 
code.
To an individual, unfam iliar w ith either program m ing or physiologically-based 
modelling, it is not simple to separate the im portan t aspects of the model from 
the  mechanisms of the program. In such a case, the representation of the model 
actually detracts from its utility. The following sections introduce Bond Graphs 
for the representation of models. Their use will be illustrated for the representation 
of com partm ent models first and then for physiologically-based pharm acokinetic 
models.
3.9 B ond Graph M odel R epresentation
Bond graphs [105] provide a means of graphically representing system  models. 
They were originally used to represent engineering models bu t have been used 
in m any other areas [106]. For instance, Karnopp and Rosenberg [107] describe 
the  use of bond graphs for mechanical, electrical, therm al and acoustic systems. 
Bond graphs have also been used to  represent biological models. As examples, 
P lan t and Horowitz [108] used bond graphs to represent chemical reactions and ion 
transport; Karnopp and Azarbaijani [109] introduced bond graphs for generalised 
com partm ental models; Lefevre and Barreto [110] used a com bination of block 
diagrams and bond graphs to  represent biochemical models and Thom a and Atlan 
[111] represented osmosis using bond graphs. Further diverse applications are 
described by Thom a [112].
These applications illustrate the utility of the bond graph representation
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technique. Given this utility, the bond graph technique has therefore been used 
to  represent the physiologically-based models described earlier in t,hq chapter.. .
3.9.1 B ond Graph N otation
This section is intended to provide an informal introduction to  bond graph 
elem ents and their notation. Of course, full description of the notation is given in 
standard  tex t books such as [107] and [113]. Bond graphs consist of components, 
junctions and their interconnections. Common to all bond graphs are the concepts 
of effort and flow which can also be term ed ‘across variables’ and ‘through 
variables’. A simple example is voltage as an effort variable and current as a 
flow variable for an electrical system. In some bond graphs, true  power bond 
graphs, the product of effort and flow gives the instantaneous power flow in the 
system. This is the case in the electrical example. In o ther situations, the effort- 
flow product does not have the dimensions of power and these bond graphs are 
term ed pseudo bond graphs. Bond graph components can represent loss, storage, 
or transform ation of quantities appropriate to the system  model being represented. 
Bond graph junctions provide no loss or storage but conserve m aterial or energy.
C o m p o n e n t a n d  J u n c t io n  In te rc o n n e c tio n s
1. Bonds.
A bond represents an ideal connection which possesses no loss, storage or 
transform ation of m atte r or energy. Each bond therefore has one effort 
and one flow associated with it. A bond is illustrated in Figure 3.13. The 
half arrow on the bond signifies the assumed positive direction of energy or 
m aterial flow. As indicated in Figure 3.13, horizontal bonds have their effort 
variable w ritten above them  and their flow variable below. Non-horizontal 
bonds have their effort to the left of the bond and their flow to the right.
Chapter 3. Modelling the Pharmacology o f Anaesthesia 97
effort OR effort
flow
flow
Figure 3.13: A Bond and its Notation
2. Signals.
Signals allow one way transfer of inform ation. Signals are usefully employed 
to represent the transport of m aterial and this feature is exploited in later 
examples. The difference between a bond and a signal is illustrated  later 
following introduction of the rem aining bond graph notation.
Junctions
There are two types of bond graph junction. A common effort or ‘0’ junction is 
characterised by each of the bonds attached to it having the same effort and the net 
sum of the flow variables on the bonds attached to it being zero. A common flow 
or ‘1’ junction is characterised by each of the bonds attached to it having the same 
flow and the net sum of the effort variables on the bonds attached to it being zero. 
The notation of bond graph junctions is sum m arised in Figure 3.14. To further 
illustrate their use, Figure 3.15 gives a simple electrical exam ple of two resistors 
either in series or in parallel. The parallel pair have the same voltages across 
them  (a common effort) and the to tal current in the resistors is the sum of the 
individual currents (net flow sum is zero). This arrangem ent can be represented 
using a common effort junction. In the series com bination, both resistors have 
the same current (a common flow) and their individual voltage drops sum to the 
to tal applied voltage. This arrangem ent can be represented using a common flow
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junction.
A
e2 f2
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fl
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f3
el = e2 = e3 
f 1 = f2 + f3
A
e2 f2
el
fl
e3
f3
f 1 = f2 = f3 
el = e2 + e3
Figure 3.14: Bond Graph Junctions and their Notation
V
vl v2
Figure 3.15: An Electrical Example for Illustration of Junction Types
C om ponents
1. The Resistor.
This component is used to represent resistance to flow and dissipation. 
Electrically, a voltage applied across a resistor causes a current through
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pi
it. Conversely, a current flowing through a resistor causes a voltage to be 
established across it. Similarly, the djffusipn. of a  drug across a membrane* 
(a flow) depends upon the existence of a concentration gradient across the 
m em brane (an effort). In power bond graphs, the product of the effort 
and flow variables associated with a resistor gives the power dissipated in 
it. Some examples of different uses of bond graph resistors are shown in 
Figure 3.16.
R
p 2
single pipe
!\
pl-p2
p l p2
R1
A
vl-v2 vl-v2 il
v l il 
O  ►
v 2  
— O
vl_
il
A  1
v2
TT~
A
R1
electrical resistor
Figure 3.16: The Resistor and its Notation
2. The Flow Store
The flow store is illustrated by the fluid system  of Figure 3.17. In this 
example, the fluid accum ulated in the tank (flow store) causes a pressure 
at the bottom  of the tank (an effort). Because the pressure in the pipes 
entering and leaving the tank is the same as th a t in the tank, the bond 
graph representation for the tank involves a common effort junction. In more
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abstract term s, a linear flow store can be considered to have the relationship
effort =  ~  • /flow  d t (3.18)
G J
where C is a constant (e.g., capacitance) with dimensions appropriate to the
I
! selection of effort and flow variables.
fl
/
p fl-f2
P
fl f2
Figure 3.17: The Flow Store and its Notation
3. The Effort Store.
The effort store is the dual of the flow store therefore,
flow =  y  • J  effort d t (3.19)
where I is a constant (e.g., inertance) with appropriate dimensions.
Effort stores are rare in physiological systems.
The D ifference betw een Bonds and Signals
Figure 3.18 illustrates the differences between bonds and signals. In the diagram 
on the left of the Figure, the flow out of the first tank depends upon the  pressure
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difference between the tanks. In other words, the second tank  can apply a back­
pressure to the outflow of the first tank. In th$ diagram, on the. right, the pressure* 
in the second tank has no effect on the outflow of the first and the flow therefore 
depends only upon the pressure in the first tank. Portions of a bond graph 
representation for these systems are included in the Figure. Note th a t when the 
flow from the tank depends upon bo th  the forward and back pressures, a bond is 
used. W hen it depends only upon the forward pressure, a signal is used.
R
o p2
f  f
bond: f = (pl-p2)/R
O
piO— — ^ 1
signal: f = pl/R
■> O p2
Pi
-------
R
Pi
R
p2 p2 L
flow depends upon pressure at either end flow depends upon only one pressure
Figure 3.18: Comparison of Bonds and Signals
C ausality
One of the central themes of bond graph representation is th a t of causality. 
Causality, in this context, means com putational causality, which determ ines the 
order in which the equations of the system m ust be solved. A simple example is 
th a t of a  resistor. The relationship defining the characteristics of the resistor can 
be expressed as either of
effort =  flow • resistance
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or
_ effort
ilow =  — :............ ........................................
........................................................................ resistance
Causality determ ines whether the equations of the system  should be solved so 
as to  determ ine the  effort or flow for such a component first. The appropriate 
version of the relationship is then applied. In a bond graph containing sources of 
effort or flow or both , causality is defined for each source and cannot be changed. 
This is illustrated  for effort and flow sources in Figure 3.19 An effort source
effort 
 -**.
effort source Se: " ^________ — I
flow
^ effort
flow source Sf: I--------------------- >»
flow
Figure 3.19: Causality of Effort and Flow Sources
determ ines the  effort input to  the system bu t the system  determ ines the  flow 
through the  source. A flow source determ ines the flow through the system  but 
the  system  determ ines the effort across the source.
Flow stores and effort stores have preferred causality as shown in Figure 3.20. 
It is clear th a t for a flow store, it is desirable th a t the flow into the store is 
determ ined by the system  and th a t the effort returned by the store is determ ined 
by the store. The opposite is true for an effort store.
A further effect of causality is m anifested at junctions. At a  common effort 
junction, all bonds share a common effort. It is not possible for more than  one 
bond to convey this effort to the junction. All bonds except one therefore accept 
the effort value from the junction. Conversely, for the common flow junction, only 
one bond may apply the flow to the junction, all others must accept it. These 
situations are illustrated in Figure 3.21.
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Figure 3.20: Causality of Effort and Flow Stores
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! flow
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Figure 3.21: Causality of Bond Graph Junctions
C on stitu tive  R elations
The constitutive relation of a component is a physical or em pirical law which 
describes its behaviour. In discussion so far, only linear relationships have been 
considered. In general, any non-linear relationship can form the  constitutive 
relationship for a component. The use of non-linear constitutive relationships is 
illustrated  later.
3.10 B ond Graph R epresentation  o f C om part­
m ent M odels
In this section, the  bond graph representation of com partm ent models is derived. 
This serves to illustrate  the use of bond graph bonds, signals, junctions and 
components in the representation of a well-known class of models. In this way,
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the characteristics of the representation are m ade distinct from the characteristics 
of the  model. F irst, the bond tgrapji foi; a. tw orcom partm ent model is derived.- - - - 
The bond graphs for different arrangem ents of tw o-com partm ent models are then 
given for comparison. The bond graph for a th ree-com partm ent model is then 
used to  derive simulation equations. These are param eterised using d a ta  on the 
population pharmacokinetics of propofol and sim ulation results are presented.
The com partm ental model notation employed in this section is th a t suggested by 
Hull [114].
3.10.1 D eveloping th e R ep resen tation  for a T w o-C om partm ent 
M odel
The schem atic diagram for a tw o-com partm ent model is shown in Figure 3.22. The 
com partm ental model implied by this schem atic consists of the following parts: 
two com partm ents (labelled 1 and 2), a drug source (Sf) and three m icroconstants 
(labelled k12, k21 and A:10).
The C om partm ents
Each com partm ent represents a notional am ount (volume or mass) of a  tissue.
The injection or infusion of drug into the com partm ent results in an amount 
and a concentration of drug in the com partm ent. The concentration is given 
by cone =  ^  for drug am ount x and com partm ent volume (or mass) V. The 
com partm ent is analogous to a water tank, since a flow of water into the tank 
results in pressure at the base of the tank.
In bond graph notation, this behaviour is displayed by a capacitance. The 
constitutive relationship for a capacitance in the context of com partm ent models 
is shown in Figure 3.23.
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Sf
k121 2
k 21
k10
Figure 3.22: A Tw o-Com partm ent Model
Concentration
V y/x = 1/C
Amount
Figure 3.23: A Capacitance in Pharm acological Context
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M icroconstants define trahsfers between com partm ents. W ith  aq mg of drug 
in com partm ent 1, and a m icroconstant k i2 s _1 describing the transfer from 
com partm ent 1 to com partm ent 2, the ra te  of drug flow from com partm ent 1 
to  com partm ent 2 is k1 2  • m g/sec. This transfer depends only upon the  amount 
of drug in com partm ent 1, bu t not upon th a t in com partm ent 2.
In bond graphs, a one way transfer can be represented by a signal. The 
m icroconstant can be represented using a resistor. An appropriate arrangem ent is 
shown in Figure 3.24. In this arrangem ent, c\ is the concentration in com partm ent 
1, cB is the concentration on the signal and /  is the flow of drug from com partm ent 
1 to  com partm ent 2. The drug flow is therefore
r j  C\f lo w u  =  - g -  =  -
But the signal goes from a common-flow junction. It therefore carries flow only 
and c3, the effort variable, is therefore zero.
For this representation to  be equivalent to the com partm ental model, the  drug 
flow values predicted by each representation m ust equate. This is achieved by 
selection of R  as follows:
if V\ is the volume of com partm ent 1 then
so
C l 1
R  =
k i2 • x i k12 • Vi
The m icroconstant representing transfer from com partm ent 2 to com partm ent 
1, k2 i , can be similarly represented. The m icroconstant representing clearance 
from the model, k i 0  is represented in bond graphs as a resistor placed between the 
first com partm ent and the environment. The value of this resistor is calculated in 
the same way as th a t for the other microconstants.
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R
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f  f
Figure 3.24: Bond G raph Representation of a  M icroconstant 
O v e ra ll R e p r e s e n ta t io n .
To complete the representation, it is now only necessary to ensure th a t drug is 
conserved w ithin the model. Thus, for each com partm ent, drug flows can be 
from an external drug source into the com partm ent, from another com partm ent, 
to another com partm ent, or to the environm ent. At all tim es, these flows must 
sum to zero because drug is conserved within the model. Also the flows from a 
com partm ent are all dependent upon the am ount in it. In bond graphs, both of 
these conditions are satisfied by the placem ent of com partm ent and m icroconstant 
representations about a “0” or “common-effort” junction. This final arrangem ent 
is shown in Figure 3.25.
S t r u c tu r a l  C h a n g e s  in  th e  M o d e l a n d  B o n d  G ra p h
Figure 3.26 shows the schem atic diagram  for a two com partm ent model which 
has drug elim ination from the second com partm ent, and the bond graph for this 
model. It can be seen th a t the changes in both the schem atic diagram  and bond 
graph are very simple.
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Figure 3.25: Bond Graph of the Tw o-Com partm ent Model with Elim ination from 
C om partm ent 1
k01
kl2
k21
k20
R21
o| ^ C2
R12
Figure 3.26: A Two Com partm ent Model w ith Elim ination from Com partm ent 2 
and its Bond Graph
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3.10.2 B ond Graph R epresentation  o f a T hree-C om p artm ent 
 M odel
Figure 3.27 is the bond graph of a three com partm ent model for propofol.
Using da ta  from [35], and refinements provided by M arsh e t al. [36] the Model 
Transform ation Toolbox (M TT) [115] was used to  autom atically derive blood 
concentation estim ates in the notional central com partm ent for a constant rate 
infusion of 6 m g/kg /hour (Figure 3.28). The sim ulation results are in agreement 
w ith the experim ental da ta  published by Gepts et al. [35] as would be expected.
kOl
k31 kl2
k21kl3
klO
R31
N
C 3 ^ - O
Sf
R21
1
O  ^  C2
RIO Cl
\
R13
V
R12
Figure 3.27: Three-C om partm ent Model and its Bond Graph
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Figure 3.28: Sim ulated Central Com partm ent Concentration for Propofol Model
3.11 B ond Graph R epresentation  o f P hysio logically-  
based M odels o f Inhaled A gent Pharm a­
cokinetics
As described in Section 3.8, understanding of physiologically-based pharm acoki­
netic models is hindered by the lack of an appropriate model representation 
scheme. Central to the physiologically-based models developed by Mapleson [40] 
and pursued by Davis [46] and Higgins [103], are the concept of circulation, the 
use of physiological da ta  to param eterise tissue groups and the use of real physico­
chemical data.
In representing the more abstract tw o-com partm ent model, sufficient bond 
graph elements have been used to allow representation of the physiologically- 
based models. In the Mapleson models, drug is transported  to the tissues of
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the body in the blood. The models actually represent the movement of drug 
alone bu t the param eters used in this process em body bo th  physiological and 
physico-chemical data. In Mapleson’s models, the concept of anaesthetic tension 
is im portan t because a t equilibrium , the tension in all tissues is the same.
The bond graph representation of M apleson’s Model P is presented in Fig­
ure 3.29. The bond graph of the model can be com pared w ith its circulation 
schem atic diagram (Figure 3.11). In the bond graph, each tissue group is repre­
sented by a capacitance. W here a tissue has a blood pool associated w ith it, this 
has been combined with it to reduce the order of the model. This approxim ation 
is further described in C hapter 4. The capacitances have been assumed to be 
linear and have a m agnitude which represents the capacity of the tissue group for 
the drug. For instance, the arterial pool has capacitance given by
C a rtp o o l  — * Xblood  ’  V a rtp o o l
where Xbiood is the blood-gas partition  coefficient and Vartpooi is the volume of the 
arterial pool.
Because drug is transported by the blood, the am ount of drug being delivered 
to a tissue group is given by the concentration of the  drug in the  blood reaching 
the tissue m ultiplied by the blood flow to the tissue. This am ount does not depend 
upon the am ount or concentration of drug already in the tissue. This is analogous 
to the behaviour of microconstants in com partm ent models (Section 3.10.1). The 
delivery of drug to a tissue group is therefore represented by a bond graph resistor 
and a signal as shown in Figure 3.30.
In this arrangem ent, the mass flow of drug between the  tissue groups 
represented by C l and C2 is from C l to C2 only and depends upon the anaesthetic 
tension (an effort) on C l and the resistance R. The resistance R relates the  tension 
on C l to the drug flow to C2. R therefore reflects the blood flow of the  tissue 
group represented by C2 and the partition coefficient of the blood.
In contrast to Model P, M apleson’s Model 0  did not represent circulation tim e
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Figure 3.29: Bond Graph for Mapleson Model P
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Figure 3.30: The Arrangem ent used to Represent Drug Transport
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delays or make explicit arterial and venous flows. Model O has the fluid analogue 
illustrated m Figure .3-31 •. Its bond  graph is shown in Figure 3.32. In this* case, the* 
bond graph does not require signals due to the absence of circulation in the  model. 
As before, each tissue group is represented by a capacitance which represents the 
capacity of the tissue group and its associated blood pool for the drug. T he blood 
flow for each tissue and the  blood:gas partition  coefficient are em bodied in the 
resistance values.
viscera
lungs
mouth lean
fat
Figure 3.31: The Model 0  Fluid Analogue
The Model Transform ation Toolbox (M TT) [115] was used to  autom atically 
generate MATLAB simulation equations for both  Model 0  and Model P from 
a graphical representation of their bond graphs. Comparison of their respective 
brain tension values for a step input of nitrous oxide a t tim e 0 concentration are 
shown in Figure 3.33. The effect of representing circulation tim es accurately in 
Model P are clear in comparison to the approxim ation of circulation times used 
in Model 0 .
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Figure 3.32: The Model 0  Bond Graph
Comparison of Mapleson model O and model P (—) outputs
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Figure 3.33: Comparison of Model 0  and Model P Brain Tensions
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3.12 B ond Graph R ep resentation  o f Injected
A gent Pharm acokinetics
Equation 3.11 described the am ount of drug in a fluid space in term s of the 
am ounts unionised in water, ionised in water, bound to  protein and dissolved in 
fat. Given th a t both  ionised and unionised drug may bind to  protein, equilibration 
m ay be schem atically illustrated as shown in Figure 3.34.
protein
ionised unionised
fat
Figure 3.34: Schematic for the Equilibration of Drug in a Fluid Space
 t'F
fl £2
Figure 3.35: The Notation for a Bond G raph Transform er
In the current bond graph approaches, the effort variable has been assumed to 
be concentration and the flow variable is the mass flow of the drug. Representation 
using these choices can proceed using a bond graph transformer. The generalised 
bond graph transform er is drawn as shown in Figure 3.35 and its behaviour is
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described by an equation of the form of Equation 3.20.
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el a e2
. 0 b
(3.20)
It is often assumed th a t a =  If a / |  then more general relationships can be 
represented. Ionisation, dissolution in fat and protein binding can be represented 
as follows.
1. Ionisation.
From Equation 3.10, for an acid drug,
Ci = io (pH- p/Co) • C 9
This can be represented by a transform er w ith the  constitutive relationship
(3.21)
where /„■ and / l5 are the mass flows from standard  form to ionised form and 
ionised form to standard form respectively.
2. Fat Solution 
From Equation 3.5,
Cf  = \ - C 8
This can be represented with the  transform er defined by
(3.22)
where f s j  and f j s  are the mass flows from standard  form to fat dissolved 
form and fat dissolved form to standard form respectively.
c , - ' 1 0  ( p H - p K a )  Q ’  c . '
f s i 0  1 f i t
---
-1 1 1 o
1
’ C5 '
1 1 0 1
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EqUatibn ‘3.8 gives,*
r  C'
” C, +  K.
c,
pb
p ro t
This can be represented by the transform er defined by
---
---
--
1 1
Cp r o t
C s + K p b 0 c , '
. f ’ p . 0 1 .  f p > .
(3.23)
where f 9p and f pa are the mass flows from standard  form to protein bound 
form and protein bound form to standard  form respectively.
Considering the general transform er constitutive relationship, Equation 3.20, 
it is apparent th a t the effort-flow products are not equal on either side of the 
transform er unless a=b (left-hand product =  e\ • f \  and right-hand product =  
-  *ei */i- In a power bond graph, this would imply th a t energy has been introduced 
to  the  system.
For the transform ers defined above (Equations 3.21, 3.22 and 3.23) the effort- 
flow products are not equal on both sides. W hile this is the case, because the 
coefficient relating the flow variables is unity in each transform er, there is no ‘gain’ 
of drug in the system. Flow through the transform er therefore occurs until the 
concentrations have equilibrated in accordance w ith the transform ers constitutive 
relationship.
Using the transform ers defined above, a bond graph can be drawn to represent 
the equilibration of an injected drug within a tissue or fluid space. This bond 
graph has the general form shown in Figure 3.36. In this figure, C :cpl and C:cp2 
are capacities representing the available protein binding sites for the unionised and 
ionised forms of the drug respectively. The capacitors C:cw represent the water 
within the  tissue or fluid and the capacitor C:cf represents lipids. Transformers 
TF :tsp  and T Frtip  have the form of Equation 3.23. The resistor elem ents in
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Figure 3.36 can be used to represent the finite ra te  of equilibration between the 
various phases. Alternatively, jf  .the model considers, equilibration * to  be near* 
instantaneous, the resistor elements are given very small values. In the lim it case, 
equilibration is assumed to be instantaneous and the resistor elem ents are removed 
from the bond graph and the bond graph represents only the steady -sta te  of the 
system .
C:cv£----------- |o
C:cp2
TF:tii
C:cw
Rrrsi
C:cf
Figure 3.36: The Bond Graph for Injected Agent Equilibration in a Fluid Space
To illustrate this approach to the representation of drug equilibration, a bond 
graph has been created to represent the equilibration of fentanyl in plasma. The 
bond graph is based upon the model described by Higgins [103] and param eter 
values are taken from the same source. Higgins found th a t it was necessary to 
model the ionisation of fentanyl along w ith the binding of both  unionised and 
ionised forms of the drug to plasm a proteins. The inclusion of lipid dissolution 
was not found to be necessary. Higgins also found th a t, for fentanyl, protein
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binding in plasm a could be realistically approxim ated by the linear equations;
a boundi
and
C b ou n ds  —  P  ’ C a •  k a
where Cboundi is the concentration of ionised bound drug, Cbounda is the concen­
tra tion  of unionised bound drug, P  is the concentration of plasm a protein sites, 
Ci is the concentration of ionised drug, Ca is the concentration of unionised drug 
and ki and ka are constants chosen so as to  m atch experim ental results. The bond 
graph of Figure 3.36 therefore reduces to th a t of Figure 3.37. Using d a ta  given
C:cpl^-
R:: rsp ^
\ C:cp2
A R:rip
TF:tsp
C:cv£- ■^ TF:tsi-
1/
R:rsi
TF:tip
A C:cw
Figure 3.37: The Bond Graph for Fentanyl Equilibration in P lasm a
by Higgins [103] gives
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P =  747 /Ltmol/kg
• ki ' ^  1.246 X 10"3 ......................................................................................................
ka , 0 =  1.9121 x lO” 2 
pK a =  7.85
and there are assumed to  be 68 grammes of proteins per kilogram of plasm a 
and 915.5 grammes of water per kilogram of plasma.
The Model Transform ation Toolbox was used to  autom atically generate 
SIMULAB code for the fentanyl model. This code was then used to  sim ulate 
fentanyl pharm acokinetics in plasm a. The sim ulation could be perform ed at any 
pH value and the  value of pH could be changed during simulation. Figure 3.38 
shows the ratios of free ionised to free unionised concentrations and of bound 
unionised to  free unionised concentrations a t a pH of 7.4. Figure 3.39 shows the 
ratio  of bound ionised to free ionised concentrations a t a pH of 7.4.
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Figure 3.38: Fentanyl D istribution in P lasm a at pH 7.4 
W ith a pH of 6.0, the ratio  of free ionised to free unionised concentrations
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Figure 3.39: Fentanyl D istribution in P lasm a at pH 7.4
changes as shown in Figure 3.40. The ratios of bound unionised to free 
unionised concentrations and bound ionised to free ionised concentrations do 
not change as shown in Figure 3.40 and 3.41. These results, which have 
been automatically generated following definition of the transform er constitutive 
relations and construction of the bond graph, are in complete agreem ent with 
those presented by Higgins. This clearly dem onstrates the u tility  of the  bond 
graph representation technique.
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Figure 3.40: Fentanyl D istribution in P lasm a at pH 6.0
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Figure 3.41: Fentanyl D istribution in P lasm a at pH 6.0
C hapter 4 
A  P hysiologically—B ased  M odel 
o f Isoflurane P harm acokinetics
SUMMARY
This chapter derives a physiologically-based model o f isoflurane phar­
macokinetics using physiological and physico-chemical data available 
in the literature. The model is represented using a bond graph and the 
determination o f the bond graph component values is described. Using 
equations automatically generated from  the bond graph, the effects o f  
intra-individual and inter-individual physiological changes upon isoflu­
rane pharmacokinetics are investigated via simulation.
4.1 T he Structure and Q uantification o f a
Physiologically—B ased M odel o f Isoflurane 
Pharm acokinetics
Isoflurane is a commonly used inhalational anaesthetic agent. Despite this, 
physiologically-based models of isoflurane pharm acokinetics have only recently
123
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been developed [116] [117]. A physiologically-based m odel of isoflurane pharm a­
cokinetics has been developed to suppprt work in this th esis .. The model is i n - . 
tended to allow:
• representation of the effects of physiological changes w ithin the  individual 
on isoflurane pharmacokinetics and,
•  representation of the effects of body composition differences, between 
individuals, on isoflurane pharmacokinetics.
4.1.1 M odel S tructure
The structure  of the model is schematically represented in Figure 4.1. T he model 
is based upon M apleson’s Model P and therefore incorporates blood pools for the 
slower tissues. The model groups the tissues of the body into a  visceral group, a 
lean group and a fat group, the lungs are explicitly represented, as is a peripheral 
shunt. The blood volume is distributed between an arterial blood pool, a venous 
blood pool, and tissue blood pools. A sample brain tissue com partm ent has been 
added to allow investigation of brain tension. The quantification of the model is 
as follows:
4.1.2 P hysiological Q uantification
Davis and Mapleson [45] adopted the circulation schem atic of Figure 3.12 to  allow 
representation of the pharmacokinetics of bo th  injected and inhaled agents. The 
m ain difference between the schematic of the model for injected and inhaled 
drugs and those of the earlier schematics [40] is the  explicit representation of 
the kidneys and liver and their circulations. This alteration directly supported 
the representation of the m etabolism  and excretion of drugs. This model was 
param eterised using data  from the ICRP and was described by Davis and 
Mapleson [45].
Chapter 4. A  M odel o f Isoflurane Pharmacokinetics 125
Arterial poolVenous pool
Lungs
Peripheral shunt
Brain sample
Viscera T3 O O
Viscera
Lean pool_______ _ ________
—    Lean
Fat pool
Fat
Figure 4.1: Circulation Schematic for the Isoflurane Model
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In generating a physiologically-based model of isoflurane pharm acokinetics, 
there is no requirem ent for the explicit represent at ipn of tjie.liyer a,nd kidneys, 
because isoflurane is not significantly m etabolised or excreted. In the model 
developed here, the kidneys, liver and portal circulation are therefore incorporated 
w ithin the visceral tissue group. This returns the model to  the  form of M apleson’s 
Model P [40].
The volumes, blood flows and blood volumes associated w ith the tissue groups 
were described by Davis and Mapleson and are sum m arised in Table 4.1.
Tissue Volume (ml) Perfusion (m l/in in) Associated Blood Volume (ml)
Viscera 5067 4012 2117
Lean 34955 1147 2115
Fat 14786 342 631
Shunt 0 979 326
Total 54808 6480 5189
Table 4.1: Sum m ary of Tissue Group Characteristics
The breakdown in blood volume is m ade in order to  accom m odate the
circulation tim es for each tissue group. The circulation tim e for each tissue is 
taken to  be the  m ean transm it tim e for the tissue and is given by
. J. J. associated blood volume
circulation tim e =  ----------—---- — --------------
blood flow
Table 4.2 gives the resulting circulation tim e for each tissue group.
Tissue Group Circulation Tim e (secs)
Viscera 31.66
Lean 110.6
Fat 110.7
Shunt 19.98
Table 4.2: Tissue Group Circulation Times
In deriving the “simplified scheme” of their model, Davis and Mapleson 
calculated the circulation tim e for the combination of the fastest visceral tissue
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to be 18.7 seconds. This tim e was subtracted from the to ta l circulation tim e for 
each tissue group and local blood pools were Ridded to  .each, tissue group wi t ha*  
to tal circulation tim e greater than  18.7 seconds. The local tissue pools were sized 
so as to  represent the difference between the to ta l circulation tim e for the tissue 
group and the  assumed m inim um  circulation tim e (18.7 seconds).
In Table 4.2, the fastest to ta l circulation tim e is th a t of the peripheral shunt. 
The circulation tim e of this tissue group is approxim ately 20 seconds. Using the 
same approach as th a t of Davis and Mapleson, a  ‘central’ circulation tim e of 20 
seconds has been assumed and local pools created to represent the additional local 
circulation times. The blood pool volumes for each tissue are chosen using the 
formula:
pool volume =  (to tal circulation tim e —central circulation tim e)-tissue blood flow
Table 4.3 gives the resulting local circulation tim es and blood pool sizes for 
each of the tissue groups.
Tissue Group ‘local’ circulation tim e blood pool volume (ml)
Shunt 0 0
Viscera 11.66 780
Lean 90.6 1733
Fat 90.7 517
Total 3030
Table 4.3: Local Blood Pool Volumes
Davis and Mapleson sta te  th a t 25.9% of the to ta l blood volume (5189 ml) is 
arterial and th a t 17.2% of the blood in the tissue pools is arterial. The total 
am ount of arterial blood is therefore 0.259 x 5189 =  1344ml. The am ount of 
arterial blood within the local tissue pools is 0.172 x 3030 =  521ml. The remaining 
arterial blood volume is therefore 1344 — 521 =  823ml and this is placed in the 
arterial blood pool. The rem aining blood is therefore 5189—(3030+823) =  1336ml 
and this is placed in the venous blood pool. Using these values and those
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of Tables 4.1 and 4.3, the physiological characteristics of the model can be 
sum m arised as shown in Table 4.4. ..................
Tissue Group Volume (ml) Blood Flow (m l/m in) Blood Pool Volume (ml)
Shunt — 979 0
Viscera 5067 4012 780
Lean 34955 1147 1733
Fat 14786 342 517
Lungs 464 — 0
A rterial Pool — — 823
Venous Pool — — 1336
Totals 6480 5189
Table 4.4: Sum m ary of Tissue Group Characteristics
A ddition  o f a Brain Sam ple C om partm ent
Davis and Mapleson state  th a t the to tal circulation tim e for the brain is 20.5 
seconds. The model described above assumes a ‘central’ circulation tim e, common 
to all circulations, of 20 seconds. Therefore, a brain sam ple tissue may be added 
w ithout further representation of local circulation tim e. The concept of tissue 
samples of very small volumes and perfusions was described by Mapleson [40]. 
Taking the  values from those models, a brain sam ple can be added to  the  model 
w ithout significantly altering any behaviour in o ther tissues, or the blood, but 
providing brain tension information. A brain sample of volume 0.7 ml (identical 
to th a t originally described by Mapleson) has therefore been added to the model. 
The perfusion of the sample is proportional to th a t of the  whole brain. The brain 
has a volume of around 1300 ml and receives about 741 m l/m in  of blood flow. 
These figures give the the perfusion of the brain sam ple as 741 x =  0.4m l/m in.
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4.1.3 P hysicochem ical Q uantification
The physiological qu^njtihcation .of. the model provides a basis for the-prediction 
of the behaviour of any agent if appropriate physicochemical d a ta  are available. 
Isoflurane is not significantly metabolised or excreted in hum ans. Knowledge of 
the tissue:gas and blood:gas partition  coefficients for isoflurane therefore allow 
quantitative representation of its pharmacokinetics.
Only five distinct sources of da ta  on bloodigas and tissuergas partition 
coefficients have been found. Regrettably, there is a wide range of derived partition 
coefficients. It is difficult to suggest th a t one set of results should be considered 
b e tte r than  the others and the coefficients chosen to  provide the  physico-chemical 
param eterisation for this model are therefore the  result of arb itra tion  between 
experim entally derived results in the literature. Table 4.5 summarises the partition 
coefficients suggested by each source. The partition  coefficients for the model were 
chosen as follows:
Partition  Coefficient [118] [119] [116] [120] [121]
blood:gas 1.4 1.37 1.5 — 1.4
brain:gas — 2.26 3.6 2.09 1.9
heart:gas — 2.64 2.25 2.18 —
liver:gas — 2.99 3.45 2.34 4.1
kidney:gas — — 1.95 1.39 2.1
muscle:gas — 2.82 2.25 4.40 2.4
fat:gas 68 76.75 94.5 64.2 69
lung:gas — — 2.7 — 1.6
Table 4.5: Sum m ary of Isoflurane P artition  Coefficient D ata
1. Blood:gas Partition  Coefficient
Based upon data  from j Fiserova-Bergerova et al. [121],, Lerman et al.[119] 
and and Steward et al.[118], a blood:gas partition  coefficient of 1.4 has been 
selected.
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2. Braimgas Partition  Coefficient
The estim ates of the braimgas partitipn.coefficient of |.Fiserova--Bergerova. * 
e t al., Yasuda et al. [120] and Lerman et al. each have similar values. T hat 
of Lerou et a l.[116] is higher. Taking account of the differences, a braimgas 
partition  coefficient of 2.1 has been assumed.
3. Heart:gas P artition  Coefficient
The estim ates of heart:gas partition  coefficient are reasonably close in the 
d a ta  given by Yasuda et al., Lerman et al. and Lerou et al. A partition  
coefficient of 2.3 has therefore been assumed for the heart.
4. Liver:gas P artition  Coefficient
Estim ates of liver:gas partition coefficient range from 2.34 (Yasuda et al.) 
to 4.1 (Fiserova—Bergerova et al.). A partition  coefficient of 3.0 has been 
assumed.
5. Kidney:gas Partition  Coefficient
Estim ated kidney:gas partition  coefficients occupied a range from 1.39 
(Yasuda et al.) to 2.1 (Fiserova—Bergerova et al. ). A value of 1.8 has 
been assumed for use in the model.
6. Muscleigas Partition  Coefficient
For muscle tissue, the partition  coefficient estim ates of Yasuda et al. are 
higher than  those of other groups. This was also the case for their muscleigas 
partition  coefficients for halothane. Notably, the  standard  deviation quoted 
by Yasuda et al. was also very large in comparison to th a t derived by 
other groups. In recognition of the uncertainty associated with the da ta  
from Yasuda et al., a muscleigas partition  coefficient has been derived from 
prim arily considering the d a ta  of o ther groups. The muscleigas partition  
coefficient has therefore been chosen as 2.8.
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7. Fat:gas Partition  Coefficient
E stim ated  fat:gas partition  coefficients range from 64 (Yasuda et al.) t o *94.5* 
(Lerou et al.). The value of Lerou is significantly higher th an  those of other 
authors. A fat:gas partition  coefficient of 70 has therefore been assumed.
8. Lung:gas Partition Coefficient
i Lerou et al. and Fiserova-Bergerova et al. are the only sources of lungrgas 
partition  coefficient estimates. Because the figures quoted by Lerou et 
al. are consistently higher than those of other groups, the estim ate of 
Fiserova-Bergerova has been chosen. The lungrgas partition  coefficient is 
thus assumed to be 1.6.
To ease comparison, the coefficients provided in the  litera tu re  (Table 4.5) have 
been listed alongside those selected for use in this model in Table 4.6.
P artition  Coefficient [118] [119] [116] [120] [121] New
blood:gas 1.4 1.37 1.5 — 1.4 1.4
braimgas --- 2.26 3.6 2.09 1.9 2.1
heart: gas --- 2.64 2.25 2.18 — 2.3
liver:gas --- 2.99 3.45 2.34 4.1 3.0
kidney: gas --- — 1.95 1.39 2.1 1.8
muscle:gas --- 2.82 2.25 4.40 2.4 2.8
fat: gas 68 76.75 94.5 64.2 69 70
lung:gas — — 2.7 — 1.6 1.6
Table 4.6: Sum m ary of Isoflurane P artition  Coefficient D ata 
S e le c tio n  o f P a r t i t io n  C o effic ien ts  fo r th e  M o d e l
The partition  coefficient estim ates for the tissues derived above result from in vitro 
m easurem ents. Ideally, values for functioning tissue in patients would be available. 
Steward et al. [122] found th a t the differences between in-vivo  and in-vitro  
partition coefficients was small, suggesting th a t partition  coefficients resulting 
from in-vitro  experim ents are appropriate for the  param eterisation of a model.
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A further requirem ent is th a t a partition  coefficient is available for each of the 
tissue groups in the model j.e, blood, Lungs, lean, fat, viscera and  brain sample. * 
For these, the value described in the previous section can be used except for 
th e  partition  coefficient of the visceral tissue group. A llottet al. [123] used in -  
vitro estim ates of bloodigas, muscleigas, fatigas, lung:gas and braimgas partition  
coefficients to  provide partition  coefficients for the blood, lean, fat, lung and brain 
components of a physiologically-based model. They then derived a partition 
coefficient for the visceral tissue group in a weighted sum m ation, according to  the 
tissue masses, of the measured partition  coefficients for the  brain, heart, kidneys, 
liver and gut. Steward e t al. [124] found partition coefficients for halothane in 
the dog. They found th a t the partition coefficient for the gut was greater than 
those of the heart and kidneys, but less than  those of the  brain and liver. As an 
approxim ation, w ithout any other available inform ation, the partition  coefficient 
of the  gut has been assumed to be the same as th a t of the brain in hum ans, i.e., 
2 .1.
The partition  coefficient for the visceral tissue group can therefore be calcu­
lated as:
. _  Wje x A/. +  Wi x A/ +  Wg x Xg +  Wh x Xh +  VV& x At n i l
v,Wo “  W k + + Wg + W h + lYt 1 >
where Aviacera is the visceraigas partition coefficient, Wt symbolises the mass of 
tissue t , Af is its tissue:gas partition  coefficient and k,l,g ,h  and b are subscripts for 
the  kidneys, liver, gut, heart and brain respectively. Therefore, using d a ta  from 
[45] and the partition  coefficients derived above,
284 x 1.8 +  1721 x 3.0 +  1391 x 2.1 +  316 x 2.3 +  1339 x 2.1 o 
284 +  1721 +  1391 +  316 +  1339 “  '
(4.2)
The partition  coefficients which are to  be used in the  model for isoflurane
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pharm acokinetics are sum m arised in Table 4.7.
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Tissue Tissuergas P artition  Coefficient
Blood 1.4
Lungs 1.6
Viscera 2.4
Lean 2.8
Fat 70
Brain 2.1
Table 4.7: Model Partition  Coefficients
4.2 B ond Graph R epresentation  o f th e  Isoflu­
rane M odel
The schem atic for the isoflurane model (Figure 4.1) illustrates the allocation of 
tissue and blood volumes in the model. The exact numerical specification of each 
volume and flow was described earlier. In order to  sim ulate, or further analyse 
the  model, it is desirable to represent it in a form which assists the production of 
system  equations, or other forms of the model. The bond graph representation of 
physiologically-based models was introduced earlier in C hapter 3. This technique 
has been used to represent the isoflurane model described above. The bond graph 
for the isoflurane model is shown in Figure 4.2. In the bond graph, ventilation and 
perfusions are regarded as continuous, steady flows so as to be consistent with the 
approach of Mapleson. The bond graph, however, allows derivation of continuous 
time equations for the model whereas M apleson’s models adopted discrete tim e 
equations to  ease com putation.
The bond graph for the  model has a lot in common w ith the  original electrical 
analogue of Mapleson [37] [38] and Figure 3.9. In the analogue, flow into the 
lung capacitors is dependent upon the inspired tension, alveolar tension, and a 
resistor which has a value determ ined by alveolar ventilation. Flow from the lung
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Figure 4.2: The Bond Graph Representation of the Isoflurane Model
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capacitors to  the tissues depends upon the alveolar tension, the tissue tension, and 
a resistor which has a value dependent upon the tissue. vQlume, .tissue perfusion . 
and the  tissue:gas partition  coefficient. Of course, M apleson’s analogue made no 
distinction between arterial and venous circulation bu t this was incorporated in 
later models [40].
4.2.1 D eterm in ation  o f C om ponent V alues
The bond graph representation of the model (Figure 4.2) adopts anaesthetic 
tension as the  effort variable and mass flow of anaesthetic drug as the flow variable. 
This is consistent w ith M apleson’s original selections is his electrical analogue [38]. 
In consideration of these choices, the values of each com ponent in the bond graph 
are as follows.
1. Inspiration
The models of Mapleson [40] and Davis and Mapleson [45] have assumed an 
alveolar m inute ventilation of 4 1/min for a  70 kg man. If a tension, f0, of 
an agent is present in the inspired gas stream , then  the  flow of agent into 
the patien t, /,• is 4 x t 0 1/min assuming the alveolar gas concentration to be 
zero. If the concentration in alveolar gas is £,• then the net flow of drug, fi  
into the alveolar gas is
/i =  4 x  (t0 -  ti) 1/min =  x (t0 -  tA  1/sec.
15
This relationship is represented using the resistance labelled R:ri on the 
bond graph. The resistor is assumed to  be linear and has value calculated 
as
R  =  <Jort =  =  15
flow fi
2. Tissue or Pool Capacities
The variation of agent solubility between tissues allows different concentra­
tions to be established in each tissue at equilibrium . The capacity of a tissue
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for drug is related to  its partition  coefficient by
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............................  Ct = \ t x V t (4.4)
where C< is the tissue capacity, Xt is its partition  coefficient and Vt is its 
volume. In the model, equilibration in the  lung involves the equilibration 
of alveolar gas and lung tissue. Because the  partition  coefficient of gas is 
unity, the capacity of the  lung is
C{ Va “I- X\ung X V[ung
where Va is the volume of alveolar gas, Xjung is the lung tissue:gas partition 
coefficient and Viung is the volume of lung tissue. Using d a ta  from Davis and 
Mapleson [45] and the partition  coefficients derived above,
Ci =  2.5 +  1.6 x 0.464 =  3.24 
For a blood pool, the capacity is simply
Cpool =  Xfflood X Vpool 
The arterial pool therefore has capacity
Ccap — Xblood X Vap =  1.4 X 0.823 =  1.15 
and the venous pool has capacity
C cvp =  Xbiood x Vvp =  1.4 x 1.336 =  1.8704.
W hen a tissue group has a blood pool associated w ith it, the combination 
of the pool in series w ith the tissue may be approxim ated by combining 
their capacities. The tension in the combined capacity does not therefore 
correspond exactly to  the tension in the tissue only, bu t the use of a sample 
com partm ent can avoid th a t problem. In this model, the viscera, lean and
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fat tissue groups have associated blood pools. For the com bination of a 
tissue t with volume Vt and partition coefficient A* with an associated blood 
pool of volume Vpt and blood:gas partition  coefficient A blood, the  combined 
capacity is given by:
Ct = Af x Vt 4* A blood x Vpt
The capacities for the viscera, lean and fat tissue groups are therefore 
calculated as
Cv = Xv x Vv +  Abiood x Vyp =  2.4 x 5.067 +  1.4 x 0.780 =  13.25
C', =  A ,x f i  +  A biood x V/p =  2.8 x 34.955 +  1.4 x 1.733 =  100.30
Cf  =  Xf  x  Vf  +  A biood x Vjp =  70 x 14.786 +  1.4 x 0.517 =  1035.74
The only rem aining tissue capacity is th a t of the  brain sample tissue, it is 
given by
Cb = Xb xVb = 2.1 x 0.0007 =  0.00147
3. Flow between the Lungs and the A rterial and Venous Pools
The common effort junction labelled 0:ti in Figure 4.2 has the tension of 
the lungs as its effort variable. Blood flows into the  lungs from the  large 
veins a t mixed venous tension and this is represented in the  bond graph by 
a mass flow of drug, in one direction, from the venous pool to the lungs. 
Blood flows from the lungs, at arterial tension, into the arterial blood pool. 
This flow is also represented by a mass flow, in one direction, between the 
lungs and the arterial pool.
(a) Mass Flow from Venous Pool to Lung Capacitance
The mass flow from the venous pool to the lungs depends upon the 
venous pool tension. The mass flow of drug is given by
mass flow =  blood flow x drug concentration in the blood 
=  blood flow x Abi00d x drug tension
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The resistance value R :vprl is therefore chosen to  be
tension . . . .  I ....................................
R  : v p r l ‘ =
mass flow blood flow x Xbiood 
Given th a t the whole cardiac ou tpu t (6480 m l/m in) flows through the 
venous pool, the value is therefore
J R  ■ WPr l  =  6480 - r i  =  6 ' 6 1
60
Note th a t the use of a signal between the  common flow junction l:v p l 
and the common effort junction 0:ti ensures th a t mass flow between 
the venous pool and the lungs depends only upon the tension in the 
venous pool.
(b) Mass Flow from the Lung Capacitance to  the A rterial Pool
By analogy w ith the mass flow from the venous pool to the lungs, the 
resistor value R :aprl is similarly defined to  be
R  '■ “ P r l  =  §480 l " .  .  =  6  6 1
60
4. Mass Flow between the A rterial Pool and Tissues and Tissues and the 
Venous Pool
The representation of circulation dictates th a t the m ass flow of drug between 
the arterial pool and each tissue depends only upon the  tension of the  arterial 
pool. Again, this has been represented using signals on the bond graph 
(Figure 4.2). For a tissue t, the mass flow of drug into it depends upon its 
blood flow and the drug concentration of the blood. If the tissue receives a 
fraction, kt , of the cardiac output then the mass flow of drug into t is given
by
mass flow into t =  kt x cardiac ou tpu t X Abiood x blood tension
The resistances between the arterial pool and the tissues are therefore 
defined using the form:
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^  . . t e n s io n ......................  . 1 . . . - ...............................
mass flow kt x cardiac o u tpu t x Xbiood
Using blood flow data  from Table 4.1, the resistances for the arterial sides 
of each tissue are
R:rb2 =  107142
R:rv2 =  10.68 
R:rl2 =  37.36 
R:rf2 =  125.31 
R:rs2 =  43.77
By analogy, the resistances between the tissues and the venous pool are 
defined in the same way. Hence,
R :rb l =  R:rb2
R :rvl =  R:rv2 
R :rll =  R:rl2 
R :rfl =  R:rf2 
R :rsl =  R:rs2
The use of signals between the tissue common effort junctions and the venous 
pool ensures th a t mass transfers are only from the  tissues to the pool.
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4.2.2 G eneration  o f O ther M odel Form s
The representation qf the model using, bond graph notation allows - autom atic • * 
generation of symbolic and numerical model forms. Using a public dom ain figure 
editor, on a Sun workstation, the bond graph shown in Figure 4.2 was drawn. The 
Model Transform ation Toolbox (M TT) toolbox [115] was then used to generate 
o ther model forms. M TT can produce symbolic and num erical transfer functions, 
state-space m atrices and other model forms. Significantly, M TT is able to 
produce state-space m atrices for a bond graph which can be read into MATLAB. 
MATLAB can then be used to sim ulate and analyse the m odel’s behaviour. In 
using M TT, it is possible to generate entirely symbolic representations of systems, 
or to make partially  numeric representations, or to produce fully numeric output. 
This allows characteristics of the model e.g., cardiac ou tpu t or ventilation to  be 
retained as a symbol in the generation of state-space m atrices. Sim ulation of 
the model for varying param eters can therefore be achieved within the sim ulation 
environment.
4.3 Sim ulating the Effects o f P hysiologic Changes 
on Inhaled Agent P harm acokinetics
The use of a  physiologically-based model allows direct investigation of the 
interactions between physiological quantities and pharm acokinetics. Two types 
of physiological change are considered here:
1. In tra-individual Changes
These are short-term  variations in the physiological perform ance of the 
individual.
2. Inter-individual Changes
These result from the inate differences between people.
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4.3.1 In tra-in d iv id u al C hanges I. V entilation
Ventilation or; more specifically, alveolar ventilation provides the flow of inhaled 
agent into the body. As ventilation increases, so too does the am ount of drug 
brought to  equilibrate with alveolar blood. Conversely, if alveolar ventilation 
decreases, the am ount of drug being brought into the lungs to  equilibrate 
decreases.
In consideration of the bond graph of the isoflurane model (Figure 4.2) there is 
only one component which has a value directly related to the alveolar ventilation. 
The component is the resistor labelled R:ri which is related to  the  alveolar 
ventilation as described by Equation 4.3. The effects of changes in ventilation 
can therefore be investigated by m odulating the value of this resistor. Figure 4.3 
shows the sim ulated arterial and brain tensions for alveolar ventilations of 3, 4 
and 5 litres per m inute with all other variables assuming the values described in 
the previous sections.
It is apparent tha t changes in ventilation affect the rate of increase of both 
the arterial and brain tensions, and change the tension at which the tensions 
equilibrate. While it is not possible to measure alveolar ventilation, the total 
m inute ventilation can be measured and from this an estim ate of alveolar 
ventilation can be derived for the individual. It should be noted th a t even though 
the sim ulated alveolar ventilations deviate by ±25%  from the assumed normal 
ventilation of 4 litres per m inute, the arterial tension deviates by only about 
± 10%.
4.3.2 In tra-in d iv id u al C hanges II. Cardiac O utput
The effective circulation of blood around the body is required to deliver drugs 
to each tissue. In the bond graph (Figure 4.2), all resistors except R:ri depend 
upon the blood flow to the associated tissue group or blood pool. Clearly, a 
reduction in cardiac outpu t dictates th a t the blood flow in some of the tissues
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Figure 4.3: The Effects of Alveolar Ventilation on Brain and A rterial Tensions
m ust also reduce. In order to sim ulate the effects of cardiac ou tpu t changes upon 
the pharm acokinetics of isoflurane, the following steps were taken.
1. It was assumed th a t at each cardiac ou tpu t to be sim ulated, th a t the blood 
flow in each tissue group was proportional to  the cardiac output.
2. A range of cardiac outpu t values from 4 litres per m inute to  10 litres per 
m inute was chosen as a suitable range.
3. The alveolar and brain tension timecourses of the sim ulated isoflurane model 
were recorded for a step input of inspired concentration.
The results of the simulation for three cardiac ou tpu t values are shown in 
Figure 4.4. It can be seen th a t as the cardiac ou tpu t increases, the arterial 
tension decreases and therefore, tissue tensions are also somewhat lower. It is 
also apparent th a t the rate of rise of tissue tensions increases w ith cardiac output.
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Q ualitatively, for constant alveolar ventilation, larger cardiac outputs cause the 
alveolar gas to equilibrate w ith a larger blood volume. The end-tidal and hence 
arterial tensions are therefore lower although the uptake of the drug will actually 
be greater. W hile the arterial tension may well be lower w ith a  higher cardiac 
ou tpu t, the  equilibration of the tissues with this tension is quicker. This is directly 
due to  the  perfusion lim ited nature of inhaled agent distribution. Obviously, as 
cardiac ou tpu t increases, the blood flow to each tissue increases allowing a greater 
mass flow of drug to enter the tissue and therefore speeding up equilibration. The 
arterial and brain tensions for various cardiac ou tpu t values (4.0 1/min, 6.5 1/min 
and 10.0 1/min) shown in Figure 4.4 assume a constant alveolar ventilation of 4.0 
litres per m inute.
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Figure 4.4: The Effects of Cardiac O utput on Brain and A rterial Tensions
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4.3.3 C om parison o f th e M od el’s P red iction s w ith  E x­
perim ental R e s u lt s ...............................................................
The work of Frei et al. [125] investigated the effects of ventilatory and circulatory 
changes on the pharm acokinetics of isoflurane and halothane in the dog. During 
hyperventilation, the authors reported an increase in the ratio  of end-tidal 
anaesthetic concentration to inspired concentration. For a constant inspired 
anaesthetic concentration, this implies th a t the end -tida l concentration increases 
w ith ventilation! The simulation results presented in Figure 4.3 are therefore in 
agreem ent with this experim ental finding.
Frei et al. also reported th a t an increase in cardiac ou tpu t caused a decrease 
in the ratio  of end-tidal concentration to  inspired concentration of the anaesthetic 
agent. For a constant inspired concentration, this would result in lower end-tidal 
concentrations as cardiac output increased. The sim ulation results presented in 
Figure 4.4 are therefore also in agreement with the experim ental result.
The work of Frei et al. has provided experim ental evidence of the effects of 
ventilatory and circulatory changes on the pharm acokinetics of isoflurane in the 
dog. These results are in agreement w ith the results predicted by simulation 
of the  physiologically-based model derived in this chapter. The experim ental 
work therefore provides validation of the m odel’s representation of in tra-individual 
changes and their effects on pharmacokinetics.
4.3 .4  In ter-ind iv idu al Changes: B od y  C om position
W ithin  the population, physiologic differences can result from age and disease but 
can also be a result of natural variation. The standard m an d a ta  used by Mapleson 
[40] and Davis and Mapleson [45] describe, in specific detail, the body composition 
of one individual. Patients are somewhat different from the  standard  m an in terms 
of health  but also in term s of physiology. Some pharm acokinetic changes are a
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product of changes in body composition. Typically, it would be expected th a t 
the  pharm acokinetics of an inhaled agent in an elite marathon, runner would be . 
different from those of an obese, sedentary individual even if they were the same 
age and sex.
In order to investigate the effects of body composition changes on pharm acoki­
netics, a version of the standard m an has been adopted as a basis bu t the am ount 
of tissue in the lean and fat tissue groups has been m ade variable to  sim ulate 
different compositions.
1. Sim ulation Model Approxim ations and Assumptions.
It has been assumed, for the purposes of this investigation, th a t common to 
all sim ulated individuals is a visceral tissue group of the same size and tha t 
the lung and peripheral shunt components of the model are also common. 
Around these basic common features, variable am ounts of lean and fat tissue 
group m aterial are added. This is obviously an approxim ation to  reality but 
is necessary in the absence of any quantitative inform ation on the masses 
and volume of tissues in individuals of varying body composition. Because 
each of these common components equilibrates very quickly w ith arterial 
blood, their uptake after the first 15 m inutes or so of an anaesthetic is 
minim al and so will be their im pact upon the arterial and brain tensions. 
A less valid approxim ation made here is th a t alveolar ventilation will be 
constant in the range of individuals sim ulated. Qualitatively, larger bodies 
provide larger m etabolic dem ands at rest than  sm aller bodies. It would 
seem reasonable therefore to increase alveolar ventilation according to some 
param eter related to body size. W hile this is straightforward, its omission 
allows observation of the effects of changes in body composition alone.
I
' In consideration of physiologic ranges in body composition, it is unlikely 
that an individual should have less body fat than about 5% of body mass, 
or an amount of muscle less than about 15% of body mass. While observing
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5% body fat simultaneously with 15% muscle mass is not likely (5% body 
fat m ight t?e .associated with an. elite endurance .athlete and. greater muscle 
mass is therefore expected), the combination provides a m inim um  point from 
which further muscle and fat may be added. The model therefore consists of 
a core person with a normally perfused viscera, lungs and peripheral shunt, 
and a m inim um  am ount of muscle and fat.
The m axim um  body fat is perhaps 60% of body mass in an obese, immobile 
individual. The m axim um  muscle may approach 60% in a body builder. 
The simultaneous combination of 50% fat and 60% muscle is not possible 
bu t these may serve as upper lim its for physiological ranges.
The lean group of the standard man represents about 36.7 kg (52%) of the 
70 kg body mass. The fat group is about 13.7kg (20%). Given the assumed 
m inim a and m axim a discussed above, ranges of fat group masses between 5 
kg and 30 kg and ranges of lean group mass between 20 kg and 60 kg were 
selected for simulation.
2. Blood Volumes and Cardiac O utput.
The addition of lean and fat tissue to the model, w ithout changing blood 
volume or cardiac output causes pharm acokinetic changes alone due to  the 
relatively reduced perfusion of each tissue. In an a ttem p t to  present a 
realistic representation of the addition of lean and fat tissue, any tissue 
added has been accompanied by:
(a) An increase in cardiac output.
(b) An increase in blood volume.
The m odel’s cardiac output is increased to ensure th a t the added tissue is 
perfused to the same extent as the existing tissue of the same type. The
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blood volume is increased by adding blood to  the blood pools of the  lean 
and fat groups. This has been done in order to. keep the. circulation, times 
of these tissues constant.
3. Results.
Sim ulations were performed to  investigate the effects of
(a) changing the amount of fat with a constant lean group mass,
(b) changing the amount of muscle w ith constant fat group mass, and
(c) changing the amounts of both muscle and fat.
Figure 4.5 shows the arterial and brain tension curves resulting from 
sim ulation of the standard m an with varying quantities of fat. The fat 
com partm ent varied in mass between 5 kg and 30 kg while the lean group 
mass rem ained constant a t 40 kg. It is clear th a t increasing am ounts of fat 
tissue cause an increased uptake of drug into th a t tissue and results in lower 
arteria l and brain tensions.
Figure 4.6 shows the arterial and brain tensions resulting from sim ulation of 
the  standard m an with muscle mass between 20 kg and 60 kg w ith a constant 
fa t group mass of 12.5 kg. It is clear from the graphs th a t as muscle mass 
increases, the increased uptake of drug into the muscle causes lower arterial 
and brain tensions.
Figure 4.7 shows the sim ulated arterial and brain tensions for the complete 
range of lean group and fat group masses described earlier. The figure 
contains three sets of curves; one for a sim ulation with 5kg fat and 20 kg 
muscle, one with 30kg fat and 60 kg muscle and one for the standard man 
(12.5 kg fat, 40 kg muscle). These curves define the range of pharm acokinetic 
behaviour resulting from physiologic changes.
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Figure 4.5: The Effects of Fat Mass on Brain and A rterial Tensions
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Figure 4.7: The Effects of Body Composition on Brain and A rterial Tensions
A
It has been dem onstrated th a t physiological changes cause changes in the 
pharm acokinetics of inhaled drugs in individuals. These pharm acokinetic 
changes alter both  the rate of tissue equilibration and the ra te  of arterial 
blood equilibration with the inspired concentration. As an illustration of the 
com parative effects of body composition upon pharm acokinetics, Figures 4.8 
and 4.9 show the brain tension 30 m inutes after a step change in inspired 
concentration from 0%. After 30 m inutes, the faster tissues (visceral group) 
have practically completely equilibrated with arterial blood but the lean and 
fat groups have significant uptake.
The effect of changes in muscle mass is clearly greater than  th a t of fat mass 
in altering the equilibration of arterial blood. Despite this, small changes in 
muscle mass, or fat mass, do not have large effects upon the pharm acokinetic 
properties. As an example, assuming a fat mass of 12.5 kg (Figure 4.9 middle 
curve), and a muscle mass of 40 kg, changes in the muscle mass of ±10%
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Figure 4.8: Brain Tensions after 30 m inutes for different body compositions
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Figure 4.9: Brain Tensions after 30 minutes for different body compositions
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cause changes in the brain tension at 30 m inutes of only ±2.5% .
C hapter 5 
M odel—B ased E stim ation  o f  
T issu e Tensions
SUMMARY
This chapter introduces an estimation scheme intended to provide 
estimates o f tissue anaesthetic tensions. The scheme is based upon 
a physiologically-based model and a scheme fo r  matching the model 
to the patient using only simple, routinely applicable measurements is 
proposed. The estimation scheme is described and its performance in 
both continuous-time and discrete-time with matched and mismatched 
models are illustrated by simulation. Finally, some experimental 
results from  prototype application o f the scheme in the operating theatre 
during anaesthesia are presented.
The structure  of the physiologically-based model described in C hapter 4 
allows for representation of both individual body composition and of physiologic 
changes such as changes in cardiac output. Assuming th a t sufficient da ta  can be 
provided, or measurements made, such a model can be m atched to an individual 
person. Applying the inspired anaesthetic tension of a patient undergoing 
surgery to a model of the pharmacokinetics of the agent, m atched to the patient,
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would therefore allow tissue anaesthetic tensions to  be estim ated for the patient. 
Knowledge of the tissue anaesthetic tensions would allow quantita tive  information 
to be available at all tim es during an anaesthetic. Such inform ation would be 
useful during induction and recovery but also during m aintenance of general 
anaesthesia.
W hen considering the autom atic control of anaesthesia, Chilcoat, Lunn and 
Mapleson [79] decided tha t “in any one individual, a closer correlate of depth 
of anaesthesia is brain tension.” If this is the case, an estim ate of brain tension 
could form the basis of a controller for anaesthetic depth. This was the approach 
developed by Chilcoat, Lunn and Mapleson as described in [79]. In this work, 
a physiologically-based model of halothane pharm acokinetics was m atched to a 
dog and the m odel’s brain tension was used to determ ine the  required halothane 
doseage. The m atching of the model to the patient has three phases;
1. The m atching of the tissue masses and volumes of the model and its 
bloodrgas partition  coefficient. This phase occurs once only.
2. The update, every 10 seconds of the model using estim ates of alveolar 
ventilation and cardiac output.
3. The m easurem ent, every 30 m inutes, of arterial tension and the  subsequent 
adjustm ent of the m odel’s cardiac output so as to  m atch the m odel’s arterial 
tension with the measured value.
The only drawback in this scheme is the requirem ent for measurement of 
arterial tension. The following sections describe a procedure which provides an 
estim ate of tissue tensions in a patient undergoing surgery. This scheme requires 
only non-invasive m easurements in order to function.
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5.1 M atching the M odel to  th e  P atien t
Matching*a physiologically-based m odel to a'patifent ideally fec[ufres;
1. estim ation or measurem ent of tissue masses, volumes and perfusions
2. estim ation or m easurem ent of tissue:gas and blood:gas partition  coefficients
3. estim ation or m easurem ent of alveolar ventilation
4. estim ation or m easurem ent of cardiac output.
The estim ation of tissue partition coefficients requires invasive m easurem ents 
and is therefore im practical. As an approxim ation, the partition  coefficients 
derived for the isoflurane model and listed in Table 4.7 will be assumed for all 
individuals. The measurem ent of cardiac ou tpu t is not routinely applied and 
is generally invasive. Such a m easurem ent will not be pursued. The scheme 
developed to estim ate tissue tensions therefore requires the  following steps to 
m atch  the  model;
1. estim ation of tissue masses, volumes and perfusions
2. estim ation of alveolar ventilation
3. estim ation of cardiac output
5.1.1 E stim ation  o f T issue M asses, V olum es and Perfu­
sions
In m atching their pharm acokinetic model for the dog, A llots Steward and 
M apleson [123] actually measured the masses of the main organs and estim ated 
partition  coefficients so as to produce a ‘s tandard ’ dog. The standard dog was 
used in their later work [79] to provide individual param eterisation for each dog. 
As a first approximation, it is conceivable th a t the ‘standard  m an’ such as that
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detailed by Davis and Mapleson [45] could be simply scaled to an individual 
patien t, on the basis of body mass, to produce tissue masses, volumes, perfusions, 
blood pools and a cardiac output for a m atched model. Unfortunately, the range 
of body composition in humans is extensive. Furtherm ore, there are fundam ental 
differences between the body composition of men and th a t of women. This makes 
straightforward scaling of the standard m an’s proportions to  a p a tien t’s body mass 
inadvisable.
The non-invasive assessment of body composition in hum ans generally assumes 
the body to be composed of two com partm ents: the body fat and the fa t-free  mass 
[126]. The body fat is assumed to have a constant density of around 0.90 kg/1 and 
and the fat-free com partm ent com partm ent is assumed to have density of around 
1.10 kg/1. Body fat contains no potassium  or water. The fat-free mass contains 
both  potassium  and water. These characteristics allow estim ates of the masses or 
fractions of both  com partm ents to be made by measuring to ta l body potassium , 
to ta l body water or body density.
The measurement of to tal body potassium  and to tal body water requires 
laboratory analysis and special preparations. The m easurem ent of body density 
can be achieved using underwater weighing (see D urnin and Raham an [127] for 
details) but this is not routinely applicable.
The m easurem ent of skinfold thickness and body density has been used to 
derive tables of percentage body fat versus skinfold thickness for different age 
classes. This approach has been described by Durnin and Womersley [126]. In 
producing estim ates of percentage fat from skinfolds, these workers measured 
body density by underw ater weighing. Assuming th a t the body is composed of 
two com partm ents of different density d1 and d2, the fraction of body weight m ade 
up by m aterial 1, w\ is related to the to ta l body density, D  by
1 di • d2 d\
W' " d ' (d2 - d x) ~  ( d t - d , )
This equation is derived by Brozek et al. [128]. This fraction was then used to
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derive regression equations for use in tables relating the  skinfold thickness to fat 
percentage. This approach is lim ited by the assum ption of constant density in 
the body fat and fat-free com partm ents. As described by D urnin and Womersley 
[126], th is has greatest effect in individuals w ith very low or very high proportions 
of bone in their fat-free mass.
Accepting these lim itations, it is apparent th a t the m easurem ent of skinfolds 
can offer a simple and effective means of assessing the  body com position of an 
individual. The technique requires four m easurem ents using skinfold calipers, no 
laboratory  analysis and the results are drawn from standard  tables.
T he scheme proposed for m atching a physiologically-based model to  a patient 
is illustra ted  in Figure 5.1. The scheme requires only the input of the pa tien t’s 
mass and percentage fat.
Patient
measure mass, estimate % fat
calculate fat-free mass
calculate fat group mass
add drug parameters
divide fat-free mass 
between viscera and lean groups 
in proportion to standard man
adjust model blood pools and 
blood flows to match circulation times 
and perfusions of standard man
Matched Model
Figure 5.1: Schematic of the Model M atching Scheme
This scheme has been implemented for use with the on-line estim ator and takes 
the  p a tien t’s sex, mass and percentage body fat as argum ents. If the percentage fat
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is unknown, the program assumes a value dependent upon the  sex of the patient. 
15% body fat is assumed for a man and 25% for a woman. Following .the mo.del . 
m atching procedure, the tissue group masses and volumes, blood pool volumes 
and tissue group partition coefficients are each determ ined. Full param eterisation 
also depends upon alveolar ventilation and cardiac output.
5.1.2 T he E stim ation  o f A lveolar V entilation
Equation 2.1 relates the alveolar ventilation to  the respiratory rate , tidal volume, 
m inute volume and deadspace volume. Instrum entation available on the anaesthe­
sia m achine measures respiration rate, tidal volume and expired m inute volume. 
U nfortunately, these cannot be autom atically collected from the instrum ent as 
it has no external interface. The m easurem ent can however founthe basis of an 
estim ate of alveolar ventilation. W hen ventilation is controlled, m ore precise es­
tim ation is viable because each ‘b rea th ’ is the same. In the on-line estim ator 
originally im plem ented, the alveolar ventilation was assumed constant a t 4 litres 
per m inute. This assumption introduced unacceptable error to  the estim ation pro­
cess and a means of establishing and changing the alveolar ventilation estim ate 
during estim ation was later added to the im plem entation. This modification and 
the factors which necessitated it are described later.
5.1.3 T he E stim ation  o f Cardiac O utput
The accurate estim ation of cardiac output is a complex procedure and the most 
reliable m ethods currently available are invasive. Even approxim ate m ethods such 
as im pedance cardiography present practical problems in their use [79]. In the 
estim ation scheme described in this chapter, the estim ation of cardiac output is 
an explicit step in the estim ation of tissue tensions and involves non-invasive 
techniques.
Chapter 5. M odel-Based Estim ation o f Tissue Tensions
5.2 The E stim ation  Schem e
158
In their scheme for the control of brain tension, Chilcoat, Lunn and Mapleson 
[79] used m easured arterial tensions to modify the cardiac ou tpu t of their model. 
The end-tidal anaesthetic tension is a reasonable approxim ation to  the arterial 
anaesthetic tension and can be more readily m easured. This characteristic 
has been exploited to form an estim ation scheme which, using a m atched 
physiologically-based model, m odulates the cardiac ou tpu t of the model so as 
to  make its end-tidal tension m atch th a t of the patient. The scheme is illustrated 
in Figure 5.2
Patient et
inspired cone
Q -
Model
A
CO
A
et
Controller
Figure 5.2: Tissue Tension E stim ator Scheme
As indicated, a controller is employed to drive the error, e, between the 
measured end-tidal tension, e t , and th a t of the model, et to  zero. The function 
of the estim ator is based upon the monotonic changes in end-tidal tension caused 
by cardiac output changes (see Figure 4.4). The model of the patient therefore
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depends upon the cardiac estim ate produced by the controller.
5.2.1 T he M echanism  o f O peration o f th e  E stim ator
The estim ation scheme drives the error between the  patien t and m odel end-tidal 
tensions to  zero. If the ventilation of the model is m atched to  the  ventilation of the 
patien t, th e  uptake of the model will equate w ith th a t of the patien t. If the  tissue 
masses, relative blood flows and partition coefficients are consistent w ith those 
of the patien t, the uptake in each of the tissue groups of the m odel will be the 
same as those of the patient if the m odel’s estim ate of cardiac ou tpu t is correct. 
The correct estim ation of cardiac ou tpu t therefore depends upon the  model being 
w ell-m atched to the patient.
If th e  model is not w ell-m atched to the patien t, errors will arise in the 
estim ation of cardiac output and ultim ately in the estim ated tissue tensions. For 
instance, if the  model assumes an alveolar ventilation greater th an  th a t present 
in the pa tien t, the notional flow of drug into the model is greater than  th a t into 
the patien t. This, in isolation, would tend to  increase the end -tida l tensions 
of the model above th a t of the patient all o ther things being equal. In order 
to com pensate for this situation, the estim ator will increase the m odel’s cardiac 
ou tpu t so as to increase the uptake of drug by each tissue group and therefore 
reduce end -tida l tension. The m odel’s cardiac ou tpu t estim ate will therefore be 
too large. In a similar m anner, an overestim ate of tissue group volumes in the 
model will result in greater uptake in the tissue groups of the  model than  in the 
tissue groups of the patient. This causes the model to have a lower mixed-venous 
tension and subsequently lower end-tidal tension. To m aintain end -tida l tension 
m atching, the estim ator would underestim ate cardiac ou tpu t in this situation. 
These effects will be illustrated later.
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5.3 Sim ulated Perform ance o f th e E stim ation
Schem e
In order to  test the validity of the estim ation scheme, its perform ance in a range 
of tests has been evaluated. In evaluating the scheme, one version of the isoflurane 
model derived in C hapter 4 has been used to  represent the patien t and another 
has been m anipulated by the estim ation scheme. The tests involved changing the 
cardiac ou tpu t of the patient model and observing the behaviour of the estim ator. 
These tests were carried out using MATLAB and consist of;
1. The continuous-tim e performance of the estim ator w ith a perfectly m atched 
model.
2. The discrete-tim e performance of the estim ator with a perfectly matched, 
model, (discretely available estim ator input)
3. The continuous-tim e performance of the estim ator with mismatched tissue 
groups.
4. The continuous-tim e performance of the estim ator with mismatched alveolar 
ventilation.
5.3.1 C on tin uou s-T im e Perform ance w ith  a P erfectly  
M atched M odel
To dem onstrate the performance of the estim ation scheme, a continuous-tim e 
version of the estim ator has been sim ulated using MATLAB. The controller within 
the estim ator (see Figure 5.2) has been im plem ented as a simple P I controller. The 
controller gains have been adjusted m anually to produce acceptable performance 
during simulation. The aim  of the adjustm ent has been to  produce a fast response 
of th e  cardiac output estim ate w ithout excessive overshoot or oscillation. In the
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tests described below, the proportional gain is fixed at 0.3 and th e  integral gain is 
0.06. The use of the integral term  ensures th a t the error between the  model and 
patient end-tida l tensions is reduced to zero.
In each of the tests featured below, step changes occur in bo th  the inspired 
concentration to the sim ulated patient and in the cardiac ou tpu t of the patient 
model. In each case, the estim ator’s initial cardiac ou tpu t estim ate  is 6 1/min 
and the patien t m odel’s cardiac output ig 7.2 1/min initially. In each test, the 
inspired concentration either varies between 1% and 3% or 3% and 1% after 20 
m inutes. After 30 m inutes, the cardiac outpu t either changes from 7.2 1/min to 8.0 
1/min or from 7.2 1/min to 6.0 1/min. The tim ing of the  cardiac ou tpu t changes 
is so as to allow equilibration of the faster tissue groups of the  patien t model. 
The gradient of the end-tidal curve is consequently reduced and the am ount of 
inform ation available to the estim ator is much less than  in the in itial 15 minutes. 
This presents a useful performance test which simulates the tim escale in which the 
estim ator would be most useful if used in the autom atic control of anaesthesia. 
The conditions of each test and the figures illustrating their results are listed in 
Table 5.1 In each of the figures, the upper graph shows the patien t model cardiac 
o u tpu t as a dashed line and the estim ated cardiac ou tpu t as a solid line. The lower 
graph of each figure shows the patient model and estim ated brain tensions. The 
patien t model brain tension is the dashed line and the estim ated brain tension is a 
solid line. It is apparent from these results th a t the estim ation scheme is capable 
of providing satisfactory estim ation performance.
5.3.2 D iscre te -T im e Perform ance w ith  a P erfectly  M atched  
M odel
In the  operating theatre, continuous inform ation on inspired and end-tidal 
tensions cannot be autom atically collected w ithout specialised hardware. The 
D atex U ltim a monitor, for which there is a CLASS library virtual monitor, can
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Test Ti T j COi C O f Figure
1 1% 3% 7.2 8.0 5.3
2 1% 3% 7.2 6.0 5.4
3 3% 1% 7.2 8.0 5.5
4 3% 1% 7.2 6.0 5.6
Note:Tt- and T j  are the initial and final inspired concentrations respectively and 
COi  and C O f  are the initial and final cardiac outputs of the patien t model 
respectively
Table 5.1: Sum m ary of Continuous-Tim e E stim ator Tests
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Figure 5.6: Continuous-Tim e Test 4
provide such information every 10 seconds in a d a ta  string ou tpu t at its RS- 
232 d a ta  port. The estim ation scheme code used in the  continuous-tim e tests has 
been modified so as to provide estim ator updates in m ultiples of 10 seconds. In an 
initial investigation, the performances of estim ators producing estim ates every 10, 
20 and 30 seconds were compared. Updates every 30 seconds were not considered 
satisfactory. The following tests used updates every 20 seconds to  sim ulate using 
every second Datex string. This, of course, allowed the use of every Datex string 
as a further refinement if required. The testing scheme followed the same form at 
as the continuous-tim e tests for the first four tests and these are summarised 
along with their figure numbers in Table 5.2. In addition, the performance of the 
estim ator in following a ram p-up  and ram p-dow n of cardiac ou tpu t from 5 1/min 
at 20 m inutes to 8 1/min at 25 m inutes and back to 5 1/min a t 30 m inutes with a 
constant 3% inspired isoflurane is shown in Figure 5.11. The arrangem ent of each 
of these graphs is identical to  th a t of the continuous-tim e tests. In each of these
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tests, the  controller was once again a P I type with proportional gain =  0.1 and 
integral gain =  0.25. These tests indicate th a t ^ djscrete-rtime im plem entation - 
of the estim ator, designed to take account of the practical lim itations of d a ta  
collection, can produce satisfactory estim ation perform ance.
Test Ti T f COi C O f Figure
1 1% 3% 7.2 8.0 5.7
2 1% 3% 7.2 6.0 5.8
3 3% 1% 7.2 8.0 5.9
4 3% 1% 7.2 6.0 5.10
Note:T; and T f are the initial and final inspired concentrations respectively and 
COi and C O / are the initial and final cardiac ou tpu ts of the patien t model 
respectively
Table 5.2: Summ ary of D iscrete-T im e E stim ator Tests
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Figure 5.10: D iscrete-T im e Test 4
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Figure 5.11: D iscrete-T im e Ram p Test
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5.3.3 T he Effects o f M ism atched B od y  C om p osition  Es­
tim ates
Estim ates of body fat and body muscle cannot be m ade very precisely. Any 
estim ate m ade is therefore likely to introduce errors into the estim ation scheme. 
In this case, the interpretation of the results of the estim ation changes.
In m atching end-tidal concentrations, the estim ation scheme actually attem pts 
to ensure th a t the uptake of the model is the same as th a t of the patient. If all 
the tissue masses employed in the model are correct, having the model uptake the 
same as the pa tien t’s uptake dictates th a t the m odel’s cardiac ou tpu t is also the 
same as th a t of the patient. This ceases to be the case when model tissue masses 
are not the same as those of the patient.
Early in the estim ation process, the brain sample, visceral group, lean group 
and fat group all require significant uptake of drug in order to  equilibrate with the 
arterial blood. After about 15 m inutes, the faster tissues (brain and viscera) have 
very nearly equilibrated with arterial blood and no longer contribute significant 
uptake. After this tim e, further changes in cardiac ou tpu t only alter the rate  of 
uptake of drug in the slower lean and fat groups. In m atching the uptake of the 
patient, the estim ator will place the correct am ounts of drug within the tissue 
groups (assuming correct circulatory param eterisation). If there is an error in 
calculating or measuring the mass or volume of a tissue group, there will also be 
an error in the tension estim ated for th a t group. A further complication arises 
from the error in the tissue volume estim ates: because tissue uptake increases 
w ith its capacity for the drug which, in tu rn , increases w ith the  tissue volume (see 
equation 4.4), an error in the tissue volume estim ate causes an error in the cardiac 
ou tpu t estim ate. This is because in order to equate the  uptake of two tissues of 
different mass, the smaller of the two must be more highly perfused.
These effects are illustrated in Figures 5.12, and 5.13. Figure 5.12 shows the 
effects of a 10% underestim ate of the lean group volume and a 10% underestim ate
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Figure 5.12: M ismatched Tissue Test 1
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Figure 5.13: M ismatched Tissue Test 2
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of the fat group volume in the model employed by the  estim ator. Figure 5.13 
shows the  efFects of a 10% overestim ate of the  lean group volume and a 10% 
overestim ate of the fat group volume in the model employed by the estim ator. In 
both cases, the end-tidal curves are well m atched as would be expected. The brain 
tension curve is well m atched to the actual patient sim ulation brain tension, but 
the cardiac output estim ate is no longer reliable due to  the m ism atched models.
It can be noted, however, th a t the error in the cardiac ou tpu t estim ate in both 
cases is still only 5% after 30 minutes for a 10% error in both  the lean and fat 
group volumes.
5.3 .4  T he EfFects o f M ism atched  A lveolar V entilation  
E stim ates
Alveolar ventilation cannot be directly measured bu t can be estim ated in consider­
ation of either m inute volume or tidal volume and respiration rate. Alveolar ven­
tila tion  is m inute ventilation minus the ventilation of physiologic and anatom ical 
deadspace (see Equation 2.1). Such an estim ate will also have an error associated 
w ith it.
T he alveolar ventilation determines the ra te  of delivery of drug into the patient. 
If the  alveolar ventilation increases, the end-tidal and tissue tensions also increase 
as shown in Figure 4.3. A mism atch between the model and patien t alveolar 
ventilations therefore causes errors in the subsequent estim ation.
If the pa tien t’s alveolar ventilation is larger than  th a t of the model, the 
en d -tid a l concentration predicted by the model will be lower than  th a t of the 
patien t. The estim ation scheme will compensate by reducing model tissue uptakes 
in order to raise the end-tidal tension. This will be achieved by reducing the 
cardiac output. If the model has an underestim ate of alveolar ventilation, it will 
subsequently underestim ate both cardiac ou tpu t and tissue tensions. Conversely, 
if the  model assumes an alveolar ventilation greater than  th a t of the patient,
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Figure 5.14: M ismatched Ventilation Test 1
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Figure 5.15: M ismatched Ventilation Test 2
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the model end-tidal tension will be higher than  th a t of the patient and in 
com pensating for. the .difference t.he. estim ator will produce cardiac o u tp u t and * • 
tissue tension estim ates which are too high.
These efFects are illustrated in Figures 5.14 and 5.15. Figure 5.14 shows the 
results of assuming an alveolar ventilation in the model which is 10% below th a t 
of the patien t simulation. This results in an underestim ate of cardiac ou tpu t and 
an underestim ate of brain tension. The error in the brain tension estim ation is 
however not very large. Figure 5.15 shows the perform ance of the estim ator when 
the model assumes an alveolar ventilation 10% greater th an  th a t of the patient 
simulation. In this case, the estim ator over estim ates the cardiac ou tpu t and brain 
tension. Once again the error in the estim ated brain tension is not too large.
5.4 A ctual Perform ance o f th e E stim ation  Schem e
The sim ulation of the estim ator scheme contributed greatly to the refinement 
of the approach. Further areas where refinements are necessary have been 
highlighted following the use of the estim ation scheme in theatre. The potential 
problems described earlier which are due to m ism atching of the  m odel’s ventilation 
and tissue groups become apparent in practice. F urther com plicating factors 
have also arisen, in particular, the characteristics of the inspired and end-tidal 
concentration m easurements.
5.4.1 E xperim ental E quipm ent
A prototype version of the estim ation scheme has been im plem ented as part of the 
Glasgow Anaesthesia Estim ation Libraries (GAEL). These libraries contain code 
to perform model m atching and the initialisation and updating of an estim ation 
scheme with a P I controller. Using the CLASS libraries, a virtual m onitor for 
the Datex U ltim a m onitor was created. This allowed inspired and end-tidal
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anaesthetic concentrations to be measured and passed to  the estim ation scheme. 
As described in C hapter 2, the code is w ritten in G + + , .compiled. with the 
Zortech C + +  3.0 compiler running on a Viglen III/L S  m achine. The estim ation 
scheme has been set up to produce a physiologically-based m odel of isoflurane 
pharm acokinetics m atched to the patient. In theatre , isoflurane, nitrous oxide 
and oxygen are delivered via a circle system. To m inim ise interference with 
conventional anaesthesia practice, the estim ation scheme was used in conjunction 
w ith this arrangem ent.
5.4.2 Inspired and End—T idal Isoflurane C oncentration  
M easurem ents
After a  lim ited amount of prelim inary investigation, it becam e apparent th a t the 
m easured end-tidal concentration timecourses did not appear as expected. W hen 
using closed-circuit anaesthesia, it is custom ary for the  circuit to be ‘prim ed’ by 
delivering isoflurane and other fresh gases through the circuit to  a test bag which 
sim ulates the patient so as to d istribute the fresh gas m ixture throughout the 
circuit. This ensures th a t the patient breathes a m ixture close to th a t set on 
the vaporiser and gas flowmeters. In addition to  this, an appreciable am ount of 
anaesthetic gas is stored in the circuit during prim ing and this acts as a buffer 
during the  initial large uptake of the patient.
The patient may also be presented w ith a gas m ixture including the volatile 
agent a t induction. In estim ating tissue anaesthetic tensions using the estim ation 
scheme, it is essential to have an ‘em pty’ patient i.e., a patien t having breathed 
none of the agent being used to drive the estim ation. E stim ator tests were however 
upset by apparently high end-tidal tensions at an early stage in the patien t’s 
uptake. W ithout a reliable physiological explanation for this, it was decided th a t 
the  m onitor should be tested in a range of combinations. The changes in both 
inspired and end-tidal concentrations were therefore m easured during anaesthetics
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in which the  patient and the anaesthetic circuit could either be ‘prim ed’ or ‘em pty’. 
Three tests were perform ed as sum m arised in Table 5.3. T he figure num ber for the 
graphs showing the results of these tests is also given in the  table. In these figures, 
the  solid line represents the inspired concentration of isoflurane in percent and the 
dashed line represents the end-tidal concentration also in percent as recorded by 
the D atex monitor.
Test Circuit Patient Figure
1 prim ed prim ed 5.16
2 prim ed em pty 5.17
3 em pty em pty 5.18
Table 5.3: Sum m ary of Concentration M easurem ent Tests
It is apparent, from these figures, th a t when the circuit is prim ed, the end-tidal 
concentration m easurem ent rises very rapidly initially and then  tends to follow the 
inspired tension. This would suggest th a t the m onitor’s m easurem ent of end-tida l 
tension does not accurately reflect the end-tidal tension of the  patien t. The precise 
reason for this is not clear. In contrast, the concentration-tim e curves for the 
em pty circuit and em pty patient (Figure 5.17) produce an end-tida l curve which is 
m ore realistic. Although it is apparent th a t the m onitor’s end-tida l m easurem ent 
m ay not accurately reflect the pa tien t’s end-tida l anaesthetic concentration, the 
use of an em pty circuit and em pty patient (i.e., none of the m easured agent in 
the  circuit or the patient a t the s tart of m easurem ents) has been adopted so 
as to  minimise these efFects. A further effect can be observed in Figure 5.17. 
Following the reduction of the inspired concentration at around 1300 seconds, the 
end-tidal value falls very rapidly. Once again, it seems pharmacologically and 
physiologically unlikely th a t such a rapid reduction in end-tida l concentration 
could occur after 20 m inutes of anaesthesia. Regrettably, this characteristic 
of the m easurem ent is not avoidable because such reductions in the inspired 
concentration are necessary at the end of an operation.
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Figure 5.16: M onitor Test: Prim ed Circuit, Prim ed P atien t
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Figure 5.17: Monitor Test: Prim ed Circuit, Em pty Patien t
Chapter 5. M odel-Based Estim ation o f Tissue Tensions 176
1.8
insi1.6 ...
1.4
1.2
*Z3
0.8 .........
0.6
end-tidal:
0.4
0.2
600200 400 800 1000 1200 1400
Time in seconds
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5.4.3 E stim ation  Schem e T heatre T est R esults: 
Version 1
This section discusses the characteristics of three tests of the estim ator in the 
operating theatre. As stated  earlier, each patient was not given any isoflurane 
prior to  their positioning on the operating table and the connection of the monitor. 
The anaesthetic circuit was also flushed so as to ensure th a t no isoflurane rem ained 
in the circuit. The characteristics exhibited by each test are sum m arised below.
Test A
This test took place during an operation on a 64kg m an to relieve haemerrhoids. 
Estim ates of the p a tien t’s percentage body fat were not available and the 
estim ation was set up to assume th a t the p a tien t’s body fat was in the same 
proportion as tha t of the standard man. Figure 5.19 shows the measured inspired
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and end-tida l concentrations (expressed as a percentage) as continuous lines. The 
end-tida l concentration produced by the; e^tijn^tQr is shown as.a  broken.line.on 
the  lower graph of Figure 5.19. The estim ation scheme has succeeded in following 
the  p a tien t’s end-tidal concentration as would be expected. In Figure 5.20, the
■g 0.5
0 200 400 600 800 1000 1200 1400 1600 1800 2000
Time in Seconds
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a  0 .4
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Figure 5.19: Test A: Inspired and E nd-T idal Concentrations (Model End-T idal 
Value is the Broken Line)
upper graph shows the brain tension estim ate produced by the scheme. While 
is is probably unwise to suggest th a t this plot is an accurate representation of 
the actual brain tension, it does seem to present a plausible relationship. The 
estim ated cardiac outpu t of the estim ation scheme is shown in the lower graph 
of Figure 5.20. The initialisation of the estim ation scheme provides an initial 
value of 6.5 1/min for cardiac output. As d a ta  arrives and is processed by the 
estim ator (at about 550 seconds), the cardiac outpu t estim ate changes. The 
initial estim ates are low as the estim ation scheme a ttem pts to  track the patien t’s 
end-tida l tension rise. The com plem entary case exists after around 1400 seconds
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Figure 5.20: Test A: Brain Tension and Cardiac O utpu t Estim ates
when the  estim ator increases the cardiac ou tpu t estim ate to  unrealistic values 
in a ttem p ting  to m atch the decreasing end-tidal concentration a t the end of the 
anaesthetic. The operation of the estim ator between 800 seconds and 1400 seconds 
provides cardiac output estim ates in a physiologically acceptable range and is more 
likely to be accompanied by reliable estim ates of tissue tensions.
Test B
This operation took place on a male patient weighing 67.6 kg. The patient was 
assum ed to have the body fat in proportion to the standard  man. In Figure 5.21, 
the inspired and end-tidal measured concentrations of isoflurane are shown using 
continuous lines and the end-tidal estim ate of the estim ation model is shown using 
a broken line. Tracking of the pa tien t’s end-tida l concentration was good from 
about 500 seconds until the vaporiser was turned off ju s t before 2000 seconds. 
Tracking was not as good from switch-on up to  500 seconds or after switch-off.
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Figure 5.21: Test B: Inspired and E nd-T idal Concentrations
Despite this, the brain tension estim ate shown in Figure 5.22 seems reasonable. 
If this estim ate is accurate, then the skill of the anaesthetist in controlling brain 
tension is exemplified by this brain tension response. The cardiac ou tpu t estim ate 
reflects the effort m ade by the estim ator to m atch the end-tida l tensions. As with 
the  previous test, the cardiac outpu t estim ate is too low in the initial period and, in 
this case, certainly too high at the end of the test. Between 500 and 2000 seconds, 
the  estim ation scheme provided good m atching of the patien t and model end-tidal 
tensions. The cardiac output estim ate during this period is however too high. The 
excessive estim ate produced during this period was apparent during the test. As 
considered earlier, cardiac output estim ates can be erroneous in the presence of a 
m ism atched model. In this case, the mass of the patien t was known so th a t errors 
in th e  masses of tissue groups should have been reasonably small. The other main 
source of error arises from mismatches in alveolar ventilation. At this point, the 
estim ation scheme assumed, for all pa tien t’s, an alveolar ventilation of 4 1/min.
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Figure 5.22: Test B: Brain Tension and Cardiac O utpu t Estim ates
For this patient, who was artificially ventilated, the ventilator was delivering 10 
breaths per m inute and the tidal volume was 0.51 litres. This gives a m inute 
volume of 5.1 litres. The alveolar ventilation is determ ined following subtraction 
of anatom ical and physiological deadspace. As an approxim ation, the combined 
deadspace can be estim ated as between 2 and 2.5 m l/kg  [A.J. Asbury personal 
communication]. For this patient, this gives a deadspace of between 135ml and 
170ml. These figures, in tu rn , predict alveolar ventilation of between 3.4 1/min 
and 3.75 1/min. The model has therefore assumed a greater alveolar ventilation 
than  th a t of the patient. As shown in Figure 5.14, this can result in consistently 
high cardiac output estim ates.
Test C
This operation involved the removal of a cyst on the neck of a male patient 
estim ated to be around 85kg in weight. W ithout any additional da ta  on the
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pa tien t’s body fat, he was assumed to have tissue groups and fat in proportion 
to those of the 70kg standard man. .T h e  mefLSVir^d .inspired .a n d . end-tidal 
concentrations of the patient are shown in Figure 5.23. The m odel’s end-tidal
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Figure 5.23: Test C: Inspired and E nd-T idal Concentrations
tension is shown as a dashed line in the same figure. The cardiac outpu t and 
brain tension estim ates produced during this procedure are shown in Figure 5.24. 
It is apparent th a t from about 500 seconds until around 1000 seconds th a t cardiac 
ou tpu t estim ate is too low. In fact, a hard lim it on the  lowest cardiac output 
perm issible in the estim ator was set at 2.4 1/min. The cardiac ou tpu t estim ate 
held this value for some tim e during the early stages of this procedure. There 
are m any potential sources of error in this case; the mass of the patient and the 
proportion of body fat were not precisely known, the  operation took place with 
the patien t face-down on the table which influences circulation and ventilation 
and, as in the previous case, the ventilation of the patien t differed from that 
assumed by the model. The model assumed an alveolar ventilation of 4 1/min.
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The patien t was ventilated at 12 breaths per m inute w ith a tidal volume of 0.65 
litres. Deadspace can be estim ated as being between 170 and 212 m l giving an 
alveolar ventilation of between 5.25 and 5.64 1/min. This can account for the 
system atically low cardiac outpu t estim ates.
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Figure 5.24: Test C: Brain Tension and Cardiac O utpu t Estim ates
5.4.4 E stim ation  Schem e T heatre T est R esu lts: Ver­
sion 2
It becam e apparent th a t the assumption of alveolar ventilation of 4 1/min for 
the estim ation scheme model was inappropriate. This was therefore remedied by 
adding a menu box to the interface of the program  which runs the estim ation 
scheme. In this arrangem ent, the user could alter the alveolar ventilation in the 
box during a run of the estim ator and this would be used to update  the patient 
model used by the estim ator. A lim ited num ber of tests have been performed
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using this version of the estim ator. Two of these are described below.
Test D
This procedure was a kidney transplant to a 57kg female patient. At the start of 
the procedure, the program was started  with some in-line diagnostic code present. 
This interfered with the interface to  the program  and necessitated its removal 
and recom pilation. The breathing circuit was then flushed and the  estim ator re­
started . For completeness, the da ta  gathered during the initial abortive stage has 
been included. The measured inspired and end-tida l concentrations of isoflurane 
in percent are shown in Figure 5.25 as solid lines. The estim ato r’s m atching
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Figure 5.25: Test D: Inspired and E nd-T idal Concentrations
of the end-tidal tension is shown as a dashed line in the same figure. The 
estim ator was applied a t the s ta rt of the procedure and was used for around 20 
m inutes. It is clear from the graphs of the estim ated cardiac ou tpu t (Figure 5.26) 
th a t the incorporation of b e tte r m atched ventilation has resulted in more stable,
(values around 3.3 1/min were input)
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physiologically realistic values. Regrettably, ju st after 1200 seconds, a d a ta  
collection fault resulted in the estim ator being presented w ith erroneous measured 
concentration values of about 1.7% inspired and 1.1% end-tidal. Because the 
estim ator m odel’s end-tidal concentration is still rising, the estim ator increases 
cardiac ou tpu t from this point onwards so as to  m atch the m easured end-tida l 
concentration. Disregarding cardiac output estim ates after about 1200 seconds 
gives an indication of the viability of this approach.
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Figure 5.26: Test D: Brain Tension and Cardiac O utpu t Estim ates
Test E
This operation was carried out on a 50kg woman to  perform  a lym ph node biopsy. 
The patient was assumed to  have body fat in the same proportion as the standard  
woman described in the discussion of the estim ator. Figure 5.27 shows the inspired 
and end-tidal m easured concentrations as continuous lines on the upper and lower 
graphs respectively. The estim ation scheme model end -tida l concentration is
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shown as a  broken line on the lower graph of Figure 5.27. It is apparent tha t 
the  m atching of the actual rrie^snre.d end-tida l .concentration, a n d .th a t predicted 
by the estim ator is good except in the initial and final stages of the test. The
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Figure 5.27: Test E:Inspired and E nd-T idal Concentrations
cardiac output estim ate for this test is shown in the lower graph of Figure 5.28. 
Following the presentation of da ta  to the estim ator, the cardiac ou tpu t estim ate is 
reduced to its lowest perm itted  value for a  short period. During the period of good 
m atching of end-tidal m easurements and predictions, (from about 250 seconds to 
about 1800 seconds) the estim ated cardiac output lies between 3 and 5 litres per 
m inute. This was considered to be a realistic physiologic range for a patient of this 
size and condition. The good quality of the cardiac ou tpu t estim ate suggests tha t 
bo th  the tissue groups and alveolar ventilation of the model are well-m atched. 
It is possible th a t the cardiac output estim ates are a little  low but the error is 
sm all. An error of this size could easily be introduced by a slight underestim ation 
of alveolar ventilation. The brain tension estim ate is shown in the upper graph of
"^"(values around 3 1/min were applied)
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is shown in the upper graph of Figure 5.28. Given the  quality of the cardiac 
output estim ate, it seems probable th a t the brain tension estim ate is reliable. At
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Figure 5.28: Test E:Brain Tension and Cardiac O utpu t Estim ates
the end of the  procedure, the inspired concentration is reduced sharply and the 
end-tida l m easured concentration follows a similar trajectory. The cardiac output 
estim ate exceeds physiologically realistic values a t this tim e. A lthough the cardiac 
output estim ate is not entirely satisfactory at the s ta rt and end of this test, the 
perform ance of the estim ation scheme between these tim es gave, in this case, 25 
m inutes of reliable performance. This illustrates the capacity of the approach, 
even in this prototypical form.
5.5 D iscussion  o f R esu lts
W ithout exception, in each of the practical tests conducted so far, the initial 
cardiac ou tpu t estim ates have been forced low in order to  m atch the rise in
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the m easured end-tidal concentration. In a  similar m anner, in each test where 
the anaesthetic concentration is reduced at the end of the  operation, the cardiac 
outpu t has been forced up so as to m atch the fall of the  end-tida l measurement. 
Of course, these events have occurred at the s ta rt and end of each test. While 
the errors in the cardiac output estim ate after the initial phase and before the 
switch-off of the vaporiser have been explained, to  a large extent, in consideration 
of m odel m ism atches, this argument cannot be applied to the behaviour in the 
initial phase and after switch-off.
The source of these errors appears to lie in the m easurem ents m ade by the 
Datex U ltim a. Figures 5.16 and 5.17 show th a t the  end-tida l m easurem ent 
starts high in a  prim ed circuit irrespective of whether the patien t is prim ed or 
not. This would imply th a t the end-tidal m easurem ent is altered by the inspired 
concentration. Figure 5.17 shows th a t when the vaporiser is switched off and the 
circuit fresh gas flow is increased so as to rapidly reduce the inspired concentration 
of volatile agent, the fall in end-tidal concentration follows th a t of the inspired 
concentration. This is not as expected. It seems possible, based upon these 
da ta  th a t the  measured end-tidal concentration is higher than  the actual patient 
end-tidal concentration initially and lower than  the actual value on reduction 
of the inspired concentration. If this is the case, the erroneous behaviour of the 
estim ation scheme is a result of problems associated with the m easurem ents made. 
This could be remedied by improving the quality of the m easurem ent.
In conclusion, it has been dem onstrated th a t it is possible to produce estim ates 
of tissue tensions of anaesthetic using the estim ation scheme described in this 
chapter. The reliable use of the scheme depends upon the accurate matching 
of the m odel used in the estim ator to the patien t and this concerns both the 
m atching of tissue groups and alveolar ventilation. The tests perform ed have 
dem onstrated, however, th a t physiologically realistic values can be produced by 
the estim ator without the need for invasive m easurem ents or extensive effort in
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model matching.
A further useful property of the estim ation scheme is th a t cardiac ou tpu t is 
produced as an interm ediate result. This quantity  has real physiological meaning 
and a ‘wrong’ value is very apparent to the anaesthetist. It becam e apparent 
during the  tests th a t the anaesthetists took a keen interest in the estim ate of a 
real value by the scheme. This feature greatly enhanced the acceptability of the 
scheme to the anaesthetists.
C hapter 6 
M odelling H om eostasis and th e  
Stress R esponse in A n aesth esia
SUMMARY
This chapter describes a model developed to represent homeostasis and 
the stress response. First, the characteristics o f homeostasis and the 
stress response are described. This is followed by discussion o f the 
effects o f general anaesthetics upon them. The motivation for, and 
development of, an explanatory model o f homeostasis and the stress 
response are then described. The inclusion o f drug effects within the 
model is discussed and results from  a prototype implementation o f the 
model are presented.
6.1 Physiological System s
A natom y is the study of body structures and the relationship between them . 
Physiology is the study of the function of, and interaction between body struc­
tures. The study of physiology involves consideration of activ ity  at several levels 
of abstraction. These are summarised in Table 6.1 [129].
189
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Level of abstraction Description
chemical level 
cellular level 
tissue level 
organ level 
system level 
organism level
most fundam ental 
most basic structural and functional units 
groups of similar cells perform ing a special function 
sets of two or more tissues w ith special function 
groups of organs w ith a  common function 
a living individual
Table 6.1: Levels of A bstraction in Physiology
Considering function at system  level is adequate to  describe most of the 
physiologic processes which have relevance during anaesthesia. Tortora and 
Anagnostakos [129] list the following m ajor body systems:
System Components
Integum entary
Skeletal
M uscular
Nervous
Endocrine
Cardiovascular
Lym phatic
Respiratory
Digestive
Urinary
Reproductive
skin,hair,nails,sweat glands, oil glands etc. 
bones and joints 
skeletal muscle tissue 
brain, spinal chord, nerves, eyes, ears 
glands th a t secrete hormones 
blood, heart and blood vessels 
lymph, lymph vessels and structures w ith lym phatic tissue 
lungs and respiratory passageways 
gastrointestinal trac t and associated organs 
organs th a t produce, collect and elim inate urine 
organs th a t produce, store and transport reproductive cells
Table 6.2: Physiological System of the Body
Each of these systems is involved in the m aintenance and performance of bodily 
function a t all times. During anaesthesia, however, the  m ajority  of significant 
effects and events can be explained in term s of the Nervous System, Endocrine 
System, Cardiovascular System and Respiratory System. In some cases, co­
existing disease of the patient may necessitate consideration of other systems. For 
example, a patient with kidney disease is affected by drugs differently to other 
patients. This can be explained, to an extent, by consideration of the urinary
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system which includes the kidneys.
6.1.1 T he N ervous System
The nervous system consists of the brain, spinal column, nerves and sense organs. 
Functionally, the nervous system performs three types of task; sensory, integrative 
and motor. The sense organs of the nervous system  respond to  changes in the 
body and its external environment; this is the sensory function. The integrative 
function of the  nervous system is the in terpretation  of the sensory information 
and determ ination of appropriate compensatory action. The m otor function is 
the initiation of muscle contractions or glandular secretions in order to achieve 
compensation. The nervous system transm its inform ation via nerves. Nerve 
conduction is fast and the nervous system can therefore respond quickly to 
changes.
The functions performed by the nervous system are wide-ranging and diverse. 
It is therefore divided into component sub-system s according to  function as shown 
in Figure 6.1.
The central nervous system (CNS) consists of the brain and spinal column 
and is responsible for the overall control of the nervous system including the 
in terpretation of sensory information and the determ ination of compensation.
The peripheral nervous system (PNS) consists of the nerves th a t connect the 
CNS to sensory organs, muscles and glands. W ithin the  PNS, the afferent system 
is composed of nerves which conduct impulses from sensory organs to the CNS. 
The efferent or m otor system consists of nerves travelling from the CNS to muscles 
and glands. The efferent system is further subdivided into the somatic nervous 
system  and the autonomic nervous system. The som atic nervous system comprises 
nerves travelling from the CNS to skeletal muscle and is used to in itiate and 
control movement. The autonomic nervous system  consists of nerves travelling 
from the CNS to non-skeletal muscle such as th a t in blood-vessel walls, the
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Figure 6.1: Illustration of Nervous System Components
gut and the heart, and also to  glands. The activity of the non-skeletal muscle 
and glands is not considered to be consciously controllable and the autonomic 
nervous system is therefore considered to only involve involuntary activity. The 
autonom ic nervous system is further divided into the parasym pathetic nervous 
system and the sym pathetic nervous system. Overall, the sym pathetic nervous 
system  is considered to stim ulate or increase the activity  of an organ and the 
parasym pathetic nervous system is considered to inhibit or decrease activity. The 
effects of parasym pathetic and sym pathetic nervous system  activity on various 
organs and organ systems is summarised in Table 6.3
6.1.2 T he Endocrine System
The endocrine system is composed of the endocrine glands. The endocrine glands 
secrete hormones which enter the bloodstream  and are thus carried to all the 
tissues of the body. A hormone is a chemical substance which acts as a messenger
^
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Site Sympathetic NS effect Parasympathetic NS effect
h eart
SA node increase heart rate decrease heart rate
AV node increase conduction speed decrease conduction speed
His-Purkinje system increase automaticity 
increase conduction speed
ventricles increase contractility 
increase conduction speed
lungs
bronchial smooth muscle relaxation contraction
G I tra c t
motility decrease increase
secretion decrease increase
sphincters contract relax
b lad d er
smooth muscle relax contract
sphincter contract relax
eye
radial muscle dilate pupil
sphincter muscle constrict pupil
ciliary muscle far vision near vision
liver glycogenolysis/gluconeogenesis glycogen synthesis
salivary glands increase salivation large increase in salivation
arte rio les
coronary constrict (alpha receptors) 
relax (beta receptors)
relax ? 
relax
skin and mucosa constrict relax
skeletal muscle constrict (alpha) relax
relax (beta) relax
pulmonary constrict relax
Table 6.3: Table showing the relative effects of Sym pathetic and Parasym pathetic 
Nervous System Activity
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to the tissues of the body. The function of a hormone will fall into one of the 
following categories:
1. to  regulate chemical composition and volume of the body’s internal 
environment,
2. to  respond to severe changes in environm ental conditions thereby allowing 
the  body to cope with stressors such as infection, dehydration, bleeding and 
em otional stress,
3. to  ensure smooth growth and development,
4. to  contribute to reproductive processes, and
5. to  regulate m etabolism  and energy balance.
T he effects of hormones take much longer to occur than  the effects of the 
nervous system, but those effects are likely to be present for much longer. Neuronal 
mechanism s therefore allow the short-term  fast responses required to  cope with 
m inu te-to -m inu te  or faster environm ental disturbances. Hormonal, or endocrine, 
responses provide long-term  regulation.
T he release of most hormones is governed by the body’s own feedback control 
loops. There are three possibilities.
1. The endocrine gland releases hormone in response to  changes in the variable 
which the hormone affects. This is the case for the  control of blood calcium 
by parathyroid hormone.
2. The endocrine gland releases the hormone in response to  nerve impulse 
stim ulation of the gland. This is the case for adrenaline.
3. The hypothalam us (part of the brain) releases a regulating hormone (or 
regulating factor when the chemical structure  is unknown) into the blood.
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The regulating hormone either stim ulates or inhibits the release of the m ain 
horm one by another endocrine gland. This is the  case for hum an growth 
hormone which is released from the p itu itary  gland according to blood levels 
of Growth Hormone Releasing Hormone and Growth Hormone Inhibiting 
Hormone.
Many hormones have little  chance to cause significant changes or effects during 
the tim escale of anaesthesia although some have a ma jor im pact upon the  recovery 
from anaesthesia. A sum m ary of relevant hormones and their m ain effects is given 
in Table 6.4.
Hormone Effects
A drenaline and No­
radrenaline
A ntidiuretic
Hormone
mineralocorticoids
glucocorticoids
Increase heart ra te  and contraction strength , con­
strict blood vessels, dilate respiratory passage­
ways, increase muscle efficiency
Prevents excessive urine production, constricts 
arterioles in severe bleeding
increase blood water and sodium , decrease blood 
potassium
prom ote normal m etabolism , resistance to stress 
and reduce inflam m ation
Table 6.4: Hormones Relevant to Anaesthesia and their Effects
Adrenaline and noradrenaline are both secreted by the m edulla (middle) of 
the  adrenal glands. There are two adrenal glands, one above either kidney. Nora­
drenaline and adrenaline cause effects similar to  those produced by sym pathetic 
nervous system stim ulation and are therefore term ed sympathomimetic. The re­
lease of adrenaline and noradrenaline results from stim ulation of the adrenal glands 
by the sym pathetic nervous system. Therefore, environm ental events which cause 
s tim ulation of the sym pathetic nervous system also cause the release of adrenaline 
and noradrenaline. These events include physical and em otional stresses.
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A ntidiuretic hormone is secreted by the posterior p itu ita ry  in response to  nerve 
impulses originating in the hypothalam us. ADH is secreted in response to  a 
num ber of stim uli including; low water concentration in the blood, pain, stress, 
traum a and anxiety.
M ineralocorticoids are a group of related hormones secreted by adrenal cortex 
(the outer layers of the gland). There are a t least three mineralocorticoids but 
95% of secretion is of the hormone aldosterone. The secretion of aldosterone is 
controlled by several mechanisms including decreased blood volume and increased 
potassium  ion concentration in the fluid surrounding cells.
Glucocorticoids are a group of hormones which influence m etabolism  and 
the resistance to stress. Glucocorticoids include hydrocortisone, corticosterone 
and cortisone. Hydrocortisone contributes 95% of glucocorticoid effects. The 
glucocorticoids are secreted so as to m aintain norm al m etabolism  but are also 
secreted in response to  stress. The effects of glucocorticoids which are useful in 
responding to stress are; the raising of blood sugar levels and the suppression of 
the inflam m atory response.
6.1.3 T he Cardiovascular System
The cardiovascular system consists of the blood, heart and blood vessels. The 
cardiovascular system is responsible for the delivery of oxygen and nutrients to 
cells and the removal of carbon dioxide and wastes from them . The cardiovascular 
system  also plays a role in regulating body tem perature  through changes in skin 
blood flow. Components within the blood prom ote blood clotting in wounds, help 
to  m aintain  acid-base balance and help to provide resistance to disease.
W ithin  the cardiovascular system, the heart acts as a pum p and m aintains 
circulation of the blood in blood vessels. The heart has two ventricles and two 
atria. The right atrium  is a chamber which fills with blood from the veins. Once 
during each heart cycle, the volume of blood in the right atrium  is transferred to
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the right ventricle. The right ventricle pum ps blood into the  pulm onary arteries 
which enter the lungs. In the lungs, as will be sum m arised la ter, oxygen enters the 
blood and carbon dioxide leaves it. Following passage through the lungs, blood 
enters the  left atrium . The left a trium  transfers blood to th e  left ventricle. The 
left ventricle pumps blood into the aorta  which is the largest com ponent of the 
arterial tree.
Blood vessels are responsible for the transport of blood around the  body. 
The types and characteristics of blood vessels are sum m arised in Table 6.5. The
Type Characteristics
Elastic arteries 
Muscular arteries 
Arterioles 
Capillaries 
Venules 
Veins
narrow walls in comparison with diameter, elastic 
thick muscle walls in comparison to diameter 
tiny arteries with limited muscle around them 
smallest vessels, allow exchange of nutrients and wastes with cells 
smallest veins, combination of several capillaries 
narrower walls than arteries and less muscle
Table 6.5: Summ ary of Blood Vessel Types
circulation of the blood around the tissue of the body is schem atically represented 
in Figure 6.2.
6.1.4 T h e R espiratory System
The respiratory  system includes the nose, pharynx, larynx, trachea (windpipe), 
bronchi and the lungs. Respiration is the process of gas exchange between the 
atm osphere, blood and cells. Respiration is subdivided into pulm onary ventilation 
(inhalation and exhalation) , external respiration (gas exchange between the lungs 
and the blood) and internal respiration (gas exchange between the lungs and 
cells). The respiratory system is obviously directly involved in both pulm onary 
ventilation and external respiration.
Gas passing into the lungs first enters the trachea and then either into the left 
or right prim ary bronchus. A prim ary bronchus divides into several secondary
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Figure 6.2: Blood Flow in the H eart and Blood Vessels
bronchi and these divide into tertiary  bronchi. Tertiary bronchi divide into 
bronchioles. T he bronchioles branch into term inal bronchioles. The division 
of airways from the trachea to the term inal bronchioles is called the  bronchial 
tree. Each term inal bronchiole divides into microscopic respiratory bronchioles 
and these, in tu rn , divide into alveolar ducts. Alveoli surround the alveolar ducts. 
Gas exchange between the lungs and the blood takes place when oxygen and 
carbon dioxide diffuse between the gas in the alveoli and the blood in the  capillaries 
which run through the alveoli. The m em brane between the alveolar gas and the 
capillaries around the alveoli is about 0.5/Jm thick. There are estim ated to be 
about 30 million alveoli together creating a surface area of around 70 m 2 for the 
exchange of gases between the lungs and blood.
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6.2 H om eostas is
The cells of the  body contain fluid and are surrounded by fluid. T he fluid 
within the  cells is called intracellular fluid and the  fluid outside the  cells is 
called extracellular fluid. Extracellular fluid exists e ither between the  cells as 
in terstitial fluid or within blood vessels as intravascular fluid. These are illustrated  
in Figure 6.3.
cell
lar fluid 
interstitial fluid
capillary
plasma and blood cells
Figure 6.3: Illustration of Bod)' Fluid Subdivisions
Homeostasis is the  m ain tenance of the b o d y ’s internal environm ent w ithin 
physiological limits. T he  existence of homeostasis requires th a t  the  internal 
environment;
1. contains op tim um  concentrations of gases, nutrients, ions and water,
2. has an optim al tem p era tu re
3. has an op tim um  pressure
A stress is any stim ulus which creates an im balance in the  internal environ­
ment. Some stresses result from external environm ental changes such a.s extrem es 
of tem pera tu re ,  oxygen deficiency or sudden noises. O thers have internal origins
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and include pain and high blood pressure. The body has m any well-developed 
regulatory loops which m aintain homeostasis. These make use of components in 
all of the  systems listed in Table 6.2.
In the  context of anaesthesia, m any of the clinical signs reflect the activity 
of the homeostasis loops or of the stress response. Of the m easurem ents made 
during anaesthesia, the m ajority are concerned with either the cardiovascular or 
respiratory systems although the blood volume affects each. The following sections 
describe the control of circulation, respiration and the blood volume by the body’s 
control loops.
6.2.1 Control o f C irculation
Blood flows through the heart as shown in Figure 6.2. Cardiac outpu t is the to tal 
blood flow out of either ventricle and is also the product of heart ra te  and stroke 
volume. The stroke volume is the amount of blood ejected by a ventricle during 
its contraction. The stroke volume is the difference between the amount of blood 
in the ventricle prior to its contraction (end-diastolic volume) and the amount 
remaining after contraction (end-systolic volume). The end-diastolic volume can 
be increased as a result of increased venous pressure which causes greater filling 
of the ventricles. As heart rate  increases, less tim e is available for the filling of 
the ventricles and end-diastolic volume will decrease. The end-systolic volume 
depends upon arterial pressure. The pressure in the ventricle m ust exceed tha t 
in the arteries before blood can flow out of the ventricle into the arterial tree. 
Raised arterial pressure therefore increases end-systolic volume. Increased force 
of contraction of the heart muscle causes greater flow from the ventricle into the 
arterial tree and a reduction in end-systolic volume.
The body has control loops which monitor and regulate bo th  the arterial and 
venous pressures. These loops employ both neuronal and hormonal mechanisms 
and can be summarised as follows:
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C o n tro l o f A r te r ia l  P r e s s u r e
Pressure sensitive cells (baroreceptors) exist in the aorta  and in the carotid arteries 
(which supply blood to the head). The carotid baroreceptors and the associated 
carotid sinus reflex are involved in the m aintenance of norm al blood pressure in 
the brain. The aortic baroreceptors and the associated aortic reflex are involved 
in the regulation of blood pressure elsewhere in the arterial system.
Increases in blood pressure cause baroreceptors to  generate impulses a t a 
higher rate. Impulses from arterial baroreceptors are conducted to  the m edulla (in 
the brain stem ) and these influence the activity of the cardioacceleratory centre, 
cardioinhibitory centre and the vasomotor centre. A decreased blood pressure 
causes a reflex increase in the activity of the cardioacceleratory centre and of the 
vasomotor centre. The cardioacceleratory centre causes an increase in heart ra te  
and force of contraction thus increasing cardiac ou tput. The vasomotor centre 
causes constriction of veins, small arteries and arterioles. The constriction of 
veins increases the flow of blood into the heart thus increasing end-diastolic 
volume which helps to  raise stroke volume. The increase in heart force of 
contraction reduces the end-systolic volume thereby further increasing stroke 
volume. The increase in heart rate in com bination with the increased stroke 
volume, increases cardiac output. The constriction of small arteries and arterioles 
increases peripheral resistance. The increased cardiac ou tpu t flowing through 
the  increased peripheral resistance increases arterial pressure. These reflexes are 
responsible for the m inute-by-m inute  regulation of blood pressure.
C o n tro l o f V en o u s P re s s u re
T he a tria  of the heart contain baroreceptors which are sensitive to the lower venous 
pressures. Increases in venous pressure result in reflex dilation of blood vessels 
and also a reflex increase in heart rate (Bainbridge Reflex). These changes reduce 
venous pressure in the short term . A lowered venous pressure results in reciprocal
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changes.
In the longer term , the vasodilation or vasoconstriction caused by the atrial 
reflex also constricts or dilates the arteries entering the kidney. This affects the 
ra te  of water loss by the kidney due to changes in perfusion pressure. A further 
effect of the atrial reflex is m odulation of the secretion of an ti-d iu retic  hormone 
by the hypothalamus. This further influences the water loss by the  kidney.
The baroreceptor and atrial reflexes are responsible for the m inute-by-m inute 
regulation of arterial and venous pressure. O ther factors can also cause changes 
through a combination of effects on the heart and blood vessels. For example, 
raised potassium  ion or sodium ion concentrations in plasm a decrease heart rate 
and strength of contraction. Increased body tem perature increases heart rate 
and decreased tem perature decreases it. Some effects are caused by changes in 
hormone levels and these are summarised in Table 6.6.
Hormone Effects
adrenaline 
noradrenaline 
anti-diuretic hormone 
angiotensin II 
aldosterone
increase heart rate, force of contraction and vasoconstriction
as above
promotes water loss can cause vasoconstriction 
causes vasoconstriction and release of aldosterone 
causes water reabsorbtion
Table 6.6: Hormonal Effects on Blood Pressure
6.2.2 Control o f R espiration
Respiration ensures th a t the cells of the body are supplied w ith oxygen and 
have carbon dioxide removed from them. Although it is possible, to  an extent, 
to consciously control respiration, the regulation of respiration normally occurs 
subconsciously. Regulation m aintains levels of oxygen and carbon dioxide in the 
blood. Carbon dioxide levels are reflected in the concentration of hydrogen ions 
and it is likely tha t respiration control loops are sensitive to these.
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Cells sensitive to  levels of chemicals or ions are term ed chemoreceptors. 
W ithin  the medulla, a chemosensitive area is sensitive to carbon dioxide levels. 
Chem oreceptors in the carotid arteries and the aorta  are sensitive to  both  carbon 
dioxide and oxygen levels. Increases in blood carbon dioxide cause reflex increases 
in the  ra te  and depth  of respiration allowing more carbon dioxide to  be removed 
from the body and blood levels to be returned to norm al.
The chemoreceptors are much less sensitive to  arterial oxygen. The normal 
partial pressure of oxygen in the blood is about 105 mmHg bu t reflex increase 
in respiration due to  lowered oxygen partial pressure do not occur until about 50 
mmHg. The respiratory control centres are responsible for generating a regular 
breathing rhythm  and for changing the ra te  and depth  of respiration. This is 
achieved by altering the activity of the diaphram  and intercostal muscles which 
are used in respiration.
6.2.3 C ontrol o f B lood  V olum e
The volume of blood in the body reflects the body’s overall fluid balance. The inate 
sensitivity of cells to  their environment dictates th a t the volume and concentration 
of body fluids is regulated precisely. The control of blood volume takes place in 
parallel w ith the control of venous pressure which was discussed earlier. Increased 
blood volume causes an increase in venous pressure and cardiac ou tpu t. This 
is com pensated for, in the short term , by reflex vasodilation and reductions in 
heart ra te  and contractility. The long term  reduction requires the  reduction of 
blood volume. This is accomplished through increased elim ination of water by 
the kidney. This occurs due to  two mechanisms; the vasodilation of the  kidney 
arteries which increases kidney filtration pressure and water elim ination and, the 
reduced secretion of an ti-d iuretic  hormone (ADH) which further enhances water 
elim ination. A reduced blood volume results in cardiac and blood vessel changes to 
com pensate in the short term  but long term  compensation requires the addition of
Chapter 6. Modelling Homeostasis and the Stress Response  204
fluid either by ingestion (the normal process) or by intravenous adm inistration (as 
used in theatre). The mechanisms involved in the production of vasoconstriction 
or vasodilation and in the regulation of ADH secretion were described earlier.
6.3 The Stress R esponse
The hypothalam us is sensitive to changes in the chemistry, tem perature  and 
pressure of the blood, and is also directly connected to  the em otional and other 
brain centres. In being responsive to both  physical and emotional stresses, the 
hypothalam us coordinates the stress response. The stress response or General 
A daptation Syndrome (GAS) can be in itiated  by any extrem e or unusual stress. 
W hile homeostasis loops operate so as to m aintain the  internal environment, the 
GAS overrides these to prepare for an emergency. The GAS is considered to have 
three phases;
1. The initial or alarm  response,
2. the resistance reaction, and
3. exhaustion.
The alarm response is characterised by activation of the  sym pathetic nervous 
system and the adrenal medulla. This produces a very quick but short-acting 
response which prepares the body for vigorous physical activity. The effects 
of the alarm  response include increased heart ra te  and force of contraction, 
vasoconstriction of blood vessels aside of those in skeletal muscle, the brain and 
heart, vasodilation of the blood vessels in muscle, the brain and heart, dilation of 
airways, increased respiration rate, and sweating.
The resistance reaction follows the alarm  reaction and relies upon hormones 
to achieve its goals. The most im portant hormones are the glucocorticoids and 
mineralocorticoids which are produced and secreted by the adrenal cortex. These
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hormones act so as to m aintain blood volume, increase blood sugar, decrease 
inflam m ation and sensitise blood vessels to stimuli which cause their constriction.
If the resistance reaction fails to overcome the stressor, the exhaustion stage 
occurs. This is largely due to the excessive elim ination of potassium  due to 
m ineralocorticoid activity.
In the absence of anaesthesia, surgery would elicit an alarm  response. Inade­
quate anaesthesia m ay therefore result in some rem nant alarm  response becoming 
apparent. The resistance reaction is essential to a pa tien t’s recovery from surgery.
6.4 D rug Effects upon H om eostasis and th e  
Stress R esponse
A general anaesthetic is adm inistered so as to alter central nervous system 
activity and produce anaesthesia. However, general anaesthetics have effects 
in tissues other than  the central nervous system  and produce other effects as 
well as anaesthesia. These include effects upon the regulatory loops of the 
body. The effects are specific to the agents, or chemical group of agents used 
but are also dose-dependent. The m ajority  of experim ental investigation has 
resulted in empirical description of the effects w ithout explanation of the possible 
mechanisms. The best explained of the effects are those which alter cardiovascular 
and respiratory behaviour. The effects of general anaesthesia upon these are 
sum m arised below.
6.4.1 T he Effects o f G eneral A n aesth etics  upon th e  Car­
diovascular System
Based upon observation of the effects of inhaled anaesthetics, many circulatory 
changes are common to to all anaesthetics. Stoelting [27] reviews the effects of the
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most commonly used anaesthetics on blood pressure, heart rate , cardiac output, 
right atrial pressure and peripheral resistance. These effects are sum m arised in 
Table. 6.7 where changes are from awake values.
Drug Combination arterial
pressure
heart rate cardiac
output
right atrial 
pressure
peripheral
resistance
halothane 
enflurane 
isoflurane 
nitrous oxide
decrease
decrease
decrease
none/inc.
none 
increase 
increase 
small inc.
decrease 
decrease 
small dec. 
increase
increase 
increase 
small inc. 
increase
none 
decrease 
decrease 
small inc.
Table 6.7: Effects of General Anaesthetics upon Cardiovascular Variables
A dm inistration of a volatile agent, such as isoflurane, in nitrous oxide results 
in a lesser blood pressure decrease than  th a t produced by isoflurane alone. This 
is due to the slight excitatory effects of nitrous oxide.
The mechanisms of effect of volatile agents are incompletely understood and, 
although some mechanisms have been discovered, these are not common to all 
agents. Changes in cardiac output, heart ra te  and blood pressures can be created 
by changes in peripheral vascular resistance, the performance of the heart o r  the 
performance of the regulatory loops concerned w ith arterial and venous pressure.
A review of the anaesthetic effects upon the regulatory loops concerned with 
circulation by Prys-R oberts [130] suggests th a t anaesthetic agents may sensitise 
baroreceptors thereby causing more frequent discharges in response to blood 
pressure changes. The ability of volatile agents to  depress the sym pathetic nervous 
system to a greater extent than  they depress the parasym pathetic nervous system 
is also noted. Prys-R oberts suggested th a t volatile agents could produce both 
a ‘resetting’ of the baroreceptor reflexes to a new equilibrium pressure and also 
cause a decrease in the sensitivity of the regulation to changes in pressure.
Further effects of relevance are generated by the  direct effects of volatile agents 
upon the heart and blood vessels. Some volatile agents, especially halothane and 
enflurane, cause depression of the  heart muscle therefore im pairing its activity.
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The reduction in cardiac output produced during anaesthesia w ith these agents 
(see Table 6.7) is consistent w ith these effects. In contrast, isoflurane has very 
little  depressant effect upon the heart, and cardiac ou tpu t is relatively constant 
during isoflurane anaesthesia. The effects of anaesthetic agents on the  heart have 
been reviewed by Sm ith [131]. An editorial by M arty and Reves [132] discusses 
the effects of anaesthetics upon the baroreflex control of arterial pressure. The 
work of K ortly et al. [133] describes the steady -sta te  value and sensitivity of 
blood pressure regulation for anaesthetic combinations using isoflurane. The work 
of Takeshima and Dohi [134] compares the s teady -sta te  value and sensitivity 
of the  baroreflexes before anaesthesia, during anaesthesia, during anaesthesia 
and surgery and during recovery after anaesthesia for isoflurane and enflurane. 
They found th a t the sensitivity of the baroreflex response increased following the 
onset of surgery compared to th a t prior to the onset of surgery w ith isoflurane 
anaesthesia. The steady-sta te  arterial pressure also increased at this tim e. The 
authors reasoned th a t isoflurane depressed the sym pathetic nervous system and 
this caused the reduction in arterial pressure, bu t th a t the onset of surgery caused 
further stim ulation of the sym pathetic nervous system  and partial reversal of 
baroreflex depression.
The effects of general anaesthetic agents on the circulation and cardiovascular 
system are therefore dependent upon the agents used and may affect combina­
tions of baroreceptors, brain centres, the heart and blood vessels. Surgical stim ­
ulation can result in additional sym pathetic nervous system  activity to increase 
cardiovascular variables but individual values reflect the existing com pensation for 
physiological imbalances, the effects of the anaesthetic and the  effects of surgical 
stimulus.
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6.4.2 T he Effects o f G eneral A naesthetics upon th e  R es­
piratory System
General anaesthetics cause alterations in the function of respiratory regulation 
loops. The effects of inhaled anaesthetics on respiration and respiration control are 
sum m arised by Stoelting [27]. Nitrous oxide, halothane and enflurane cause dose- 
related increases in respiration rate. Isoflurane causes an increase in respiration 
ra te  in concentrations up to 1 MAC1 (minimum alveolar concentration) but further 
increases in dose cause no further change in respiration rate  until the inhibition 
of m edullary activity at much higher doses.
Associated w ith the increases in respiration rate are decreases in tidal volume. 
The overall alveolar ventilation may therefore be reduced as described in equations 
2.1 and 2.2. A rterial carbon dioxide increases and the ventilatory response to  
this decreases w ith higher doses. The presence of surgical stim ulation causes 
an increase in m inute volume and a corresponding decrease in arterial carbon 
dioxide. It should be noted tha t the ventilatory response to low arterial oxygen 
is completely abolished by anaesthetic concentrations of only about 0.1 MAC.
The effects of general anaesthetics upon respiration are thought to  reflect 
depression of the ventilatory control centres of the medulla although abolition t 
of the ventilatory response to low arterial oxygen may indicate an effect of these 
agents upon the chemoreceptors. A further action of some agents e.g., halothane, 
is to alter the function of the intercostal muscles which are used in breathing. It 
is once again apparent th a t general anaesthetics can alter respiration by acting at 
combinations of the tissue sites involved in its control and th a t these effects are 
agent specific.
1the concentration required to prevent movement in response to incision in 50% of the 
population
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6.5 Q uantitative M odels o f th e  C irculation and  
R espiration
The physiologic processes involved in the regulatory and protective reflexes of 
the body are complex and interact significantly. The effects of drugs on these 
processes adds further interaction. Despite this, some workers have successfully 
represented the interactions between the  circulatory and respiratory systems and 
drugs.
The m ultiple model s tructure suggested by Beneken and Rideout [44] consisted 
of one sub-m odel for circulation and another for the transport of a m aterial 
in the  circulation. Beneken and Rideout, using carbon dioxide transport as 
an exam ple, suggested a structure for the incorporation of baroreceptor and 
chemoreceptor reflexes within a m ultiple model. The m odel of Sm ith, Zwart 
and Beneken [100] [43] incorporated the effects of halothane on circulation. The 
model of Fukui and Sm ith [41] [42] had three sub-m odels, one for each of 
circulation, ventilation and drug transport. The model represented the interaction 
between ventilation, circulation and the effects of halothane. The respiratory and 
circulatory performances of the model are altered by the  presence of halothane. 
The respiratory and ventilatory changes, in tu rn , alter the further uptake and 
distribution of halothane.
The model used by Schwid [101] used the m ultiple m odel structure  of Fukui 
and Sm ith and incorporated the effects of more drugs. The model described by 
Schwid and O ’Donnell [135] incorporates both inhaled and injected drugs and their 
effects. The pharm acokinetics of the injected drugs are represented by simple 
two com partm ent models, and their effects by simple em pirical relations. The 
interaction between drug effects in a tissue is assumed to be additive. This model 
has been used as the basis of a sim ulator for anaesthesia for the training and 
assessment of anaesthetists [135].
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A model of the cardiovascular system including m ajor blood vessels, the 
heart and regulatory reflexes has been developed by Leaning et al. [136]. This 
model represents arteries as elastic vessels and veins similarly except th a t they 
are collapsible if the volume of blood w ithin them  decreases. The heart is 
modelled as four chambers with tim e-varying elastance. The heart model includes 
representation of the tim ing of cardiac events. The effects of gravity upon the 
blood vessels and blood pressure has also been included in the  model.
Baroreceptor reflexes were modelled to include effects bo th  proportional to 
the pressure and also to the ra te  of change of pressure. To establish the effect 
of drugs, the circulation model was used to  generate the drug concentrations at 
various sites and empirical relations were then  used to establish the effect upon 
heart rate, peripheral resistance, myocardial contractility and venous volumes and 
compliances.
In validating the model [137], the authors compared the predictions of the 
model with experim ental data for circulatory changes caused by physiological and 
pharmacological events. They concluded th a t the model did not predict behaviour 
correctly over the desired range of application and th a t these deviations were due 
to inadequacies in the model of baroreceptor reflexes. The modelling inadequacy 
was due to lack of understanding of such reflexes.
6.6 Q ualitative D escriptions and M odels o f 
Physiology
The range of individual responses to physiologic and pharmacologic changes 
exhibited by humans precludes quantitative description of effects and mechanisms 
in all individuals. The m ajority of models used in physiology are therefore 
qualitative and descriptive. As an example, the earlier sections of this chapter, 
which describe the regulatory and protective reflexes of the body, use qualitative
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description. To a large extent, these models allow the understanding of many 
processes w ithout any need for quantification.
Some other models related to physiology have employed Q ualitative Reasoning 
and Q ualitative Simulation in order to make assertions and predict behaviour in 
the  absence of quantitative information. Applications of Q ualitative Reasoning 
include the KARDIO system  [138] and the work involving H unter et al. [139] 
[140] [141] [142].
6.7 Trade-offs betw een  M odel C om plexity, A p­
plicability and U tility
As discussed, there is a spectrum  of models in physiology which range from 
qualitative, textual, empirical description of events or changes through to  fully 
param eterised, quantitative models of circulation, respiration and pharmacology.
The simpler models provide adequate description of expected changes in a large 
range of individuals and are readily understood and applied. Such models may, 
however, prove inadequate when explanation of the interaction between changes 
is required.
The fully-param eterised, quantitative models provide an opportunity  to  rep­
resent the lim it of current understanding and to reveal weaknesses in understand­
ing. For example, the cardiovascular system model described by Leaning et al. 
[136] [137] highlighted the incomplete understanding of central nervous system 
mechanisms for controlling circulation. Unfortunately, these models require a 
very large num ber of param eters in order to make quantitative predictions (the 
model of Leaning et al. had 178 param eters). Param eterising such a model to 
m atch an individual or subrange of individuals is therefore not practical.
Intuitively, a compromise is possible between the simplicity of qualitative 
description and the complexity of the quantitative models. In the context
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of anaesthesia, the anaesthetist does not form quantitative predictions for the 
values of cardiovascular and respiratory variables. The anaesthetist is aware 
of physiological regulatory and protective mechanisms and also of the  effects 
of anaesthetic and other drugs. This awareness and understanding, along w ith 
clinical experience, allows the successful and effective provision of anaesthesia for 
patients.
The following sections introduce a model intended to  represent the  interac­
tions between physiologic and pharmacologic changes and the clinical signs of 
anaesthesia.
6.8 A M odel of H om eostasis and the Stress 
R esponse
The previous sections have described the physiologic processes which are involved 
in the regulation of the physiological state  and, the response of the  body to  
extrem e stimuli. The effect of general anaesthetics upon these processes has also 
been described along with some of the mechanisms of action. Unfortunately, 
description of these loops is normally given as tex t. In this form, it is difficult 
to  differentiate between structural and functional components and their areas of 
interaction. In an a ttem p t to resolve these problems, a model of homeostasis and 
the stress response has been developed to satisfy the following aims;
1. To predict changes in clinical signs resulting from changes in the  physiolog­
ical state.
2. To represent the structural (anatom ical) elements of the reflex loops.
3. To represent the functional (physiological) aspects of the structural ele­
ments.
4. To illustrate areas of interaction between reflex loops.
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5. To allow iterative refinement of the model as m ore understanding is 
developed.
Because the description of the regulatory loops and the stress response is most 
commonly qualitative and tex tual and because of the  difficulty associated with 
quantitative models of this this form, it was decided th a t the model should use 
qualitative values. Similarly, because experim ental and theoretical results tend to 
describe the behaviour of loops in isolation, it has been decided th a t the model 
should serve to highlight interactions bu t the modelling of these interactions has 
not been a ttem pted  due to the lack of information. Given these criteria, the model 
is then explanatory2.
6.8.1 M odel D evelopm ent —  U nderstanding th e  Pro­
cesses
The author has no formal experience of physiology or pharmacology. Because the 
development of a model requires an adequate level of understanding of the system 
to be modelled, the development of a model of homeostasis and the stress response 
necessitated two tasks:
1. The development of an understanding of the appropriate physiology.
2. The modelling of this understanding.
The first of these tasks was considered to be the m ost im portant because it 
determ ined the lim its of the second. The development of an understanding took 
place in several stages. Initially, basic physiology textbooks such as [129] [143] 
[27] were consulted. More specialised texts such as [144] [130] [145] [146] [147] 
were then chosen so as to enhance the depth of understanding. At this point, 
it became apparent th a t to understand the physiological descriptions required
2Leaning et al. [136] suggest that a model may be descriptive, predictive, explanatory or 
pragmatic
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a basic degree of familiarity w ith anatom ical and physiological term s. A set of 
diagram s was therefore produced by the author to accomplish the following:
1. Fam iliarisation with anatom ical and physiological term s.
2. Presentation of the understanding of each loop.
3. Identification of other determ ining factors.
4. Provision of a platform for discussion and refinement of understanding.
These diagrams have been included in Appendix B. Following their produc­
tion, they were discussed with Dr. D.P. Gilmore3 and Dr. A .J. A sbury4. The 
diagrams proved an effective means of satisfying the aims for which they were 
developed.
6.8.2 M odel D evelopm ent —  R ep resen ting  th e  Loops
The representation of the loops involved in homeostasis and the stress response 
should allow the im portant features of each loop and the common features of loops 
to become apparent. To an extent, anatom y and physiology already highlight 
many of the im portant features. Physiology describes the existence of receptors, 
integrative centres and effectors. A receptor is sensitive to  changes in the internal 
or external environment of the body e.g., a pressure, a tem perature  or the  chemical 
composition. The receptor generates nerve impulses which often pass along nerves 
to  an integrative centre. An integrative centre is responsible for the coordination 
of the body’s response to a change in the internal or external environment. The 
integrative centre achieves compensation by m odulating the activity  of effectors. 
The communication of information to the effectors may employ the nervous system 
or the endocrine system. An effector participates in the com pensation for changes
3Senior Lecturer, Institute of Physiology, University of Glasgow
4Consultant Anaesthetist and Senior Lecturer, Department of Anaesthesia, University of 
Glasgow
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in the body’s environment by altering its level of activity. The change in activity 
can result from changes in the neuronal stim ulation of the effector, changes in the 
horm onal input, or both. Examples of effector actions include the heart pumping 
a t a higher ra te  and the kidney excreting less water.
The grouping of the elements of the reflex loops as receptors, integrative centres 
and effectors is on the basis of their function. For each individual loop, there may 
be one or more groups of anatom ically-distinct receptors. There is generally a 
single, anatom ically-distinct integrative centre and the loop may employ several 
effector sites which are also anatom ically-distinct. Using this information allows 
the construction of a generalised regulatory loop as shown in Figure 6.4. This
int centre 2
receptor 1 effector 1
effector 2int centre 1receptor 2
receptor 3 effector 3
- must exist 
• may exist
Figure 6.4: The Structure of a Regulatory Loop
figure reflects the existence of physiologically and anatom ically-distinct tissue 
sites. For the general loop under consideration, it is shown th a t at least one 
receptor group m ust exist bu t th a t more may also be present. For example, the 
baroreceptor reflex loops rely upon baroreceptors in both  the aorta  and carotid 
arteries. The generalised loop is considered to have a single integrative centre 
which communicates with at least one effector. In the general loop, no distinction 
is made between neuronal and hormonal communication. In Figure 6.4, it is also
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shown th a t an effector site may be influenced by at least one integrative centre 
and possibly more. Each of these integrative centres will operate to  control one 
aspect of the regulatory or protective reflexes. As an exam ple, the h eart’s activity 
is m odulated by m any different loops including the baroreceptor reflexes and the 
stress response.
A further characteristic of regulatory loops is th a t their receptors are sensitive 
to the internal or external environment and the actionsof their effectors are often 
visible or m easur ;able. The physiological state  of the body has been assumed to 
consist of both those variables which are regulated by the body and also those 
which reflect effector activity. Each loop will therefore be sensitive to some of 
the variables of the physiological state  and will a lter others. This interaction is 
schematically represented in Figure 6.5.
Physiological Slate
Regulatory Loop
VAR 1
VAR 2
V A R n
Figure 6.5: The Relationship between the Physiological S tate  and A Regulatory 
Loop
The consideration of anatom y and physiology has allowed the identification 
of distinct tissue sites which participate in homeostasis and the stress response. 
These sites are grouped according to their function and com m unicate with other 
tissue sites. The construction of the generalised reflex loop forms the basis of an
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individual representation of specific reflex loops.
6.8.3 M odel D evelopm ent —  T he R ep resen tation  o f Spe­
cific Loops
The description of the generalised reflex loop and its interaction with the 
physiological state  emphasised th a t each loop could have several receptors, several 
effectors and a single intergrative centre. In the representation of a specific 
reflex loop, each tissue site of the model corresponds to  an actual tissue site. 
Similarly, each communication link between tissue sites corresponds to a neuronal 
or hormonal pathway in the body. To represent these features in a model, each of 
the anatom ical tissue sites (receptors, integrative centres and efTectors) and the 
physiological state  have been regarded as objects. The term  objects is used to be 
consistent with the term s of object-oriented representation [148].
In object-oriented representation, objects are collections of da ta  and functions. 
The data  of an object are term ed its attributes and the functions are term ed 
its operations. In representing individual loops and the com bination of loops 
involved in homeostasis and the stress response, the a ttribu tes  of an object 
can be used to  hold the structural (anatomical) inform ation and the states of 
variables. The operations of the object can then be used to  describe its functional 
(physiological) characteristics. Each tissue site w ithin the physiological loop can 
then be represented as an object. The representation of receptor sites, integrative 
centres and effectors is described in the following sections.
T h e R ep resen ta tio n  o f R ecep to r  S ites
In physiology, receptor sites are described in term s of the quantity  to which they 
are sensitive and their location. For instance, baroreceptors are sensitive to pressure 
and the carotid baroreceptors lie in the carotid arteries. It is therefore appropriate 
to include the nam e of the receptor group and the quantity  to which it is sensitive
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as a ttribu tes of the receptor object. Because the quantity  to  which a receptor is 
sensitive is a feature of the physiological s ta te  of the body, the quantity  will be 
an a ttrib u te  of the physiological state  object (to be described later). Instead of 
containing the nam e of the quantity to which the receptor site is sensitive as an 
a ttrib u te , a receptor object contains the nam e of the appropriate a ttrib u te  of the 
physiological state  object. Each receptor site, or group of receptors, transm its 
inform ation to an integrative centre in the body. Each integrative centre is also 
considered to be a specific anatom ical site. Given th a t an integrative centre object 
will be defined, for the model, to  represent the integrative centre site in the body, 
the receptor object can include the nam e of the appropriate integrative centre 
object of the m odel as an a ttribu te .
Functionally, a receptor site monitors the  quantity  to which it is sensitive 
and transm its this value to the relevant integrative centre. The operations of 
the receptor object are therefore defined to be the m easurem ent of its associated 
variable and the transm ission of this value to  the appropriate intergrative centre. 
T he structure of the receptor object defined for the model is illustrated in 
Figure 6.6.
Attributes
Name
Monitored Value 
Integrative Centre
Operations
Measure Value 
Transmit Value
Figure 6.6: The A ttributes and Operations of a Receptor Object
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T h e  R e p r e s e n ta t io n  o f I n te g ra t iv e  C e n tre s
Integrative centres are specific anatom ical sites of the body. Integrative centres 
have physical links to  receptor sites and to  effector sites. As outlined in the 
description of the generalised loop, an integrative centre may receive input from 
several receptors and may m odulate the activity of several effectors. Because it 
is possible for the values transm itted  from each receptor site to be different, the 
integrative centre is required to arb itra te  between potentially conflicting inputs. In 
the  body, the most im portant imbalances take priority over those less im portant 
in the determ ination of compensation. W hile the precise mechanisms of this 
arb itra tion  may be unknown, the characteristics are clear. As an approxim ation 
to the physiological reality, each integrative centre object has been defined to 
include a list of the receptor objects which correspond to the actual receptor 
sites to which the actual integrative centre is connected, and associated with each 
receptor object in the list is a priority. The priorities have been assigned to  each 
receptor site in the list so as to enable the integrative centre to  establish the most 
im portan t value for which compensation is required.
Integrative centres in the body also influence the behaviour of effector sites. 
The integrative centre object therefore includeja list of effector objects to represent 
the  neuronal or hormonal communication between the actual integrative centre 
site and effector sites.
In addition to the prioritised list of receptor objects and the list of effector 
objects, the integrative centre object also has an a ttrib u te  containing the value 
of the highest priority imbalance recorded by one of its receptors, an a ttribu te  
containing the current compensatory activity required by the integrative centre 
and an a ttrib u te  containing the nam e of the integrative centre.
The functional characteristics of the integrative centre object include the deter­
m ination of the highest priority imbalance from the receptors, the determ ination 
of the compensation for the imbalance and the transm ission of the compensation
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request to the effector objects. The operations of the integrative centre object 
therefore include these activities. The overall structu re  of an integrative centre 
object is shown in Figure 6.7.
Attributes
Name 
Imbalance 
Compensation 
Receptors —*=
Effectors
Operations
Determine Imbalance 
Determine Compensation 
Inform Effectors
Figure 6.7: The A ttributes and Operations of an Integrative Centre O bject 
T h e  R e p r e s e n ta t io n  o f E ffe c to r  S ite s
Effector sites are responsible for enforcing changes in the physiological state  of the 
body. The regulatory reflexes employ effectors to re tu rn  a physiological quantity 
from an unacceptable value to a reasonable one. The stress response overrides 
the regulatory responses in the event of an extrem e or unusual stress. In the 
body, the activity of the  effector site may be influenced by nerve impulses from 
an integrative centre, by circulating hormones or both. It is generally the case 
th a t when hormones provide a communication link, the release of the hormone is 
controlled by an integrative centre. An effector object is intended to represent an 
effector site. Because the tissue site is anatom ically d istinct, the effector object 
has an a ttribu te  to  contain the nam e of the effector site. Another a ttrib u te  holds 
a value indicating the required activity of the effector. Because effectors can be 
required to produce increases or decreases in activity, two further a ttribu tes are 
included to specify the increase action and decrease action of the effector site 
respectively.
[[reel p l][rec2 p2] ... ]
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As described earlier, each effector site may be influenced by several integrative 
centres. In the body, the most im portant imbalances or the most extrem e stimuli 
are given priority. As for the interaction between integrative centres and 
m ultiple receptors where the mechanisms of determ ining the m ost im portant 
stim ulus are not precisely known, the effectors’ mechanism for determ ining the 
most im portan t com pensation is not known. To represent the apparent priorities 
of several reflexes, each effector has an a ttribu te  containing a list of the integrative 
centre objects to which it has either neuronal or hormonal connections and each 
of the  integrative centres in the list has a priority associated w ith it.
Each effector site is capable of altering one or more quantities within the 
physiological s ta te  e.g., the heart enforces changes in heart rate , blood pressures 
and cardiac output. Each effector object therefore has an a ttr ib u te  containing a 
list of the variable values in the physiological state  object which it alters.
The operations of an effector object have been chosen so as to  approxim ate 
the behaviour of effector sites. The effector object therefore contains operations 
to determ ine the most im portan t integrative centre request and change its level 
of activity. The overall structure of an effector object shown in Figure 6.8.
Attributes
Name 
Activity 
Increase Action 
Decrease Action 
Integrative Centres 
Physiological Variables
Operations
Determine Compensation 
Change Activity
[[int_cl p l][in t_c2p2]... ]
[varl var2 ... ] I
Figure 6.8: The A ttributes and Operations of an Effector O bject
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T h e  R e p r e s e n ta t io n  o f th e  P h y s io lo g ic a l S ta te
The reflex loops m onitor the physiological state  of the body and make any 
necessary adjustm ent using effector sites. The physiological s ta te  is dependent 
upon changes in the internal and external environm ent and the  actions of effector 
sites. The physiological state  object has been defined to  represent the physiological 
state  of the patient. This object contains relevant physiological variables as 
a ttributes. These variables are modified as a result of effector actions and 
are m onitored by receptors. In the model, the nam e of the variable will appear in 
the physiological variable list of each effector object and in the  m onitored value 
a ttrib u te  of the each receptor object which is sensitive to  its value and changes.
The physiological state  object has an operation associated w ith it which allows 
the update of each of its variables. For this m ethod to  function, each of the 
variables m ust have a list of the effector objects which are associated with it. Each 
physiological variable has therefore been represented as a physiological variable 
object as described below. The overall structures of the physiological state  object 
is shown in Figure 6.9.
Attributes 
Variable 1 
Variable 2 
Variable k 
Operations 
Update Variables
Figure 6.9: The A ttributes and Operations of the Physiological S tate Object
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T h e  R e p r e s e n ta t io n  o f P h y s io lo g ic a l V a ria b le s
For completeness, a physiological variable object was defined to  represent each 
physiological variable. Each physiological variable contains an a ttrib u te  contain­
ing its name, an a ttrib u te  containing its value, an a ttrib u te  containing a list of 
receptor objects which are sensitive to its value and an a ttr ib u te  containing a list 
of effector objects which can change the value of the variable.
Each physiological variable object has an operation which allows the updating 
of the variable’s value based upon the actions of its effectors. It also has an 
operation to  inform receptor objects of a change in its value. The structure of a 
physiological variable object is shown in Figure 6.10.
Update Value 
Inform Receptors
Name
Value
Receptors
Effectors
Attributes
Operations
[reel r e c 2 ... ]
[effl e f f 2 ... ]
— i
Figure 6.10: The A ttributes and O perations of a Physiological Variable O bject 
S u m m a ry  o f th e  R e p r e s e n ta t io n  o f L o o p s
The previous sections have described the definitions for objects intended to repre­
sent the anatom ical and physiological inform ation of relevance to homeostasis and 
the stress response. The anatom ical inform ation has generally been incorporated 
w ithin the a ttribu tes of objects and the physiological inform ation within their 
operations. The current object definitions incorporate some redundancy within 
the representation of anatom ical and physiological inform ation. For instance, an
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effector object contains a list of all the physiological variables which it can alter 
and each physiological variable object contains a list of all the  j effectors .
which can alter it. This obviously involves the duplication of information. 
In isolation, however, this representation is more expressive because each object 
has w ithin it, details of all its interactions. A further useful feature is th a t, unlike 
the physiological reality, links in the model can be traversed in both  forward and 
reverse directions. This feature will be dem onstrated to  be useful later.
6.8 .4  A  P rototyp e Im plem entation  o f th e  M odel
The original specification for the m odel’s perform ance was to produce a qualitative 
description of the changes in clinical signs arising from qualitative changes 
in physiological variables. Given th a t the values in the model are therefore 
qualitative, they can be represented symbolically. The value of a physiological 
variable can therefore be ‘lowered’, ‘norm al’ or ‘raised’. T he value held by a 
receptor object can have the same values. An integrative centre may decide to 
‘raise’ or ‘lower’ a variable or to make no changes. Effectors may ‘increase’, 
‘decrease’ or make no change in their activity. These possible values and the 
tissue site, physiological state  and physiological variable objects have been
im plem ented using the MUSE Al Toolkit. The definitions of each of the objects 
were used to  produce classes of objects (actually called schemas in MUSE). 
A class is a specific type of object which defines the structu re  and behaviour of 
all instances which are derived from it. An instance is a particu lar object and 
has unique values for its attribu tes. For this model, as an exam ple, the receptor 
object is used to define a receptor class and instances of this class include the 
carotid baroreceptors. As described earlier, the object definitions include some 
redundancy. This im plem entation therefore makes use of a subset of the available 
a ttribu tes and operations.
Using the im plem entation of the model, the user is able to ‘raise’ or ‘lower’
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the values of variables within the physiological s ta te  object. Once this process is 
com pleted, the model is allowed to work towards the resulting compensation for 
the applied imbalances. The process of determ ining the compensation proceeds 
as follows:
1. The physiological s ta te  object is prom pted to update  the value of each of 
its variables using its ‘update variables’ operation.
2. Each of the variables is then prom pted to inform its receptor objects of its 
current value using its ‘inform receptors’ operation. This process ensures 
th a t each receptor object has an u p -to -d a te  account of the variable which 
it monitors.
3. Each receptor object is then prom pted to update  its value to reflect that 
passed to  it by its physiological variable.
4. Each integrative centre object then finds the most im portan t imbalanced re­
ceptor value using its ‘determ ine im balance’ operation. It then determ ines 
the com pensation required for this imbalance using its ‘determ ine compen­
sation’ operation.
5. Each effector object determ ines the m ost im portan t of the requests for 
changes in its activity using its ‘determ ine change’ operation to investigate 
the com pensation requests of each of its integrative centre objects and their 
priorities. The selected change in activity is then im plem ented using the 
‘change activ ity’ operation.
6. The cycle returns to the first step so as to  include effector activity in the 
determ ination of the next physiological state.
This process is schematically represented in Figure 6.11. In the prototype 
im plem entation, an object, the sequence object, has been defined to control
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Integrative
Centres
Receptors
Physiological
State
Object
Effectors
Figure 6.11: The Overall O peration of the Model
the performance of steps 1 to 5. The sequence object has no physiological or 
anatom ical significance bu t ensures th a t the process of com pensation in the model 
is easily understood and presented.
6.8.5 Illustration  o f M odel Perform ance
The process described above allows realistic representation of the  reflex loops and 
their interactions but it is not capable of producing a suitable representation of 
object activity. MUSE allows the creation of indicators and fields on a graphical 
display. An indicator is a box on the screen which can be shaded to different 
extents and a field is an area in which text can be printed.
To represent the model, an indicator was created for each physiological 
variable, receptor, integrative centre and effector and a field was provided for 
each physiological variable and effector. Indicators are shaded when a variable is 
not ‘norm al’, the receptor receives a non ‘norm al’ value or when an integrative 
centre or effector is effective. At other tim es indicators were clear. The fields were 
used to express the qualitative value of each physiological variable and the action 
being taken by effectors.
Figure 6.12 shows the MUSE screen display after initialisation of the model.
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On startup , all indicators are clear, all values are norm al and there are no effector 
changes from an assumed stable physiological state.
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Figure 6.12: Screendum p of the Model a t S ta r tup
Figure 6.13 is a screendum p of the  model during a run. In this test, the user 
has m ade changes in the  physiological s ta te  of the  model so as to raise the e n d -  
tidal carbon dioxide concentration (e tC 0 2 )  from norm al, and raise arterial blood 
pressure (art-bp) from normal. T he indicators for these variables have therefore 
been shaded and their fields altered to reflect their new values.
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Figure 6.13: Screendum p of the Model during Homeostasis Simulation
T he  changes in the physiological s ta te  have been processed by the receptors. 
The chem oreceptors5 in the  m edulla  (brainstem) and the  aortic and carotid bodies 
have been stim ulated  in response to the  change in carbon dioxide levels. T he  
carotid and aortic baroreceptors6 have been activated by the  increased arterial 
pressure. T he  indicators for these receptors are shaded by the model to reflect 
their participation.
T he  respiration control centres in the m edulla react in response to the changes 
detected by the  chemoreceptors. T he  cardiac and vasomotor control centres 
respond to the changes detected  by the baroreceptors. T he  partic ipa tion  of these 
integrative centres is reflected in the shading of the ir  indicators.
In com pensating for increased carbon dioxide, the respiration control centre 
has caused an increase in the respiration rate  and the  involvement of the intercostal
5receptors sensitive to chem ical com position
,Jreceptors sensitive to pressure
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muscles in respiration. These changes are sum m arised in the fields associated with 
the inspiratory and expiratory muscle objects. The indicators of these sites are 
shaded to  show their involvement. In response to  the  raised arterial pressure, 
the cardiac and vasomotor centres have caused the dilation of veins, arterioles 
and the kidney afferent arterioles and a decrease in heart ra te  and strength of 
contraction. The effectors involved in these changes have their indicators shaded. 
Their associated fields sum m arise the action taken.
Following the stage indicated by Figure 6.13, the changes in the effector activity 
rectify the original imbalances in the carbon dioxide and blood pressure variables. 
The compensatory effort has caused an increase in respiration ra te  and a decrease 
in heart rate. This in shown in the screendump of Figure 6.14.
Chapter 6. Modelling Homeostasis and the Stress Response 231
MJ3E P i i pTa l k  T o n i  - Rh I hhhh o n  i ue6B020 r u n n i n j  BnriflS R u i n * * *
k i d n e y  *P
vo l i me
P h y s i c a l  S t a t e
l o v e r e d  
n o r a a l  
n o r a a l  
n o r a a l  
n o r a a l  
n o r a a l  
n o r a a l  
n o r a a l  
n o r a a l  
n o r a a l  
r a i s e d  
r a i s e d  
T e w p e r a t u r e l n o r a a l
o s n o l a r l t v
t r i p s
m m m m
1 r . T l go t o T
c h e a o r e c e p t o r s
a e d u l l a  C02 
a o r t a  0 2 | C02
c a r o t i d  0 2 | C0 2
b a r o r e c e p t o r s ___
c a r o t i d  R F ]  
a o r t i c  [<>]
a t r i a l  R F ]
o s e o r e c e p t o r s ___
h y p o t h a l a a u s  [<> 1
s p e c i a l  c e l l s
36k RFj
a d .  c o r t e x  RFl
c a t e c h o l a a l n  |<> I 
t h e r a o r e c s . 
h y p o t h a l a a u s  1<> I
s t r e s s  r t o r  ED
I n t e g r a t i v e  c e n t r e s
a e d u l l a  
r e s p l r a t l o r j o  
c a r d i a c  RF 
v a s o a o to r  RF
h y p o th a l a a u s  
p r e o p t i c  |<> I 
o s a o t l c  I<‘>1
30k [ o ]
ad . c o r t e x  1<> I 
s t r e s s  c t r  g > ]
a
b l o o d  v e s s e l s  
v e i n s
a r t e r i o l e s  
s k i n  
a u s d e s  
b r a i n  & h e a r t  
o t h e r  v i s c e r a  
k i d n e y  a f f .  R F  
k i d n e y  e f f . I Q
B S B S
h e a r t ED
r e s p i r a t i o n  
1 n s p .  a u s d e j o ]  
e x p . a u s d e s  l<> I
ED
k i d n e y s
16*
p r o x .  t u b  
d 1 s t .  t u b .  R> 
c o l l .  d u c t s  RF 
c o l l .  d u c t s  RF
a d r e n a l s  
c o r t e x  RF
a e d u l l a  RF
p i t u i t a r y  
a n t e r i o r  RF 
p o s t e r i o r  [<F
t h i r s t  c e n t r t  
s x e a t  g l a n d s  
t h y r o i d  
s h i v e r  c e n t r
[ Gd—1
C o m p i l i n g  c h a n g a . d a 1 a y . p t  . . .  
C o m p i l i n g  d«mo _ f u n c a . p t  . . .  
C o m p i l i n g  i n i t . p 80_ d i s p l a y . p t  
C o m p i l i n g  s u p p o r t _ f u n c s . p t  . . .  
c o m p i l e d . . .
Ty p s  h a l p ( ) ;  f o r  h e l p  on  conxnanda
.-MltsTl s I ' l c c -p s j u n  i i . u  u . 'j  B  j . - =p5=i
Figure 6.14: Screendum p of the  Model after Homeostasis Simulation
Figure 6.15 illustrates the m ode l’s response to an ex trem e or unusual stressor. 
Because the  stress response can be elicited by any sufficiently ex trem e  or unusual 
stim ulus, a generalised stress receptor has been included in the  model. For clarity, 
this receptor has been assumed to be connected to a stress centre  (notiona.lly the 
hypothalam us) which then  coordinates the  stress response. In F igure 6.15, the 
active sites have their indicators shaded as before and the  effector fields indicate 
the  changes effected. T he  model has predicted th a t  a stress response will be 
characterised by the  constriction of blood vessels, the  increasing of heart, ra te  
and s trength  of contraction and the secretion of catecholamines (adrenaline and 
noradrenaline) by the adrenal medulla.
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Figure 6.15: Screendum p of the Model Stress Response
It should be noted th a t  during the m ode l’s operation, the  sequence object 
processes the  physiological s ta te  object, then the receptors, then  the  integrative 
centres, the  effectors and then s ta r ts  again. To give an expressive dem onstra tion , 
there is a user-defined tim e delay between the processing of each group. T he  
default value is five seconds which allows sufficient tim e to see the  rec ru itm en t of 
each centre. The appearance of the model a t each individual stage in this process 
has not been illustrated  because it would required too m any screen dum ps. This  
feature proves useful in the understanding of the  model and the  physiological 
processes.
6.9 In c o rp o ra t in g  D ru g  Effects in th e  M ode l
Section 6.4 described the effects of anaesthetic  drugs on the circulatory and 
respiratory systems. Many of these effects were explained in te rm s of the  effects
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of the anaesthetic drugs a t specific sites. Halothane, for instance, caused changes 
in the circulatory system behaviour as a result of its direct effect on the  heart. 
Isoflurane causes changes due to its dilating action on blood vessels.
The model of homeostasis and the stress response derived in th is chapter 
explicitly represents the anatom ical and physiological inform ation relevant to 
tissue sites w ithin the reflex loops and their connections. Given th a t the  effects 
of anaesthetic drugs can be described in term s of their action a t those sites, 
the  effects of drugs on the reflex loops can be easily represented. This process 
involves the addition of pharmacological inform ation to  the existing anatom ical 
and physiological information embodied in each tissue object.
The most straightforward im plem entation of this change is to  add an a ttribu te  
to  each tissue site object for each drug which can alter its behaviour. Associated 
w ith these are operations which are used to  m odulate the activ ity  of the site 
according to  the  drug level. A further operation m ay be added to  produce an 
overall m odulation of the sites activity in the event of m ultiple drug effects. The 
structure  of the tissue site object will then be of the form shown in Figure 6.16.
Attributes
existing
attributes
Drug A Level 
Drug B Level
Operations
existing
operations
Drug A Effect 
Drug B Effect
Overall Effect
Figure 6.16: A Tissue Site O bject Incorporating Pharm acological Inform ation
To illustrate this approach, a possible incorporation of the effects of halothane 
can be considered. Halothane depresses the activity  of the heart. This can be 
included in the effector object representing the  heart. If the level of halothane
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in the  heart object is ‘low’ then no changes are m ade in the perform ance of the 
object. If the halothane level is ‘norm al’ or ‘high’, the heart ra te  and strength of 
contraction can be ‘lowered’ from their present value for the heart object. The 
change in the activity of the heart then influences the physiological s ta te  object’s 
variables. In this way, the physiological and pharmacological influences on the 
clinical signs of anaesthesia can be illustrated.
The representation of the effects of general anaesthetics are the most im portant 
in the representation of the physiological and pharmacological influences of the 
clinical signs. The incorporation of the effects of other drugs could however 
proceed in a  sim ilar way.
The model development process described in this chapter was not intended 
to produce a model incorporating the effects of drugs. This has been made 
particularly straightforward because of the explicit incorporation of anatom ical 
and physiological inform ation in the model. The explicit representation of 
anatom ical sites supports the representation of pharmacological effects at those 
sites. An approxim ation to  this approach is incorporated in C hapter 7 and future 
developments involving this structu re  are described in C hapter 8.
C hapter 7 
M odel—based D iagnosis o f  
A n aesth etic  S tate  Im balances
SUMMARY
This chapter describes the development and use o f the Reversed Model 
o f the regulatory and protective reflexes in the diagnosis o f anaesthetic 
state imbalances. The use o f automatic monitoring system s in anaes­
thesia is reviewed before introduction o f the Reversed Model concepts.
The prototype implementation o f a Diagnoser is described and its off­
line and on-line performances are presented.
7.1 Technological A ssistance in th e  M onitoring  
of A naesthesia
As described in C hapter 2, monitoring in anaesthesia consists of monitoring;
1. the anaesthesia machine and drug delivery,
2. the physiological condition of the patient and,
3. the depth of anaesthesia, of the patient.
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It is apparent th a t the vigilance of the anaesthetist is essential in the rapid 
detection of adverse conditions in any of these areas. A slow detection of an 
adverse condition delays the s tart of its m anagem ent and in th a t tim e it is likely 
to  become worse. Simple alarms were initially added to  m onitors and drug delivery 
equipm ent to generate audible or visual indications of an adverse condition. Sykes 
[149] suggests th a t there are two m ajor problems w ith current alarms;
1. Alarms are generated by equipm ent which may be scattered around the 
operating room making their identification difficult.
2. Alarms may sound when there is no danger to the patient.
Sykes highlighted current incorporation of trend analysis to  alarm  systems and 
the  integration of alarm s from m any sources in a single display according to their 
im portance. Sykes referred to the work of Westenkow et al. [150] as an example 
of such integration.
Philip [151] suggested th a t an alarm  system should indicate when the pa tien t’s 
s ta te  changes from a predeterm ined state. The anaesthetist then in terprets the 
change to which lie/she has been alerted and takes any action which may be 
appropriate.
Quinn [152] suggested th a t alarms should be centrally presented according to 
their im portance and should clearly identify their source. He suggested th a t in 
response to  audible alarm s, the anaesthetist’s response was to want to “s to p -th a t-  
noise” and not to resolve the underlying problem.
Schreiber and Schreiber [153] also advocate central display of alarm inform a­
tion and suggest th a t an alarm  can be either
1. a warning which requires im m ediate attention,
2. a caution which requires prom pt a ttention, or
3. advisory which requires awareness.
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They suggested th a t warning alarms are signalled by continuous sounds, 
caution alarm s by in term itten t sounds and advisory alarm s by either single short 
sounds or w ithout sounds. A further suggestion was th a t a screen display with 
three areas is used to identify current alarms.
Beneken and van der Aa [154] review m any recent approaches to  monitoring
and alarm  systems. They suggest the inclusion of alarm  levels (emergency,
caution, alert and inform ation) and suggest th a t the  values a t which alarms are 
triggered may be determ ined by a num ber of m ethods including
1. forming the consensus opinion of experienced anaesthetists
2. using predictions of pharmacologic models
3. ‘tuning-in’ the alarm s to the patien t during a change
4. using statistical d a ta  from previous patients
5. using inform ation derived from the combination of signals.
Beneken and van der Aa believe th a t future alarm  system s will be based upon 
d a ta  stored from previous anaesthetics.
Fukui and Masuzawa [155] describe a knowledge-based approach to providing 
intelligent alarms. Their approach involves interpreting signals to detect an event 
in the signal, relating the events of different signals to each other, recognising the 
state  transitions of the patient and activating appropriate alarms. This approach 
incorporates some m onitoring activity in th a t it in terprets signal information. The 
authors give an example of a system in which the physical condition of elderly 
people is m onitored rem otely and autom atically. In one example, given in the 
paper, the system detects an ‘abnorm al heart ra te ’ but establishes th a t this is due 
to movement.
Schecke et al. [156] describe a knowledge-based system  which is intended to 
m onitor the p a tien t’s physiological state  during anaesthesia and eventually suggest
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therapeutic  action. The system has been developed for cardiac anaesthesia and 
identifies “state  variables” relevant to the area. These sta te  variables are to be 
m aintained in a “norm al” range. I f  ... then ... rules allow determ ination of the 
condition of the state  variables from current m easurem ent values. The system 
incorporates fuzzy logic to deal w ith uncertainty. This system  operates on the 
current values of variables and the reasoning involves qualitative considerations 
e.g. “vascular tone is too high if systolic pressure is above norm al and ...” . The 
authors plan to incorporate the use of m easurem ent trends in the ir future work.
7.2 A n A utom atic M onitor o f th e  P a tien t’s 
A naesthetic  S tate
The work of Fukui and Masuzawa [155], Schecke et al. [156] and Greenhow [77] 
involves in terpretation of physiological variables so as to m onitor the patien t’s 
state, each approach has involved the generation of rules to  relate physiological, 
pharmacological and environm ental events.
The rem ainder of this chapter describes the concepts and a prototype imple­
m entation of a m odel-based approach to  the m onitoring of the anaesthetic state  
of a patient. The approach has been developed to support;
1. monitoring of the physiological state  of the patient,
2. m onitoring of the depth of anaesthesia of the patient,
3. the incorporation of the effects due to anaesthetic drugs,
4. the incorporation of the effects due to non-anaesthetic  drugs, and
5. the use of both  value and trend information for each m easurem ent.
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7.3 T he A naesthetic  S tate
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Section 2.5.2 of C hapter 2 discussed the contention associated w ith the definition 
of term s related to  anaesthesia. To clarify the  use of some of these term s in the 
thesis, definitions were given of the term s to be used. Of particular interest to this 
chapter are the  definitions of the anaesthetic state , anaesthetic sta te  imbalances 
and an appropriate anaesthetic state.
The anaesthetic s ta te  was defined to consist of the physiological and pharm a­
cological states of the patient. This definition was adopted so as to em phasise the 
m utual dependence of the physiological and pharmacological states. Following 
from this, the activities of the anaesthetist in managing the p a tien t’s anaesthetic 
state  can also be seen to consist of both  physiological and pharmacological m a­
nipulation.
The definition of anaesthetic s ta te  imbalance adopted a perspective which 
would support control development. An anaesthetic s ta te  imbalance was defined 
to be an inappropriate component of the pa tien t’s anaesthetic s ta te  which 
could be remedied by physiological or pharmacological changes. An appropriate 
anaesthetic state  was then defined as an anaesthetic s ta te  of the patien t which 
exhibited no anaesthetic state  imbalances. This definition was intended to be 
consistent with the approach employed by anaesthetists but was also intended 
to be suitable for the development of an autom atic controller for the anaesthetic 
state.
In providing anaesthesia for a patient, the anaesthetist does not approach 
each pa tien t’s anaesthetic with the intention of providing a predeterm ined set of 
values bu t tolerates values which have ‘norm al’ ranges and which do not exhibit 
undesirable characteristics. To m irror this, an autom atic  controller, aiming to 
produce an appropriate anaesthetic state, would make changes so as to remove 
or remedy any anaesthetic state  imbalances. To paraphrase, the controller’s goal 
is to produce ananesthetic state  w ith ‘nothing wrong’ which is in contrast to the
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goals of most controllers which a ttem pt to make ‘everything righ t’.
This relaxation of the controller goal simplifies the development of a controller. 
Instead of having to  identify and m aintain a ‘correct’ anaesthetic sta te , the 
controller identifies anaesthetic state  imbalances and corrects those. The most 
im portan t step in this process is the identification of anaesthetic state  imbalances.
7.4 A naesthetic  State Im balances
The definition of an anaesthetic state  imbalance was given in Section 2.5.2. 
A naesthetic state  imbalances have been subdivided into physiologic anaesthetic 
s tate  imbalances and pharmacologic anaesthetic state  imbalances according to the 
m anipulation required to correct them . These are described in more detail below.
7.4.1 P hysiological A n aesth etic  S ta te  Im balances
A physiologic anaesthetic state  imbalance has been defined as an anaesthetic state 
imbalance which can be corrected by a change in the  physiologic s ta te  of the 
patient. This definition has been used to assist in controller development: when 
a physiologic anaesthetic state  imbalance is detected, its correction mechanism 
is apparent. The most common physiologic anaesthetic s ta te  imbalances will be 
rectified by changes in fluid delivery or ventilation. As examples, bleeding as a 
result of surgery, if significant, will reduce the circulating blood volume. In the 
short term , the blood volume deficit is com pensated for by the baroreflexes as 
described in C hapter 6. The long term  m aintenance of homeostasis depends upon 
the restoration of the blood volume by the adm inistration of blood or fluids. A 
related example occurs during autom atic ventilation of a patient during muscle 
relaxation. The arterial carbon dioxide tension may rise above or fall below normal 
values. The pa tien t’s ability to compensate for this is im paired because their 
respiration reflex loops are not in tact due to  the paralysis of their respiratory
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muscles. The correction of the carbon dioxide tension is achieved by alteration of 
ventilator settings or fresh gas m ixture composition.
Pharm acologic A naesthetic S tate Im balances
A pharmacologic anaesthetic state  imbalance may be corrected by a change in the 
pharmacologic state  of the patient. The most obvious pharmacologic anaesthetic 
s ta te  imbalances are due to inadequate or excessive delivery of anaesthetic drugs. 
The correction of these imbalances requires an increase or decrease in the rate  of 
adm inistration of the anaesthetic.
7.5 T he D iagnosis o f A naesth etic  S tate  Im bal­
ances
W hile the definition of anaesthetic state  imbalances supports correction of the 
imbalance, the unique and correct identification of imbalances is essential to the 
function of any controller. In order to diagnose an anaesthetic s ta te  imbalance, 
it is necessary for the imbalance to cause consistent and recognisable changes in 
the clinical signs of the patient. This is because the clinical signs are the source 
of information used in the assessment of the p a tien t’s anaesthetic state. The 
diagnosis of the imbalance then requires the in terpretation  of the clinical signs. 
This is the technique used to guide the m anual adm inistration of an anaesthetic 
by each anaesthetist except tha t, in this case, the intention is to  autom atically 
interpret the clinical signs.
A model of the homeostasis loops and stress response of the body was de­
scribed in C hapter 6. This model predicts the effects of physiological anaesthetic 
state  imbalances and the effects of the stress response on the clinical signs. The 
effects of the stress response generally become apparent if the anaesthetic is inad­
equate. The model therefore includes the effects of physiological anaesthetic state
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imbalances and the likely effects of an inadequate anaesthetic (a pharmacological 
anaesthetic state  imbalance).
To complement the representation of inadequate anaesthesia, excessive anaes­
thesia can be incorporated within the existing structu re  of the model described 
in C hapter 6. In representing the stress response, a  ‘stress receptor’ passes infor­
m ation to the ‘stress centre’. The stress centre then alters the activity  of effector 
objects to produce the stress response. In all other integrative centres, the presen­
ta tion  of a ‘lowered’ value from receptors results in a ‘raise’ request being passed 
to the effectors. To enable the stress centre object to also exhibit this behaviour, 
an extrem e or unusual stim ulus was represented by the value ‘lowered’ held by 
the stress receptor object and presented to the stress centre object. Considering 
the effects of general anaesthetics to  be the ‘inverse’ of the stress response1 the 
effects of excessive general anaesthesia is therefore represented by applying the 
value ‘raised’ to the stress receptor object in the model causing the stress centre 
to  ‘lower’ the activity of the appropriate effectors.
This inclusion allows the model to represent both  physiological and pharm aco­
logical anaesthetic state  imbalances and their effects upon the clinical signs of the 
patien t as shown in Figure 7.1. This form of the model works forward  from im­
balances to compensations. In an earlier section, Section 6.8.3, it was emphasised 
th a t the object definitions included anatom ical and physiological information and 
th a t there was redundancy w ithin this representation. The Forward Model used 
some of the anatom ical and physiological links w ithin it to derive clinical signs 
patterns after imbalances. The Reversed Model uses some of the other links to 
derive imbalances from clinical sign patterns.
1This is a reasonable approximation since the stress response causes stim ulation of the 
sym pathetic nervous system whereas general anaesthetics cause its inhibition
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Forward
Model
Uncompensated Compensated
Physiological State Physiological State
Figure 7.1: Forward Model O peration
7.5.1 T h e R eversed  M odel o f H om eostasis and th e Stress 
R esp on se
The Forward Model interacted w ith a physiological sta te  object which contained 
physiological variables. Each variable has associated w ith it a list of receptor 
objects which are sensitive to its value and a list of effector objects which can 
alter its value. Variables which have receptor sites associated w ith them  are 
regulated by the  body (e.g., arterial blood pressure). Variables w ithout receptor 
sites reflect effector activity (e.g., heart rate). The physiological state  ob ject’s 
variables therefore consist of both regulated variables and effector actions. The 
clinical signs used by the anaesthetist are a subset of the possible physiological 
variables because not all physiological variables can be, or need to be, measured. 
W ithin the  clinical signs, some are regulated variables and some are effector 
actions. The clinical signs can therefore be used to provide information for the 
Reversed Model as shown in Figure 7.2. This inform ation can be used to produce 
diagnoses of anaesthetic s ta te  imbalances.
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Figure 7.2: The O peration of the Reversed Model
7.5.2 D iagnosis o f A n aesth etic  S ta te  Im balances using  
th e  R eversed  M odel
Figure 7.3 illustrates the diagnosis procedure which operates as follows. From a 
set of clinical sign m easurem ents, those which are regulated variables are presented 
to the appropriate receptor objects of the model. Those which are effector 
actions are passed to the appropriate effector objects of the model. The diagnosis 
involves checking the consistency of the receptors and effectors associated with 
each integrative centre. This process is carried out for each integrative centre 
once for each of its effectors for which an effector action m easurem ent is available. 
Each effector with a non-norm al value passes its value, in tu rn , to  its integrative 
centres. The integrative centres compare each effector value against their receptor 
values. The comparison yields outcomes as listed in Table 7.1.
‘Conflict’ Implies th a t the integrative centre could not have been responsible 
for the effector action. ‘Com pensated Im balance’ indicates th a t the integrative 
centre could have contributed to the effector activity  in order to com pensate for an
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RegUlaKd Reversed Model
Variables Actions
R3
Measurements
Figure 7.3: The Presentation of Clinical Sign Inform ation to  the Reversed Model
Effector Receptor Outcome
Lowered
Lowered
Lowered
Normal
Normal
Normal
Raised
Raised
Raised
Low
Normal
High
Low
Normal
High
Low
Normal
High
Conflict 
Com pensated Imbalance 
Partially Com pensated Imbalance 
Conflict 
(never evaluated)
Conflict
Partially Com pensated Imbalance 
Com pensated Im balance 
Conflict
Table 7.1: Possible Outcomes in the Evaluation of Integrative Centre Involvement
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im balance and th a t com pensation is now complete. ‘Partially  C om pensated Im ­
balance’ indicates th a t the integrative centre is likely to be involved in the  partial 
com pensation for an im balance in the regulated value. The partia l com pensation 
may be due to  the ‘blunting’ of the regulatory reflexes by anaesthetics or may 
reflect a large imbalance for which compensation cannot be com plete w ithout 
external intervention. As an integrative centre is evaluated, it to tals the num ­
ber of conflicts, com pensated imbalances and partially  com pensated imbalances 
which occur. W hen each of the m easured effector actions has been propagated to 
evaluate the appropriate integrative centres, the totals in each category within the 
integrative centre reflect the likelihood of its participation in the production of the 
current clinical sign pattern . In the current im plem entation of the reversed model, 
the presence of any conflicts excludes the integrative centre from  consideration as 
a  candidate, com pensated imbalances support the existence of a  hypothesis and 
partially com pensated imbalances indicate the existence of a hypothesis, where 
the hypothesis is th a t the integrative centre has contributed to  the pa tte rn  of 
clinical signs by compensating for its particular imbalance.
T.6 P rototyp e Im plem entation  o f th e  D iagnoser
The Forward Model of the regulatory and protective reflexes employed qualitative 
description of values: a physiological state  value being either ‘raised’, ‘norm al’ or 
‘lowered’ and integrative centres deciding to ‘raise’ or ‘lower’ the ir activity. The 
Reversed model uses the same representation and therefore the same qualitative 
values. This is in contrast to the m ajority of m easurem ents made by the 
anaesthetist which are presented as integer or decimal num bers e.g., pressures 
in mmHg, tem peratures in celsius, gas fractions as percentages etc. The use of 
the reversed model, in its current form, therefore requires conversion of numerical 
values to the qualitative values used b}r the model. The m ost simple approach to
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this is the generation of simple threshold values such th a t a value rising above 
an upper threshold becomes ‘raised’ and one falling below a lower threshold 
becomes ‘lowered’. More sophisticated techniques such as those based upon Fuzzy 
Logic aim to sm ooth the transition between categories. In order to  generate a 
fuller description of changes in physiological variables, the techniques described 
by Cheung and Stephanopoulos [157] [158] have been adopted.
7.6.1 T he R epresentation  o f P rocess Trends
Cheung and Stephanopoulos [157] define a representation which allows the 
quantitative, sem i-quantitative and the qualitative description of process trends. 
Full discussion of the representation formalism is not necessary here but the 
relevant aspects are sum m arised below.
The qualitative state of a variable a:, a t a tim e /, w ithin a tim e interval [a, b] is 
denoted Q S ( x yt). Q S ( x , t )  is undefined if x  is discontinuous a t t but is otherwise 
defined to be
< >
where
+  if x(t )  > 0,
[x(t)] =  < 0 if x(t)  =  0,
— if x(t )  <  0.
-f if x' (t)  >  0, 
0 if x'(t) =  0, 
— if x' (t)  < 0.
[£&c(i)] =
+  if x ”(t) >  0, 
0 if x"(t)  =  0, 
— if x"(t)  <  0.
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The qualitative trend of a variable is represented by the continuous sequence 
of qualitative states over [a, 6]. The qualitative trend  is uniquely defined by a 
concise qualitative history. A concise qualitative history is composed of maximal 
episodes. A m axim al episode over the interval [ti,tj] is defined for th e  variable x 
as the pair.
<  tem poral extent, Q S ( x , t j) >
where the tem poral extent =  and Q S ( x , t i , t j )  =  Q S ( x , t )  V£ € (t i , t j).
A  m axim al episode is one for which there is no other episode w ith the  same 
qualitative s ta te  and overlapping tem poral extent. The qualitative trend  therefore 
has the form:
Q S ( x , t0), Q S ( x , t a, <i), QS(x ,  U),  • • •, QS (x ,  <„_i, tn), Q S ( x , tn)
Discrete points w ithin the qualitative trend are geometric distinguished time 
points. A geometric distinguished tim e point for a variable x  over an interval [a, b] 
exists at a and b together with the points where;
1. x ( t) has a discontinuity in its value or first derivative or,
2. x(t)  = 0 or,
3. x'(t)  =  0 or,
4. x"(t)  =  0.
Episodes between geometric tim e points are always m axim al.
An additional concept is th a t of the domain distinguished tim e point. A domain 
distinguished tim e point is a point at which either the  value of the variable 
or its first derivative has an ‘interesting’ value in the  context of the domain. 
The combination of geometric and domain distinguished tim e points produces an 
essential point history. The descriptive state of a variable, at a tim e point, is the 
com bination of its qualitative state  at the tim e point w ith its sem i-qualitative
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state. The sem i-qualitative state  consists of the value and first derivative of the 
variable or adjacent lim its if the value of the variable is discontinuous at the tim e 
point. The com bination of descriptive states generates the descriptive trend of the 
variable.
7.6.2 T he Im p lem entation  o f a Q ualitising F ilter
Of particular interest in the in terpretation of clinical signs using the reversed 
model is the  generation of the qualitative trend for each variable but also the 
generation of domain distinguished tim e points. A qualitising filter has therefore 
been im plem ented in C + +  to achieve the following;
1. The production of a geometric qualitative description of a variable based 
upon numerical sample values.
2. The production of a domain-specific qualitative description using variable 
domain landm arks and the same numerical samples as the above.
The structure  of the filter is illustrated in Figure 7.4.
The qualitiser is initialised with the sample interval used to  generate the 
clinical sign samples. This value is used by the quantita tive  filter to calculate 
first and second derivatives of the input da ta  value. The value, first and second 
derivatives are then processed by two additional filters. The qualitative filter 
generates a qualitative assessment of the current qualitative state. The domain 
filter produces domain specific assessment of the current quantitative state. If 
the value of the d a ta  value exceeds the domain-specific upper lim it, its specific 
state  (sx) becomes + . If it lies below the domain-specific lower lim it, it becomes 
—, otherwise it is zero. The same procedure produces the specific state  for the 
first derivative of the da ta  value, sdx, and th a t of the second derivative, sddx. 
The outputs of the qualitative filter and the domain- specific filter are combined 
to give a descriptive state. The perform ance of the qualitising filter has been
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Filter
Data Value, x
;ddx
Domain
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Value, 1st and 2nd derivative Value, 1st and 2nd derivative 
Lower limits Upper limits
Figure 7.4: The S tructure of the Qualitising F ilter
tested by presenting a sine wave at the input and observing the  descriptive state 
for varying domain-specific lim its. In its current im plem entation, the qualitising 
filter can have the domain-specific upper and lower lim its changed during filtering 
of the data. This supports the generation of qualitative inform ation for input to 
a reversed model.
7.6.3 Im plem entation  o f th e  R eversed  M odel o f H om e­
ostasis and th e Stress R esponse
Im plem entation of a comprehensive Reversed Model involves representation of 
many different loops. In order to present a  more tractab le  task and investigate the 
perform ance of the Reversed Model concepts, a prototype has been implemented 
so as to provide the ability to autom atically deduce the  following anaesthetic state 
imbalances;
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1. Reduced circulating blood volume,
2. Overload of fluids,
3. Inadequate anaesthesia,
4. Excessive anaesthesia,
5. Inadequate carbon dioxide elim ination, and
6. Excessive carbon dioxide elimination.
The Reversed Model uses a qualitising filter for each of; respiratory rate, 
end-tida l carbon dioxide, heart ra te  and systolic arterial pressure. Of these, the 
domain-specific state  of the respiratory rate  is passed to  the respiratory muscle 
site in the reversed model, the end-tida l carbon dioxide domain-specific state  is 
passed to the chemoreceptor sites, the heart ra te  dom ain-specific state  is passed 
to  the heart effector site and the systolic arterial pressure domain-specific state  
is passed to the baroreceptor sites. In addition to  this, if the systolic arterial 
pressure is ‘raised’, according to its domain-specific state , thenllowered’ is passed 
to the stress receptor. Otherwise, ‘raised’ is passed to the stress receptor.
Following the update of each appropriate receptor and efFector site in the 
model w ith the domain-specific qualitative state, the  procedure for evaluating 
the contribution of each integrative centre described earlier is carried out.
7.7 Perform ance o f the R eversed  M odel
Two versions of the Reversed Model have been im plem ented in order to test its 
capacity. The first version employs the diagnosis strategy described above to 
retrospectively assess the anaesthetic state  imbalances using d a ta  logged from 
previous anaesthetics. In these logliles, the actions of the anaesthetist have been 
entered at, or very close to, the tim e of their occurrence and explanations of
* |^ to represent light anaesthesia.
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the reasons for each action have been added. The hypotheses generated by 
the Reversed Model can therefore be compared with the actions taken by the 
anaesthetist. Some examples are given below.
In the second version, an interface has been added to the  Reversed Model 
to  allow the anaesthetist to dynamically set upper and lower lim its for heart 
ra te , respiration rate, end-tidal carbon dioxide tension and systolic arterial 
pressure. The im plem entation of this interface has employed a PC which is 
taken into the operating theatre  and which autom atically  receives da ta  from the 
anaesthesia m onitors using the CLASS libraries (Section 2.7.2). The interface 
also includes display of the numerical values of each m easurem ent, their dom ain- 
specific qualitative value (i.e. ‘raised’, ‘lowered’ or ‘norm al’) and hypotheses about 
blood volume, elim ination of carbon dioxide and depth  of anaesthesia. Some 
examples of the on-line perform ance of the Reversed Model are also given.
7.7.1 T he O ff-line Perform ance o f th e  R eversed  M odel
As an aid to understanding the performance of the anaesthetist, a logging program 
was developed to autom atically gather d a ta  from the anaesthetic monitors and also 
accept keyboard input. The keyboard was used to  log drug changes, fluid changes 
and ventilation changes along with the m otivation for those. O ther comments 
could also be added. The logging process therefore produced fully annotated data 
files which illustrated the practical monitoring and control of the anaesthetic state.
These logged d a ta  files have been used to test the Reversed Model. D ata from 
the files has been passed into the Reversed Model and its hypotheses have been 
compared with the m otivations for changes given by the anaesthetist during the 
procedure. The main advantage of using off-line d a ta  in this application is that 
the same anaesthetic can be reviewed by the Reversed Model several times using 
different lim its for each variable.
This process is illustrated using data  collected from an operation performed on
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a 53 year-old female patient to create a vein loop for use in dialysis. The heart rate 
and blood pressure lim its have been chosen within physiologically realistic ranges 
for the patien t and are m ade less tolerant towards the end of the procedure so as 
to  m im ic the change in tolerance exhibited by the anaesthetist during a procedure.
Heart Rate and Heart Rate Limits (—)
&
C304
20 10040
Time (minutes)
Figure 7.5: H eart R ate M easurements and Limits for the Offline Test
Figure 7.5 shows the m easured heart ra te  along w ith the chosen upper and 
lower lim its of the  ‘norm al’ range. Figure 7.6 shows the m easured systolic arterial 
pressure along with the upper and lower lim its for the  ‘norm al’ range used by the 
Reversed Model. Table 7.2 summarises the behaviour of the Reversed Model using 
the chosen limits. It is clear th a t during the early stages of the procedure (up to 
13 m inutes) the Reversed Model diagnosed a fluid problem. At this stage in the 
operation, the anaesthetist adm inistered fluids. Between 55 and 59 m inutes, the 
Reversed Model considered the anaesthetic ‘light’ but the anaesthetist m ade no 
changes during the actual procedure. Between 70 and 80 minutes, the Reversed 
Model considered the anaesthetic to be ‘deep’. At 72 m inutes, the anaesthetist
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Tim e in 
m inutes
Heart
Rate
Systolic
Pressure
Fluid Depth A naesthetist’s
Action
0 to  12 high low low norm al unable to achieve 
good fluid inflow
13 high low low norm al rapid infusion given, 
vaporiser to 1%
14 to 44 normal low normal normal —
45 to 48 normal norm al normal normal —
49 to 54 high normal normal norm al —
55 to 59 high high normal light —
60 to 61 high normal normal normal —
62 to 65 normal norm al normal normal —
66 to 69 norm al low normal normal —
70 to 71 low low normal deep —
72 low low normal deep vaporiser to 0.5%
73 to 80 low low normal deep —
81 to 83 normal low normal norm al —
84 to 86 high low low normal —
87 to 88 high normal normal norm al —
89 to 92 
END
high high normal light ---
Note: Fluid =  fluid hypothesis; D epth =  depth hypothesis
Table 7.2: A Sum m ary of Reversed Model Hypotheses for the Off-line Test 
Example
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Systolic Pressure and Systolic Pressure Limits (—)
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Figure 7.6: Systolic Arterial Pressure M easurem ents and Limits for the Offline 
Test
reduced the anaesthetic concentration. At the end of the operation (80 -  92 
m inutes) the Reversed Model considered the anaesthetic to  be ‘ligh t’. The 
anaesthetist generally aims to ‘lighten’ anaesthesia a t the end of the operation 
due to  the decreased surgical stim ulus and to speed the recovery of protective 
reflexes.
This case provided a useful test for the Reversed Model because a differential 
diagnosis between the fluid and anaesthetic problems was required. The Reversed 
Model has proved capable of this diagnosis.
7.7.2 T he O n -lin e  Perform ance o f th e R eversed  M odel
The off-line tests carried out using the Reversed Model, as exemplified by the test 
described in the previous section, have indicated th a t the  Reversed Model can be 
used to generate realistic diagnoses of anaesthetic s ta te  imbalances. An on-line
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im plem entation  was therefore developed so as to de term ine  w hether the  technique 
can be useful during an actual procedure and opera te  in those conditions.
Structurally , no changes were m ade to the  Reversed Model b u t  an interface 
was developed to ease its use in theatre . T he  interface was designed to allow the 
following.
1. T he  display of current heart rate, S3>\stolic ar terial pressure, respiration rate  
and end - t id a l  carbon dioxide values.
2. T he  setting and alteration of upper and lower limits of the  ‘no rm al1 range 
for each variable.
3. T he  display of the qualita tive assessment of each variable i.e., ‘low1, ‘no rm al1 
or ‘h igh1.
4. T he  display of hypotheses generated by the Reversed Model.
Display 
Qualitative Value Display
Hypothesis Display
Screen
Limit Choosers
Systolic
Pressure
Values
-Value
Q Values
Carbon
Dioxide
lespiratioi
Rate
Hypotheses
F lu id  I l l
Anaesth .. H2 
C Q 2  H3
Figure 7.7: The Layout of the On-Line Reversed Model Interface
Chapter 7. Diagnosis o f Anaesthetic S ta te  Imbalances 257
The interface was designed to  use mouse input during a run. The layout of the 
interface is illustrated  in Figure 7.7. Using this arrangem ent, the  anaesthetist 
could set and change variable lim its at any tim e during a run  using only the 
mouse. Three separate tests using this arrangem ent are described in the  following 
sections. In each test, thiopentone was used at induction and isoflurane and 
nitrous oxide were used during maintenance.
Test 1
This procedure was carried out on a 58 year-old male patient to  repair an inguinal 
hernia. A statistically-based predictor for systolic arterial pressure uses the 
formulae
SAP =  108 T  i  • age
for a m ale and
SAP =  98 +  j  • age
for a female [61]. Using these formulae, the expected value for this patient was 
calculated as 137 mmHg. The initial lower and upper lim its for the ‘norm al’ 
range of systolic pressure for this patient were therefore set as 130 and 140 mmHg 
respectively. The initial heart ra te  lower and upper lim its were set a t 70 and 80 
beats per m inute respectively. Figure 7.8 shows the m easured heart ra te  of the 
patien t along with the heart ra te  lim its used to define the ‘norm al’ range for the 
Reversed Model. Figure 7.9 shows the m easured systolic arterial pressure and the 
lim its used to define the ‘norm al’ range for the Reversed Model.
Table 7.3 summarises the hypotheses generated by the Reversed Model during 
the procedure. In the first 5 m inutes, the Reversed Model considers the patient to 
be low on fluid. This coincides with the running of an infusion by the anaesthetist. 
Between 6 and 8 m inutes and again between 10 and 12 m inutes, the  Reversed 
Model considers the anaesthetic ‘light’. At 6 m inutes, the anaesthetist increased 
the vaporiser setting to 3% and gave an increm ent of morphine. The anaesthetist 
returned the vaporiser to 2% a t 15 m inutes at which tim e the model considered the
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Heart Rate and Heart Rate Limits (—)
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Figure 7.8: Heart Rate M easurements and Limits for Test 1 
Systolic Pressure and Systolic Pressure Limits (—)
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Figure 7.9: Systolic Arterial Pressure M easurements and Limits for Test 1
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anaesthetic to be ‘OK’. Between 18 and 20 minutes the Reversed Model indicated 
th a t the anaesthetic was ‘deep’. At 19 minutes, the anaesthetist reduced the 
vaporiser setting to 1.5%. Between 22 and 27 m inutes, the Reversed Model again 
reported th a t the anaesthetic was ‘deep’. At 25 minutes the anaesthetist reduced 
the  vaporiser setting to 1%. At 37 minutes, the variable lim its were adjusted so 
as to make all variables ‘norm al’ because the anaesthetist was satisfied with the 
p a tien t’s anaesthetic state  a t this time.
Tim e in 
minutes
Heart
Rate
Systolic
Pressure
Fluid Depth A naesthetist’s
Action
0 high low low normal Vaporiser at 2%
1 to 5 high high normal light Infusion running
6 high high normal light Vaporiser
to 3%, Morphine in­
crem ent given
7 to 8 high high normal light —
8 to 9 high normal low OK —
10 to 12 high high normal light —
13 to 14 normal high normal OK —
14 to 15 normal normal normal OK —
15 normal normal normal OK Vaporiser to 2%
15 to 16 normal low normal OK —
17 to 18 normal low normal OK —
18 to 19 low low normal deep —
19 low low normal deep Vaporiser to 1.5%
19 to 20 low low normal deep —
21 to 22 normal low normal normal —
22 to 25 low low normal deep —
25 low low normal deep Vaporiser to 1%
25 to 27 low low normal deep —
27 to 28 normal low normal OK —
28 to 29 normal normal normal OK —
39 to 36 normal high normal OK —
37 — — — — Reset Limits
38 to 45 
END
normal normal normal OK —
Note: Fluid =  fluid hypothesis; Depth =  depth hypothesis
Table 7.3: A Summary of Reversed Model Hypotheses for On-line Test 1
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During this operation, the anaesthetist was asked to assess the  validity of 
the hypotheses produced by the Reversed Model. W hen hypotheses seemed 
less realistic, variable lim its were adjusted. At other tim es, the hypotheses 
were considered appropriate. Because of this, Table 7.3 cannot be interpreted 
as an indication th a t the Reversed Model is capable of achieving perform ance 
comparable to tha t of the anaesthetist because the anaesthetist is aware of the 
M odel’s hypotheses and was directly involved in the m anipulation of the variable 
limits.
Test 2
This operation was carried out on a 63 year-old man to excise varicose veins. The 
target systolic arterial pressure predicted by the form ula given previously is 139 
mmHg, but the anaesthetist recommended systolic arterial pressure limits of 125 and 
135 mmHg< The heart rate lim its were set at 70 and 90 beats per m inute. During 
this procedure, a da ta  collection fault occurred at around 40 m inutes resulting in 
no new data  being presented to the Reversed Model. This fault persisted until 51 
minutes and the program was restarted a t this time. The heart ra te  measurem ents 
for the procedure are shown in Figure 7.10 along w ith the lim its of the ‘norm al’ 
range chosen during the procedure. Figure 7.11 shows the lim its and measured 
values of systolic arterial pressure during the procedure. The perform ance of the 
Reversed Model during this operation is summarised in Table 7.4.
In the first 6 minutes of the procedure, the Reversed Model concluded th a t the 
anaesthetic was ‘deep’. After 3 minutes, the anaesthetist reduced the vaporiser 
setting from 3% to 1.5%. From 6 minutes to 19 m inutes, the Reversed Model 
diagnosed no anaesthetic state  imbalances. The anaesthetist reduced the vaporiser 
setting at 19 minutes to  1%. Between 20 and 24 m inutes the Reversed Model 
considered the anaesthetic ‘deep’. The Reversed Model produced no imbalance 
hypotheses from 24 minutes to 28 minutes when it again found the anaesthetic
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Figure 7.10: Heart Rate M easurements and Limits for Test 2
Systolic Presure and Systolic Presure Limits (—)
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Figure 7.11: Systolic Arterial Pressure M easurements and Limits for Test 2
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‘deep’. This assessment was valid from 28 m inutes until 33 minutes. The 
anaesthetist reduced the anaesthetic dose at 31 m inutes to  0.5%. Between 33 
and 40 m inutes, no anaesthetic state  imbalances were found. At 40 minutes the 
da ta  collection fault occurred. The program was restarted  a t 51 minutes and the 
variable lim its were restored to their previous values. At 52 m inutes, the Reversed 
Model considered the anaesthetic ‘light’. This coincided w ith the increase of both 
inhaled and injected anaesthetic drug delivery by the anaesthetist. Between 54 
and 60 minutes, the Reversed Model concluded th a t the anaesthetic was ‘deep’. At 
56 m inutes, the anaesthetist reduced the vaporiser setting to  2%. The anaesthetist 
reduced the vaporiser setting to 1% at 83 minutes. At this tim e, the Reversed 
Model considered the anaesthetic s tate  appropriate. For short periods at 84 and 86 
minutes, the Reversed Model considered the anaesthetic ‘light’. The anaesthetist 
made no changes at this tim e. For the rem ainder of this procedure, the Reversed 
Model reported no imbalances in the anaesthetic state.
In this test, the diagnoses of anaesthetic state  imbalances presented by the 
Reversed Model were realistic throughout the procedure. Limitations of the 
technique are illustrated by the change made by the anaesthetist at 19 minutes. 
The anaesthetist has realised th a t the pa tien t’s systolic arterial pressure is falling. 
The reduction of drug dose reverses this trend. In its present im plem entation, the 
Reversed Model only uses value information and the diagnosis of anaesthetic state 
imbalances is based upon this. The Qualitising Filters employed in the Reversed 
Model im plem entation do, however, provide ra te  information. This could be used 
within the Reversed Model to improve diagnostic performance.
Another aspect of note is tha t, during this procedure, the pa tien t’s systolic 
arterial pressure was consistently lower than the expected range. Towards the 
end of the procedure it was noted tha t the patient was being treated with 
antidepressant drugs which potentiate the eJTects of isoflurane. The arterial 
pressure can therefore be expected to be lower than expected for this patient
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Tim e in H eart Systolic Fluid Depth A naesthetist’s
m inutes R ate Pressure Action
0 — — — Vaporiser at 3%
1 to 3 low low normal deep —
3 low low normal deep Vaporiser from 3% to
3 to 6 low low normal deep
1.5%
6 to 8 normal low normal OK —
8 to 19 normal low normal OK —
19 normal low normal OK Vaporiser from 1.5%
20 to 24 low low normal deep
to 1%
24 to 28 normal low normal OK —
28 to 31 low low normal deep —
31 low low normal deep Vaporiser from 1% to
32 to  33 low low normal deep
0.5%
33 to 40 normal low normal OK —
40 to 51 FAULT FAULT FAULT FAULT —
51 — — — — RESTART
52 high high normal light Vaporiser from 0.5% 
to 3%, M orphine in­
53 to 54 normal high normal normal
crement
54 to 56 low low normal deep —
56 low low normal deep Vaporiser from 3% to
56 to 60 low low normal deep
2%
60 to 83 normal low normal normal —
83 normal low normal normal Vaporiser from 2% to
84 high high normal light
1%
85 normal high normal light —
86 high high normal light —
87 to 102 normal low normal normal —
102 normal low normal normal Vaporiser O FF
102 to 104 normal low normal normal —
END
Note: Fluid =  fluid hypothesis; Depth =  depth hypothesis
Table 7.4: A Summary of Reversed Model Hypotheses for On-line Test 2
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during isoflurane anaesthesia. Because this effect was not noted at the s tart 
of the  procedure and it would not have been practically possible to predict its 
m agnitude, the arterial pressure lim its were unnecessarily high. Nonetheless, the 
Reversed Model has generated satisfactory, realistic hypotheses.
Test 3
This operation was carried out on a 36 year-old female to  repair a hernia. The 
target for systolic arterial pressure was calculated as 125 mmHg and the initial 
lim its were therefore set as 120 and 130 mmHg. The heart ra te  lim its were set at 
70 and, 85 beats per minute.
Figure 7.12 shows the measured heart rate  along with the heart rate lim its used 
during the procedure. Figure 7.13 shows the systolic arterial pressure measured 
values and the lim its used by the Reversed Model. The diagnosis of the Reversed 
Model and the actions of the anaesthetist are summarised in Table 7.5.
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Figure 7.12: Heart R ate M easurements and Limits for Test 3
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Figure 7.13: Systolic Arterial Pressure M easurements and Limits fori Test 3
For the first 6 minutes, the Reversed Model diagnosed a fluid imbalance and 
indicated ‘low’ fluids. At this tim e, a 500ml infusion was started . The vaporiser 
was altered from 2% to 3% at 6 minutes and back to 2% at 8 minutes. Between 8 
and 10 minutes the Reversed Model diagnosed no imbalances in the anaesthetic 
state  but between 10 and 27 minutes, it diagnosed ‘low’ fluids. At 15 minutes a 
further 500ml fluid infusion was started. This diagnosis persisted until about 35 
minutes and a further infusion was started at 32 m inutes. The Reversed Model 
diagnosed no anaesthetic state  imbalances between 35 m inutes and 49 minutes.
During this procedure, the diagnoses of the Reversed Model were dominated 
by ‘low’ fluid status. These diagnoses were, a t all stages, considered realistic 
by the anaesthetist. The provision of fluid reduced the heart ra te  to within the 
chosen ‘norm al’ limits but the systolic arterial pressure stayed ‘low’ for the bulk 
of the procedure. It seems probable therefore tha t the ‘norm al’ lim its for this 
p a tien t’s arterial pressure should have been lower than those chosen although the
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Tim e in 
minutes
Heart
R ate
Systolic
Pressure
Fluid Depth A naesthetist’s
Action
0 — — — Vaporiser at 2%
1 to 6 high low low OK Infusion started  
(500ml)
6 high low low OK Vaporiser to 3%
7 to 10 high normal low OK —
10 to 15 high low low OK —
15 high low low OK Second infusion 
started  (500ml)
16 to 27 high low low OK —
28 normal low normal OK —
29 normal low normal OK —
30 to 32 high low low OK —
32 high low low OK Third infusion 
started  (500ml)
32 to 35 high low low OK —
35 to 49 normal low normal normal —
49 to 51 high low low OK —
51
END
high normal low OK Infusion rate  
increased
Note: Fluid =  fluid hypothesis; Depth =  depth hypothesis
Table 7.5: A Summary of Reversed Model Hypotheses for O n-line Test 3
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anaesthetist was content with the chosen values.
7.7.3 D iscussion  o f R esu lts
The Reversed Model has been dem onstrated to  present accurate, timely diagnoses 
of anaesthetic state  imbalances. The mouse-controlled interface developed for the 
use of the Reversed Model in the operating theatre  has supported its use on-line.
The Reversed Model is intended to produce diagnoses of anaesthetic state 
imbalances suitable for use in a controller of the anaesthetic state. Comparison of 
the M odel’s diagnosis w ith the actions of the anaesthetist in the off-line test and 
each of the three on-line tests reveals th a t the the Model has provided diagnoses 
which would have elicited the same action as th a t taken by the anaesthetist in 
practically all cases. Based upon this observation, it seems th a t, with some further 
refinements, such as the inclusion of rate information, the  Reversed Model could 
provide the basis for a controller of the anaesthetic state.
A further point of note is th a t, in the same m anner as the estim ation scheme 
described in C hapter 5, the Reversed Model makes deductions with physiological 
and pharmacological concepts and values as interm ediate stages in the process. 
The Reversed Model therefore generates hypotheses which are not only familiar 
to the anaesthetist bu t which are relevant to the m anagem ent of the patien t’s 
anaesthetic state. This property ensures th a t if a controller based upon the 
Reversed Model is developed, the anaesthetist can be informed explicitly of 
the specific physiologic or pharmacologic anaesthetic s ta te  imbalances which 
are being m anipulated. If the anaesthetist does not consider the hypothesis 
valid, the controller can be halted. The incorporation of interm ediate stages 
with physiological or pharmacological meaning is very difficult in conventional 
controllers. Developments of the Reversed Model and uses for it are described in 
the next chapter.
C hapter 8
C onclusions and Further W ork
SUMMARY
This chapter summarises the developments made in the work o f 
the thesis and introduces the GAEL and M A SIE  software libraries.
Further work in the refinement and application o f the techniques 
described in the thesis is suggested with the intention o f focussing future 
efforts.
8.1 Conclusions
The work described in this thesis has used engineering skills to support modelling, 
model representation and provide techniques suitable for use in the control of 
anaesthesia. Fundam ental in each aspect of the work has been the preservation 
of the concepts which originate within anaesthesia, physiology or pharmacology. 
Specifically, this thesis has:
• D em onstrated the utility of bond graphs in the representation of physiologically-
i
based models of inhaled and injected agent pharmacokinetics.
• Param eterised a physiologically-based model of isoflurane pharmacokinetics 
and used the bond graph representation of this model to analyse the
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effects of inter-individual and intra-individual physiologic changes upon the 
pharmacokinetics.
• Introduced a scheme to allow the m atching of a physiologically-based model 
of inhaled agent pharmacokinetics to an individual using only body mass and 
body fat measurements.
•  D em onstrated the performance of an estim ation scheme developed to  esti­
m ate cardiac output and tissue anaesthetic tensions bo th  in sim ulation and 
on-line in theatre.
•  Described the development of a model of the homeostasis loops and 
the stress response of the body intended to represent compensation for 
physiological imbalances and dem onstrated the performance of a prototype 
im plem entation of the model.
•  Described the concepts of a Reversed Model of homeostasis and the stress 
response intended to infer physiological and pharmacological anaesthetic 
state  imbalances from the clinical signs and dem onstrated the performance 
of a prototype im plem entation using both  off-line d a ta  and on-line data  in 
theatre.
The implemented prototype of the estim ation scheme has, following some 
refinement, proved capable of producing realistic and stable estim ates of cardiac 
ou tpu t indicating th a t the model matching scheme is successful and th a t the 
estim ated tissue anaesthetic tensions are likely to be reliable. The specific use of 
the  brain tension estim ate from this scheme could be used w ithin a controller of 
depth  of anaesthesia.
As an aid to future developers wishing to use the estim ation scheme the 
Glasgow Anaesthesia. Estim ation Libraries (GAEL) have been developed. These 
libraries include explicit representation of the patient, including the model
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m atching scheme, explicit representation of an inhaled drug incorporating its 
physicochemical param eters and a representation of the estim ation scheme which 
uses the patient and drug representations to produce its internal model of 
pharm acokinetics for the patient and the drug.
The prototype im plem entation of the Reversed Model has shown th a t it 
can generate realistic diagnoses of anaesthetic state  imbalances using clinical 
sign inform ation gathered autom atically during a procedure. The on-line tests 
performed using the Reversed Model indicate th a t it could form the basis of a 
controller for the anaesthetic state.
To support further developments using the Reversed Model, the M odel- 
based Anaesthetic State Imbalance Evaluation libraries (MASIE) have been 
developed. The MASIE libraries include im plem entations of the qualitising filter, 
the Reversed Model and the m ouse-driven screen interface used in the prototype 
im plem entation described in the thesis.
Overall, this thesis has described the development of techniques which pre­
serve the anatom ical, physiological and pharmacological inform ation relevant to 
them . Because of this, an anaesthetist is able to understand and verify the tech­
niques and their interm ediate stages e.g., the estim ation scheme includes a cardiac 
output estim ate as an interm ediate stage. The use of physiologically meaningful 
interm ediate stages ensures th a t poor performance is im m ediately obvious due to 
unrealistic interm ediate values e.g., cardiac output estim ates outwith physiolog­
ical ranges. The performance of the techniques has indicated tha t the explicit 
representation of anatom ical, physiological and pharmacological information con­
stitutes a valid and fruitful approach in the modelling and control of anaesthesia.
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This section describes straightforward extensions of the techniques developed in 
the thesis to  provide controllers for anaesthesia. Minor changes to  the estim ation 
scheme are described and then three schemes are presented. These correspond to 
use of the estim ation scheme, the use of the Reversed Model and the combination 
of the estim ation scheme and the Reversed Model within controllers.
8.2.1 R efinem ent o f th e E stim ation  Schem e
The perform ance of the estim ation scheme described in C hapter 5 was seen to be 
ham pered by the characteristics of the m easurem ents of end-tidal anaesthetic 
concentrations (Section 5.4.2). These characteristics led to  the system atic 
underestim ate of cardiac output at the s tart of an anaesthetic and its overestimate 
a t the end. The error in cardiac output estim ate produced further effects upon 
the tissue tension estim ates. The exact source of the error in the end-tidal 
m easurem ent has not become apparent. The development of a m easuring system 
capable of accurately measuring inspired and end-tidal concentrations has been 
achieved by Morris et al. [159]. This system was dem onstrated to produce end- 
tidal m easurem ents comparable to those predicted theoretically. The modification 
of such a system to measure isoflurane concentrations would therefore avoid the 
errors described above.
Another area of improvement lies in the estim ation of alveolar ventilation. 
In the present im plem entation, an estim ate of the p a tien t’s alveolar ventilation 
is entered using a menu panel on the interface to the estim ation scheme. If 
inform ation such as respiration ra te  and tidal volume were available from a 
respiration m onitor via a communication interface, the estim ation of alveolar 
ventilation could be autom atically produced and updated. This would make the 
estim ation scheme much simpler to use.
Chapter 8. Conclusions and Future Work 272
One potential area of development concerns the generation of the cardiac 
output estim ate. In the current im plem entation, this stage relies upon the 
accurate param eterisation of the patient model and m easurem ent of inspired 
and end-tidal concentrations. The recent development of transtracheal and 
transoesophageal [160] doppler estim ates of cardiac outpu t would reduce the 
dependence upon these m easurements. The transtracheal approach described by 
Abrams et al. [161] illustrates the incorporation of the ultrasound transducer 
within the endotracheal tube. This arrangem ent would be easy to apply during 
anaesthesia.
8.2.2 A  Controller for D epth  o f A naesthesia
Aside of the errors at the s tart and end of a procedure, which have been explained 
in term s of the current hardware setup, the estim ation scheme has dem onstrated 
satisfactory performance in the estim ation of cardiac outpu t and tissue tensions. 
The estim ation scheme can therefore form the basis of a controller for brain 
tension. This is essentially the same arrangem ent as th a t described by Chilcoat, 
Lunn and Mapleson [79] and is represented in Figure 8.1.
Patient Mass,
Body Fat and 
Alveolar 
Ventilation Cardiac Output Estimate
Estimated
Brain Tension
Target Patient
Brain Tension End-TidalInspired
Controller
Estimation
Scheme
Concentration Concentration
Figure 8.1: Control of Brain Tension using the Estim ation Scheme
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Using this scheme, the anaesthetist has access to the brain tension and 
cardiac output estim ates produced by the estim ator. The cardiac ou tpu t estim ate 
returned by the estim ation scheme gives the anaesthetist an indication of the 
quality of the estim ator performance and therefore of the likely overall controller 
performance. If the cardiac output estim ate is physiologically realistic, the 
estim ation scheme performance is likely to be reliable and the controller effective. 
This scheme could be easily implemented using the components within the GAEL 
libraries.
8.2.3 A  C ontroller for th e  A n aesth etic  S tate
The performance of the Reversed Model described in C hapter 7 has dem onstrated 
th a t the approach can successfully differentiate between physiological and phar­
macological anaesthetic state  imbalances. Using the Reversed Model, the anaes­
thetist chooses the upper and lower lim its of the ‘norm al’ range for each clinical 
sign value. The Reversed Model then forms diagnoses when values move outwith 
their chosen ‘norm al’ ranges. The use of the Reversed Model in a controller re­
quires no changes in its operation and minimal extension. To form a controller, 
the diagnoses of anaesthetic state  imbalances produced by the Reversed Model 
are used to in itiate  a control action. As examples, a ‘light’ anaesthetic indicates 
th a t the anaesthetic dose should be increased, a ‘low’ fluid status indicates tha t 
fluid should be infused. This scheme is illustrated in Figure 8.2.
Because the Reversed Model uses qualitative values generated by qualitising 
filters, a conversion from the qualitative expression of an imbalance to the 
quantitative change to be exerted is required. The most simple means of 
performing this conversion is to mimic the actions of the anaesthetist: When 
the anaesthetist makes a change during anaesthesia, the change is normally an 
increment or decrement of a setting e.g., a small change of vaporiser setting, the 
injection of an analgesic bolus or the delivery of a quantity of fluid. The controller
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Variable Limits
Clinical Signs
Reversed Model
Drug Controller
Fluid Controller
Patient
Figure 8.2: Control of the Anaesthetic S tate  using the Reversed Model
for the anaesthetic state  could then be configured to deliver these increments or 
decrements in response to a diagnosis. Simple lim its could ensure safe operation 
e.g., by allowing no more than two vaporiser setting increm ents in 10 minutes. In 
Figure 8.2, each controller represents the generation of quantitative changes from 
the qualitative input given by the Reversed Model. This form of controller could 
be produced very easily with the Reversed Model components provided within 
MASIE.
8.2.4 T he C om bination of the E stim ation  Schem e and 
R eversed M odel
The control of depth of anaesthesia is a task within the control of the anaesthetic 
state. The estim ation scheme and the controller of brain tension based upon it can 
therefore be employed by the anaesthetic state  controller based upon the Reversed 
Model. In this case, the diagnosis of ‘light’ or ‘deep’ anaesthesia by the Reversed 
Model will in itia te  a request for an increm ent or decrement of brain tension 
respectively. The increm ent will depend upon the potency of the agent used 
e.g., 0.5% may be appropriate for isoflurane. As a further advantage, because the
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brain tension estim ate is available to the Reversed Model, further changes in brain 
tension could be delayed until the previous change has exerted its effect. The brain 
tension controller may also call upon more simple, low-level controllers to  effect 
the changes in inspired concentration which it requires. It may also be envisaged 
th a t comparable control schemes may be developed to  handle fluid and ventilatory 
changes. The combination of the estim ation scheme and the Reversed Model gives 
rise to  the overall architecture for control of the anaesthetic state  which has the 
form shown in Figure 8.3. This architecture depends mainly upon the estim ation 
scheme and Reversed Model and can therefore be easily implem ented using the 
GAEL and MASIE libraries.
Fluid
Controller
Reversed
ModeL/
Brain Tension Controller
Ventilation
Controller
Low-Level Controller
Clinical Signs
Drug Delivery Equipment
Patient
Figure 8.3: An Architecture combining the Estim ation Scheme and Reversed 
Model
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In summary, controllers for brain tension and the anaesthetic state  can be read­
ily derived from the techniques described in this thesis. The GAEL and MASIE 
software libraries reduce the im plem entation overhead of such developments sig­
nificantly. In each of the suggested schemes, the physiological interm ediate stages 
present within the schemes are available for appraisal by the anaesthetist. This en­
hances the anaesthetist’s understanding of the approaches and appraisal of their 
performance. Sufficient support has been provided conceptually, theoretically 
and practically within this thesis to allow the development of anaesthesia con­
trollers based upon physiological and pharmacological models by both engineers 
and anaesthetists.
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This report describes the  design of the CLASS libraries and documents the 
programming interface to the equipm ent supported by CLASS version 1.0. The 
report consists of a description of the CLASS design concepts, docum entation of 
the m ethods of CLASS objects, and listings of the C + +  code used to  generate 
the libraries.
A .2 The M otivation for CLASS
The CLASS libraries were developed in order to simplify the use of peripheral 
instrum ents and drug-delivery equipm ent in computer-controlled experiments. 
Examples of existing applications include data  logging systems, muscle relaxant 
adm inistration systems, the com puter control of blood pressure and the control 
of anaesthesia.
Prior to the development of CLASS, each application requiring use of an 
instrum ent or drug-delivery device also required to code communication with the 
device in question. This stage was very time-consuming and detracted  from the 
m ain tasks being pursued.
CLASS aims to produce a set of link-libraries so th a t in order to use an 
instrum ent or device, an application developer simply links application code with 
the CLASS libraries in order to provide safe and reliable communication with the 
devices.
A .3 CLASS Software C haracteristics
The CLASS libraries have been w ritten in Zortech C + +  on an IBM PC AT 
compatible machine. They employ object-oriented design techniques to define 
interfaces to each item  of equipm ent. Each type of equipm ent has associated with
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it a standard set of methods which are available to an application developer as 
callable routines. These define the software interface to  the hardware devices. In 
the future, development of new CLASS objects to add other item s of equipment 
to the library requires only that routines specific to the equipm ent are developed, 
the interface will stay the same.
A .4 CLASS Hardware Support
The CLASS library currently contains support for the following hardware devices.
Device Type Product Description
Monitor
Infusion pump 
Servo-vaporiser
Datascope 3100 
Datex Ultima 
Braun Perfusor Secura 
CPBD SV100
Anaesthesia m onitor 
Anaesthesia gas analyser
Servo-controlled vaporiser
Table A .l: Currently supported hardware in CLASS
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A .5 CLASS O bjects and Services O verview
CLASS defines several classes of objects which are applicable to application de­
velopment. Communication port handlers deal w ith low-level hardware communi­
cations and buffering, virtual devices are software interfaces to a real device. The 
objects are designed to be used together and an interface structure  has been de­
veloped.The general structure of a CLASS device interface is shown in figure A .l.
real
device
application
virtual 
comm port
virtual
device
real comm 
port
Figure A .l: CLASS device interface
Real devices are; existing monitors, infusion pumps or a servo-vaporiser. The 
real communication port can be either serial or parallel communication hardware 
in the computer being used. The virtual communication port provides a uniform 
interface to the virtual device and hides the im plem entation details of the real 
communication port. The virtual device provides a uniform interface to the 
application, allowing use of all of the features of each real device w ithout requiring 
extensive knowledge of the communication param eters or protocols required to 
communicate with it. Because the virtual device uses a virtual communication
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port, changes to the detail of the real communication port do not affect the virtual 
device or, indeed, the application. Assuming th a t a virtual communication port 
exists for a target machine, then an application and its virtual devices can then 
be moved onto another machine, relinked w ith the correct virtual communication 
port and then used. No other changes to source code will be needed. This offers 
considerable savings in tim e and resources.
The interfaces to  the CLASS library communication port, m onitor, infusion 
pum p and servo-vaporiser objects which correspond to  the v irtual components 
of figure A .l are defined by the services of those objects. The services deemed 
appropriate for the objects are described in the following sections.
A .5.1 V irtual C om m unication Port
A virtual communication port provides a software interface to a real communi­
cation port on a real machine. The interface to the virtual communication port 
is provided by its services. The services provided by each virtual communication 
port are independent of the hardware details of the port and of the machine. The 
model of a virtual communication port from the application developer’s point of 
view is shown in figure A.2.
The program m er accesses both the transm it buffer and receive buffer of the 
v irtual port. The virtual port manages the real port so th a t any characters arriving 
at the port are transferred to the recieve buffer preventing their loss. Similarly, 
when an opportunity for transmission exists, characters are read from the transm it 
buffer and sent to the device. The virtual comm, port is thus event driven so 
as to avoid lengthy delays in waiting for an entire message to be transm itted  or 
received.
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Figure A.2: Model of virtual communication port.
Services
In conjunction with the developers’ model above ( figure A.2 ) the following 
services are provided by the virtual communication port;
• write character
This function should add a character to the transm it buffer to be transm itted  
when an opportunity  arises.
• write
This function adds a string to the transm it buffer for subsequent transm is­
sion.
• write buffer test
This function tests whether the transm it buffer is empty. This allows 
determ ination of whether a message has been sent.
• read character
This function removes a character from the receive buffer and returns it.
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• read
This function reads a string from the receive buffer.
•  read buffer test
This function checks whether the receive buffer is empty. This allows 
determ ination of whether a message has arrived.
A .5.2 Specific C om m unication Ports
The virtual communication port describes the interface and conceptual model of 
each communication port device. In reality, there m ust be an interface for each 
particular port type to take account of hardware differences between machines and 
also operating system differences. The CLASS library deals w ith this situation by 
making an abstract class called virtual comm port which defines the characteristics 
of all comm ports, and then specific comm port handlers become subclasses of 
the virtual comm port class and thus inherit its interface. This relationship is 
illustrated in figure A.3.
A
ibm pc 
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ibmpc
parallel
write char 
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wrt buff test 
read char 
read
rd buff test
comm port
Figure A.3: Inheritance of interface from abstract class
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A .5.3 M onitors
A virtual m onitor creates an interface to a real monitor. Each m onitor object uses 
a v irtual comm port interface to provide communication with the real monitor. 
The virtual m onitor ensures th a t the user or developer of an application does not 
need to  be aware of the specific communication settings or protocols employed by 
the device. To the developer, the virtual m onitor appears as shown in figure A.4.
^ _ _____virtual monitor
real monitor
application
data value
vector
incoming 
data buffer comm port
Figure A.4: Developers’ model of a v irtual m onitor
Thus, d a ta  received from the real m onitor via the communication port is placed 
in the da ta  buffer of the virtual monitor. D ata values from the buffer are then 
unpacked and stored in a d a ta  value vector.
Services
The services of the virtual m onitor object are as follows;
• initialise
Many monitors require an initialisation message to  be sent to the monitor
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from the com puter before data  communication can proceed. This service 
sends this message if appropriate.
• request da ta
The com puter sends a prom pt to the m onitor requesting th a t a new set of 
d a ta  values be returned.
• buffer input
This function reads input characters from the buffer belonging to  the  virtual 
communication port and stores them  in the buffer belonging to the  virtual 
monitor.
•  process input
This function removes all complete strings from the virtual m onitor’s buffer, 
unpacks the values from the last string and places the values in a data  
structure inside the m onitor object.
• re turn  data
This function returns the da ta  structure if valid d a ta  is available.
• check errors
This function returns an error code describing any errors in the m onitor or 
the communication with the monitor.
•  return  m onitor type
This function returns the type of the monitor.
A .5.4 Specific M onitors
Specific monitors are handled in CLASS using inheritance. An abstract class 
called m onitor is defined to have the interface described above, and all monitor 
handlers inherit characteristics from it. The use of a m onitor handler is thus
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independent of the particular m onitor being used. This arrangem ent is shown in 
figure A.5
z \
datascope
2200
monitor
Figure A.5: Inheritance for m onitor handlers
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A .5.5 Infusion Pum ps
T he v irtual infusion pum p describes the interface provided by CLASS for any real 
infusion pum p. The interface hides all im plem entation details and device specific 
inform ation from the application developer. Each infusion pum p handler uses a 
v irtual communication port to manage the appropriate real communication port.
Services
The following services are provided by the virtual infusion pump;
• change ra te
This function queues a message which requests th a t the infusion ra te  be 
changed. The message is queued in the transm it buffer of the appropriate 
communication port handler. This service can be used to  change infusions 
from their current value, or off, to the new value. If a non-attainable rate is 
requested, the function gives an appropriate return.
•  stop infusion
This function queues a  message requesting th a t the infusion be stopped.
• restart
This service constitutes a software reset of the infusion pum p and is useful 
after an em pty syringe is replaced, a line blockage cleared or other alarm 
condition is removed.
• check errors
This function returns an error code describing errors in the infusion pump 
of communication with the pump.
• return  pum p type
This returns the type of the pump.
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• re tu rn  drug
This returns the drug employed in the syringe.
•  re turn  concentration
This returns the concentration of drug in the syringe.
• re turn  volume infused
This returns the volume of drug solution infused thus far.
• re tu rn  am ount infused
This returns the am ount of drug adm inistered thus far.
• re tu rn  rate
Thus returns the current infusion rate.
A .5.6 Specific Infusion Pum ps
CLASS again employs inheritance to force the specific classes of infusion pump 
to adopt the interface of the virtual infusion pum p. The virtual infusion pump 
is treated  as a base class from which the specific classes inherit. This inheritance 
structure is shown in figure A.6.
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Figure A.6: Infusion pum p inheritance strategy 
A .5.7 T he Servo-vaporiser
Although only one servo-vaporiser exists at the m om ent, it is still beneficial to 
define a virtual servo-vaporiser which exhibits ‘idealised’ interface characteristics. 
Thus the virtual servo-vaporiser defines behaviour which is independent of any 
hardware or communication details. A servo-vaporiser handler also uses a virtual 
communication port to manage the communication between the virtual servo- 
vaporiser and the real one. The definition of an ‘idealised’ interface for the servo- 
vaporiser has some essential characteristics in the context of this instrum ent. At 
the current tim e, the servo-vaporiser is still a prototype and does not employ 
any standard communication protocols. In the near future, the device may be 
improved to  use RS-232 or some other ‘standard’ protocol. In such an event, 
applications already w ritten for a previous version will not have to be changed. 
The code will simply be re-linked with the updated  library object for the new 
servo-vaporiser. Any application is therefore protected from changes in hardware 
by the use of the ‘idealised’ interface.
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S e rv ic e s
The servo-vaporiser interface is defined by the following services;
• change concentration
This function changes the vaporiser concentration from the current setting, 
or off, to the new setting.
• stop vaporiser
This function moves the vaporiser to the off position.
• estim ate concentration
This returns an estim ate of the current concentration of the vaporiser.
• check errors
This function returns an error code describing errors in the servo-vaporiser 
or in communication with the vaporiser.
A .5.8 Specific Servo—Vaporisers
Although only one type of servo-vaporiser actually exists, inheritance has been 
used to produce the CLASS servo-vaporiser objects. This allows easy addition 
of any other products which enter the m arket, and also changes to the existing 
product. The somewhat trivial inheritance structure is shown in figure A .7.
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Figure A .7: Servo-vaporiser inheritance structure
A .6 CLASS O bject M ethod  D ocum entation
A .6.1 T he Serial Port H andler
The CLASS library includes an object designed to handle in terrupt driven serial 
communications via an RS-232 standard communications port. The use of a port 
for in terrupt driven i/o  requires the setting of several hardware registers associated 
with the 8250 UART device and also the registers of the 8259A program m able 
in terrupt controller in a PC system.
Having enabled the generation of interrupts, an in terrupt handler must be 
provided to  take the appropriate action on receipt of an in terrupt.
These procedures are intricate and tim e consuming. The serial port class of 
the CLASS library autom atically perform s these steps when an instance of the 
serial port class is created by an application.
Each serial port object has two ring buffers associated with it, one for 
transm itting  and one for receiving. The managagem ent of these buffers is 
independent of the user.
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S e ria l p o r t  in te r r u p ts
A serial port device can generate four different interrupts.
1. Receive da ta  available
2. Transm it holding register empty
3. Receive line status
4. Modem Status
In terrupts (iii) and (iv) can be used to detect breaks in the line or failure of the 
modem and are not used in the CLASS serial port handler. In terrupt (i) signals 
th a t a new character has arrived at the port. The CLASS serial port interrupt 
handler for this in terrupt reads the character from the buffer and stores it in 
the receive buffer associated with the port. Interrupt (ii) signals th a t there is 
no incoming data  and th a t the transm it buffer is empty. The CLASS interrupt 
handler reads the p o rt’s transm it buffer on receipt of this in terrupt and if a 
character is ready for transmission, it will be w ritten to the transm it register.
M e th o d  D o c u m e n ta t io n
The interface to the serial port class is achieved using the m ethods of the class. 
These are as follows:
• s_port::s_port( int portnum , baud.var baud_rate, data_bits_var data_bits, 
stop_bits_var stop.bits, parity_var parity, struct port_control_regs * per ) 
This m ethod is the constructor for the serial port class and is called when 
an instance of the class is created. The arguments are as follows:
-  portnum
The num ber of the port to be opened and used. Possible values are 1, 
2 or 3 for C 0M 1, COM2 and COM3 respectively.
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— baud .ra te
The desired communication baud rate. The argum ent is of type 
baud_var.
— da ta .b its
The num ber of da ta .b its  per character. This argum ent is of type 
data_bits_var.
— stop .bits
The num ber of stop bits per character. This argum ent is of type 
data_bits_var.
— parity
None, even, or odd parity. This argum ent is of type parity_var.
— per
This is a pointer to a structure containing the required set up for 
the 8250 in terrupt enable register and modem control register. This 
accom m odates the different requirem ents of each peripheral. The 
structure  port_control_regs is defined in “s_port.hpp” .
The constructor opens a serial port, attaches it to receive and transm it 
buffers, enables the required interrupts, sets up port lines and establishes 
an in terrupt handler. From this stage onwards, in terrupt driven i/o  occurs 
in the port.
Note th a t the enum erated type baud.var, data_bits_var etc. are defined so 
as to only allow acceptable values for communication param eters to be set 
up. These types are defined in the file “s_port.hpp” .
• s_port::~s_port( void )
This is the destructor for the serial port class, this m ethod takes no 
argum ents, restores the serial port devices to their state  prior to use by this
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application, and removes the installed in terrupt handler. The destructor is 
called autom atically when the serial port object is destroyed.
• int s_port::sendchar( char *c )
This m ethod accepts, as its argument, a pointer to  a character. The 
character pointed at by c is loaded into the transm it queue to be sent from 
the port on receipt of a transm it register em pty in terrupt.
This m ethod always returns 1.
• char s_port::receivechar(char *c)
This m ethod takes a pointer to a character as its argum ent. If a character 
can be retrieved from the receive buffer, a 1 is returned from the m ethod and 
the character is w ritten into the location pointed at by c. If no character is 
available, 0 is returned.
• int s_port::receive( char * buffer )
This m ethod fills the space pointed at by buffer w ith the contents of the 
receive buffer. A trailing null is added to the buffer after the last character. 
If a string was received, the m ethod returns 1. If no string was available, 
the m ethod returns 0.
•  int s_port::send( char * buffer )
Thi m ethod repeatedly calls sendchar until all of the characters in the array 
pointed at by buffer have been sent, or the queue is filled. The m ethod 
returns 1.
•  int s_port::is_transmit_buffer_empty( void )
This method checks the status of the transm it buffer associated with the 
port. The m ethod returns 1 for an em pty buffer and 0 for a non-empty 
buffer.
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• in t s_port::is_receive_buffer_empty( void )
This m ethod checks the status of the receive buffer associated w ith the port. 
The m ethod returns 1 for an em pty buffer and 0 for a  non-em pty buffer.
A .6.2 T he Infusion P um p O bject
Routine use of an infusion pum p under com puter control is hindered by the time 
taken, and skills required, to develop code to com m unicate w ith the device. The 
CLASS libraries contain a generic infusion pum p object. This object has a clearly 
defined set of m ethods and all hardware aspects of the real pum p are invisible to 
the application developer. An infusion pum p object employs a serial port object 
to perform in terrup t driven serial communication with the actual pump.
Infusion P um p O bject’s M ethods
The m ethods of the infusion pum p object are as follows:
• infusion_pump::infusion_pump( int portnum  )
This m ethod initialises general da ta  item s applicable to  all infusion pumps. 
The constructor creates a circular buffer for use by the infusion_pump object 
in buffering incoming messages. The integer argum ent portnum  is used only 
to  set up an internal record of the port num ber for the infusion pum p object.
•  braun_infusion_pump::braun_infusion_pump( int portnum  )
This is the constructor for the braun infusion pum p object and accepts the 
num ber of the serial port to which the pum p will be attached as an argument. 
The constructor creates a serial port object to provide access to the infusion 
pum p. Version 1.0 of CLASS allows portnum  to have values 1, 2 or 3 for 
COM1, COM2 or COM3 respectively on a PC or compatible.
This constructor also calls the infusion pum p class constructor.
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• infusion_pump::~infusion_pump( void )
This is the destructor and deletes the circular buffer created by the 
constructor.
•  braun Jnfusion_pump::~braun_infusion_pump( int portnum  )
This is the destructor for the braun infusion pum p class and deletes the 
serial port handler created by the constructor. This desctructor also calls 
the infusion pum p class destructor.
• int braun Jnfusion_pump::changejspeed( int ra te  )
The braun infusion pum p can be configured to  run infusions a t between
0.1 m l/ll and 99.9 m l/li for a 50ml syringe. The pum p can however also 
accom m odate a 25ml syringe, or two 50ml syringes giving an effective 100ml 
syringe. The possible infusion rates are therefore between 0.05m l/h and 1998 
m l/h .
The change speed m ethod accepts one argum ent, rate, which is the desired 
infusion ra te  multiplied by 10 so tha t the argum ent for a desired ra te  of 
45.6m l/h is 456. The m ethod calculates the actual request to the actual 
infusion pum p based upon the size of syringe used in the pum p. The size of 
the syringe is set using the m ethod set.syringe-charsQ.
The m ethod returns -1 for an error in changing speed or a bad speed request 
and 0 for no errors.
• int braun_infusion_pump::stop_pump( void )
This m ethod stops the infusion. For each type of pum p, the stop message 
will have a different form. The stop_pump m ethod is therefore virtual to 
allow derived classes to redefine the m ethod. The stop.pum p m ethod returns 
1 for a successful issue of the command and 0 for a failure.
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• int braunJnfusion_pump::interpret_messages( void )
This m ethod is used to  process the messages received from the infusion 
pum p. Messages found are the switch-on message, ra te  change acknowl­
edgements, pum p life signals, em pty/pressure alarm  messages and device 
defective alarms. If error messages are received the error word stored within 
the infusion pum p handler is updated.
This m ethod always returns 1.
• int braun Jnfusion_pump::check_errors( void )
This m ethod returns an error word which codes information relating to the 
status of both the infusion pum p and communication w ith the pum p. The 
errors coded in the error word are set up in the header file “inf_pump.hpp” . 
Note th a t failure to buffer and process input from the pum p can cause 
detection of a communication error because no message will have been 
correctly decoded for some tim e. The user of the infusion pum p handler 
is therefore responsible for regular buffering and processing of incoming 
information.
• void braun_infusion_pump::update_amounts( void )
This m ethod updates the infusion pum p handlers internal stored totals for 
the volume of drug infused and the am ount of drug infused (in milligrammes 
or microgrammes). There are no returns from the m ethod.
• float braun Jnfusion.pum p::volum e-total( void )
This m ethod returns the volume of solution infused at the current tim e and 
is the integral of the infusion ra te -tim e curve at this tim e. This method 
merely returns the value of the volumeJnfused slot.
• float inf_pump::amount_total( void )
This m ethod is identical to volume_total except th a t the am ount of drug
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infused is returned. The am ount infused is the volume infused multiplied 
by the concentration of drug in the syringe.
• int infusion_pump::setjsyringe_chars( int size, int cone, char* nam e )
This m ethod takes three argum ents, size the size of the syringe e.g. 75 for 
75ml, cone the concentration in the syringe e.g. 2 for 2m g/m l if the amounts 
are desired in mg, and name the nam e of the drug in the syringe. These 
param eters are set up and then the m ethod returns 1.
• int infusion_pump::give_pump_type( char * p )
This m ethod accepts a pointer to an array of characters as input argument. 
It copies the string holding the name of the infusion pum p type to the array 
pointed a t by p. The m ethod returns 1.
• int infusion_pump::give_drug_name( char *p )
This m ethod copies the nam e of the drug currently held in the syringe to 
the character array pointed at by p. The routine always returns 1.
• int infusion_pump::give_drug_conc( int * n )
This m ethod writes the concentration in the syringe to the integer pointed 
at by n. The concentration is assumed to be an integer in either m g/m l or 
fig /m l. The m ethod always returns 1.
•  int infusion_pump::give_syringe_size( int * n )
This m ethod writes the size of the syringe in ml into the integer pointed at 
by n. The m ethod always returns 1.
•  int infusion_pump::give_infusion_rate( float * f)
This m ethod writes the infusion rate into the float pointed a t by f. The 
m ethod always returns 1.
A ppendix A . The C LASS Libraries Report 299
A .6.3 T h e M onitor O bject
The M onitor object provides a software interface to  a real anaesthetic monitor. 
Real monitors are often capable of communicating with a com puter using simple 
serial communications. Difficulty arises in this situation in establishing secure and 
reliable communication with the device and in decoding the strings received from 
the monitor. The CLASS m onitor objects remove this burden from the application 
developer. Three m ain objects exist here; a v irtual m onitor object used to  define 
the interface to  all monitors and the m ethods common to all, a datascope 3100 
object which defines the specific characteristics of the handler for a Datascope 
3100 object and a datex object which defines the specific characteristics of the 
handler for a  Datex U ltim a gas analysis instrum ent.
M onitor O b ject’s M ethods
The m ethods of the m onitor object and the derived classes for datascope 3100 
and datex m onitors are as follows.
• int monitor::initialise(void)
This m ethod is a prototype for every m onitor and allows for initialisation of 
a m onitor. The m ethod returns 1.
• int monitor: :buffer_input( void )
This m ethod transfers incoming d a ta  from the communication port handler 
associated with each m onitor object to a circular buffer belonging to the 
m onitor object. This prevents loss of da ta  from the instrum ent and must 
be called periodically. This m ethod always returns 1.
•  int monitor::process_input( char *p )
This m ethod causes the last da ta  string from the m onitor to be removed 
from the m onitor object’s circular buffer and the d a ta  to be removed 
from the  string and loaded into a data  vector as defined in the header
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file “m onitor.hpp” . This m ethod calls getJasLstring() and unpackstringQ  
which are private routines specifically described for each m onitor type. This 
m ethod returns 1 if da ta  has been converted from a  string and 0 if no 
conversion has taken place. The single input argum ent p points to an array 
of characters which is used to store interm ediate strings involved in decoding 
m onitor messages.
•  int monitor::get_last_string( char *p )
This m ethod is used to remove the last complete instrum ent string from 
the m onitor circular buffer and store it in the array pointed a t by p.  All 
other d a ta  which preceeded the removed string are discarded. This m ethod 
is redefined by other m onitor objects. The m ethod returns 1.
•  int m onitor::unpackjstring( char *p )
This m ethod is used to remove the da ta  and status inform ation from the 
instrum ent string pointed at by p and load it into a  datavector for later 
use. This m ethod is also redefined for each type of m onitor object because 
each m onitor returns different string form ats w ith different d a ta  elements in 
them.
• int m onitor::return_data( DATAVECTOR * d )
This m ethod is applied to all m onitor object subclasses. The datavector 
pointed at by d is loaded with the most recently decoded d a ta  values. This 
m ethod returns 1. Note th a t return_data() is usually called directly after 
unpack_string().
•  int monitor::check_errors( char * p )
The monitors encountered so far give no indication of device error. The 
only errors which can be m onitored are therefore communication errors 
between the com puter and the instrum ent. This m ethod checks whether a 
message has been received from the instrum ent within a specified maximum
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tim e or whether a message to be transm itted  to the  instrum ent has been 
transm itted . These are im plem ented as simple tim e-outs based on the 
transm it and receive buffer statuses. The routine writes an error string to 
the character array pointed at by p and returns 1 for an error, bu t returns 
0 if there is no error.
• int monitor::give_monitor_type( char * p )
This m ethod writes the name of the m onitor into the character array pointed 
at by p and returns 1.
• datascope_3100::datascope_3100( int port_number )
This m ethod is the constructor for the datascope_3100 m onitor object class. 
The constructor creates a serial port handler on the port specified by 
porLnumber for the m onitor object to  use and creates a circular buffer for 
storage of received strings. The constructor also initialises the param eters 
of the m onitor and initialises the contents of the m onitor’s internally stored 
datavector to known values. The argum ent porLnumber can have value 1, 2 
or 3 corresponding to COM1, COM2 or COM3.
• datascope_3100::~datascope_3100( int port_number )
This is the destructor for the datascope_3100 class and deletes the circular 
buffer and serial port handler created by the constructor.
• int datascope_3100::initialise( void )
This m ethod redefines the initialise m ethod for the datascope_3100 class. 
The m ethod sends the correct initialisation string to the datascope. The 
methods always returns 1.
• int datascope_3100::request_data( void )
This m ethod is th a t of the v irtual m onitor object redefined for the datas- 
cope_3100. It returns 0 if the last request for da ta  was unsuccessful and 0 if
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the the last request was successful and a new request was started.
•  int datascope_3100::getJastjstring( char *p )
This m ethod is redefined to  allow the last datascope form atted string to be 
removed from the m onitor’s circular buffer. The m ethod accommodates the 
string format of the datascope instrum ent w ithin it. If a complete string is 
found in the bufFer, the m ethod returns 1 otherwise it returns 0.
• int datascope_3100::unpack_string( char *p )
This m ethod redefines the unpackjstring m ethod of the virtual monitor 
object so as to  unpack d a ta  from the datascope form at string. As with the 
virtual m ethod, the d a ta  is w ritten into the m onitor ob ject’s own datavector. 
This m ethod returns 1.
• datex_ultima::datex_ultima( int port .num ber)
This is the constructor for the datex .u ltim a class of m onitor object. The 
constructor performs initialisation specific to the Datex U ltim a such as 
establishing baud rate, and other communication param eters and then 
creates a serial port handler for the m onitor object on the communication 
port specified by porLnumber. A  circular bufFer for the storage of received 
data  is also created. The argum ent porLnumber can have value 1, 2 or 3 
corresponding to COM1, COM2 or COM3.
• datex_ultim a::~datex_ultim a( int port_number)
This is the destructor for the datex .u ltim a class of m onitor object. The 
destructor deletes the serial port handler and the circular bufFer which the 
constructor creates.
• int datex_ultima::initialise( void )
This method redefines the virtual m onitor ob ject’s initialise m ethod to suit 
the datex_ultima handler. This m ethods returns 1.
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• in t datex_ultima::request_data( void )
This m ethod is redefined from the virtual m onitor’s m ethod so as to  perform 
actions associated with establishing da ta  transfer between the Datex monitor 
and the application. If the last request for da ta  was successful a new request 
is issued and 1 is returned otherwise 0 is returned.
• int datex_ultim a::getJast_string( char *p )
This m ethod redefines th a t of the virtual m onitor object so as to detect 
da tex .u ltim a form at strings. If no complete string is found, the method 
returns 0 and if a complete string is available, it is copied into the character 
array pointed at by p and a 1 is returned.
• int datex.ultim a::unpack_string( char *p )
This m ethod redefines th a t of the v irtual m onitor object so as to unpack 
the  da ta  from the datex .u ltim a string pointed a t by p. The da ta  retrieved is 
stored in the internally held datavector of the m onitor object. This method 
returns 1.
A .6.4 T he Parallel In p u t/O u tp u t Board H andler
The servovaporiser used in the CLASS libraries requires to  be interfaced using 
a PIO board. In our prototype development, the Amplicon PC 36 has proved 
adequate for the this job. The PC 36 is an 8255 based adapter and allows splitting 
of its 24 in p u t/o u tp u t lines into three groups of either inputs or outputs. For use 
with the servo-vaporiser, port A was configued as an input to read the results of 
the servo-vaporiser a /d  conversion, port B was configured as an output to send 
the  num ber of steps to the servo-vaporiser controller, port C upper was configured 
as outputs to allow setting of control lines for the vaporiser controller, and port C 
lower was configured as inputs to  allow reading of status lines from the controller. 
The PIO handler makes these tasks simpler w ithout adding too much specificity.
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A .6.5 PIO  Board H andler M ethods
• pio::pio(void)
This is the constructor for the pio handler and establishes the appropriate 
addresses of the board and the ports for use by the handler. These address 
are established as constants in the header file “pio.hpp” .
• pio::~pio(void)
This is the destructor for the pio handler and performs no operations.
• void pio: :initialise(void)
This m ethod sets up the mode of the pio board for use as described above
i.e. port A input etc.
• void pio::read_port_A( int *val )
This m ethod reads the input to port A and writes the integer value read 
into the integer pointed a t by val.
• void pio::write_port_B( int val )
This m ethod writes the integer val to the port B of the pio board.
• void pio::set_c4( void )
This m ethod sets line 4 of port C to 1.
• void pio::set_c5( void )
This m ethod sets line 5 of port C to 1.
• void pio::set_c6( void )
This m ethod sets line 6 of port C to 1.
• void pio::set_c7( void )
This m ethod sets line 7 of port C to 1.
• void pio::reset_c4( void )
This m ethod sets line 4 of port C to 0.
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• void pio::reset_c5( void )
This m ethod sets line 5 of port C to  0.
• void pio::reset_c6( void )
This m ethod sets line 6 of port C to 0.
• void pio::reset_c7( void )
This m ethod sets line7 of port C to  0.
• int pio::read_c0( void )
This m ethod returns the value on line 0 of port C.
• int pio::read_cl( void )
This m ethod returns the value on line 1 of port C.
• int pio::read_c2( void )
This m ethod returns the value on line 2 of port C.
• int pio::read_c3( void )
This m ethod returns the value oil line 3 of port C.
VA .6.6 T he Servo—Vaporiser
T he servo-vaporiser object is used to provide a software interface to  the real 
servo-vaporiser. The real servo-vaporiser requires a pio board, another custom 
designed interface box and a controller box for the stepping m otor which turns the 
vaporiser. The servo-vaporiser object makes the hardware complexity associated 
w ith this device invisible to  the application developer.
A .6.7 Servo—Vaporiser M ethods
The m ethods of the servo-vaporiser handler are as follows:
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• servovap::servovap( void )
This is the constructor for the servovap class. The constructor creates 
a pio board handler with which to  handler communication w ith the real 
servo-vaporiser, and initialises it in the mode appropriate for its use. The 
constructor also performs initialisation of internally held data  items.
• servovap ::~servovap( void )
The destructor for the servovap class deletes the pio board handler created 
by the constructor.
• int servovap::change_conc( float new.conc )
This m ethod accepts the floating point argum ent new.conc. Servo-vaporiser 
concentration settings are between 0 and 5 % and so a negative argument 
causes the actual vaporiser to be set to 0% and any argum ent over 5 causes 
the vaporiser to be set to  5%. Between 0% and 5% the vaporiser position is 
calculated by linear interpolation between calibrated points on the vaporiser 
scale. The calibration points are stored in arrays as detailed in the file 
“vapcalib.hpp” .
This m ethod takes account of backlash in the servo-vaporiser gearbox and 
requests the correct num ber of pulses from the vaporiser interface box.
This m ethod returns 1.
• int servovap::vapour_off( void )
This m ethod sends appropriate signals to the vaporiser interface box to move 
the vaporiser to the O FF position. This m ethod always returns 1.
• in t servovap::check_position( void )
This m ethod estim ates the position of the vaporiser from linear interpolation 
of an a /d  converted potentiom eter reading. This extim ate is compared with 
the expected value of concentration stored at the last move. If the error
A ppendix  A . The C LASS Libraries Report
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• int servovap::check_errors( void )
The check_errors() m ethod employs check.position to find problems with 
the vaporiser moves. If problems are found, the error word is updated in 
internal storage. The error word is returned by this m ethod.
• int servovap::restart( void )
This m ethod allows the servovap object to be reset to a known state. 
Instructions are sent to  the vaporiser interface box to  set the vaporiser to 
the O FF position, the error word is reset to 0 for no errors and subsequent 
use can continue.
This m ethod always returns 0.
• float servovap::estimate_concentration( void )
This m ethod uses linear interpolation to estim ate the concentration a t which 
the vaporiser is positioned based upon the converted potentiom eter reading 
returned from the vaporiser. The estim ate of concentration is returned by 
this m ethod.
• int servovap::make_watchdog_pulse( void )
The servo-vaporiser requires th a t a watchdog pulse be produced periodically 
during operation of the servo-vaporiser. This m ethod generates this pulse 
and sends it to the vaporiser interface box for passing to the servo-vaporiser 
controller.
This routine always returns 1.
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A .7 D eveloping A pplications using the CLASS 
Libraries
The CLASS libraries are provided as linkable object code. To an application 
developer, using CLASS library objects to  perform communication and control of 
instrum ents and devices consists of two main steps;
1. Inserting the  c la s s .h p p  header file in the application source code.
This step allows the application to declare instances of communication port 
handlers, instrum ent handlers and drug-delivery device handlers. The file 
class.hpp actually includes all header files necessary in order to  use the 
CLASS objects.
2. Linking the compiled application code w ith the CLASS library object code. 
This stage is extrem ely simple with the Zortech compiler and consists of 
specifying “ \c la s s \c la s s .l ib ” in the command line argum ent for the Zortech 
Linker.
Both of these steps assume th a t the CLASS library code is installed in a 
directory called “class” which is positioned im m ediately below the root directory. 
The CLASS libraries have been compiled to  produce 80286 code using the Large 
memory model within Zortech C + + . The application should also be compiled to 
produce 80286 code using the Large memory model.
If necessary, a version of the CLASS libraries using 80386 code and the DOSX 
memory model will be compiled. At this stage, applications have not required 
this level of sophistication.
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